ࡱ> uwnopqrstq`  bjbjqPqP >::%```8`dre$f"fffghd%i4$hEggEEffRِِِEffِEِِ"|vffe Up`Ō4>|G|$vvpX)Yi sِyYiYiYiudYiYiYiEEEED" Df ;JED" f JE  IN THE INTERNATIONAL CRIMINAL COURT AT THE HAGUE CRIMINAL COMPLAINT OF GENOCIDE AGAINST ABDURRAZACK ZACKIE ACHMAT To: Chief Prosecutor Luis Moreno-Ocampo International Criminal Court Maanweg 174 2516 AB Den Haag/The Hague The Netherlands TABLE OF CONTENTS THE ACCUSED p 3 THE CHARGE p 3 JURISDICTIONAL FACTS p 3 PARTICULARS OF THE CHARGE p 4 CRIMINAL MENTAL ELEMENT p 23 FACTS VITIATING ANY DEFENCE OF MISTAKE OF FACT p 24 FACTS EXCLUDING ANY DEFENCES BASED ON MENTAL DISEASE OR DEFECT p 38 FACTS IN AGGRAVATION OF THE CRIME p 41 APPROPRIATE CRIMINAL SANCTION p 49 . APPENDICES Service receipt p51 Media Complicity in Genocide: the case of the Mail&Guardian: An Open Letter to Trevor Ncube, CEO: Mail&Guardian p53 THE ACCUSED The accused subject of this criminal complaint is Abdurrazack Achmat (Achmat), better known to his admirers by his pet name Zackie, a 44 year-old male, who conducts his business at 10 Main Road, Muizenberg, Cape Town, South Africa. THE CHARGE Achmat is guilty of genocide, the gravest crime among the most serious crimes of concern to the international community as a whole specified in Article 5.1(a) of the Rome Statute of the International Criminal Court, and defined in Article 6: For the purpose of this Statute, genocide means any of the following acts committed with intent to destroy, in whole or in part, a national, ethnical, racial or religious group, as such: (a) Killing members of the group; (b) Causing serious bodily or mental harm to members of the group; [] JURISDICTIONAL FACTS South Africa (the state party) is a party to the Rome Statute; Achmat is a South African national; Achmat has committed his crime on the territory of the state party; there is no common law or statutory provision for the prosecution of genocide by the state party, with the result that Achmats crime cannot be prosecuted by the national prosecuting authority in South Africa; and although Achmat commenced with the commission of his crime before 1 July 2002, the date on which the Rome Statute came into force, he has continued perpetrating it actively since this date, thus rendering him liable to prosecution before the International Criminal Court. PARTICULARS OF THE CHARGE Achmat directs Treatment Action Campaign (TAC), a professional lobby group that he founded in South Africa to shill on behalf of the multinational pharmaceutical industry by promoting the patented chemicals that it markets as so-called antiretroviral drugs (ARVs) for the treatment of AIDS. Although the TAC has criticized the pharmaceutical industry on the pricing of ARVs (thereby burnishing their commercial reputation brightly), and makes a show of being financially independent from it (but collaborates with organizations openly funded by it), to all practical effect the TAC functions in South Africa as its marketing agent. Notwithstanding the nominal posts within the TAC formally held by dozens of salaried employees in provincial offices and sub-branches all around South Africa, it is notorious that Achmat completely owns the organization, directs its agenda and operations, and deploys it as his personal executive for implementing them. In view of this, Rapport newspaper aptly described Achmat on 10 February 2002 as the mastermind (meesterbrein) behind the TAC, and he is accordingly personally culpable for its criminal activities. Since its inception in 1998 the TAC has engaged in an intense coercive, subversive political campaign against South Africas democratic government to force it to enter into trade agreements with the pharmaceutical industry for the purchase of ARVs, and to provide these drugs in public hospitals and clinics for prescription and administration to the poor, overwhelmingly African. In this project the TAC has been entirely successful. Interviewed by the Mail&Guardian online on 30 November 2006, Achmat claimed indisputably that Our biggest success is that we got government to accept a treatment plan. [Our] second-biggest success: the mother to child prevention court case that we won. Achmats reference to his biggest success was to achieving the South African governments capitulation on 17 April 2002 to his demand for the provision of ARVs in the public health system. Achmats second-biggest success was obtaining, by means of false and incomplete information presented to court, a judicial interdict on 14 December 2001, confirmed on appeal on 5 July 2002, to force the South African government to provide nevirapine, another highly toxic so-called ARV drug, in public hospitals to HIV-positive women in labour and to their new-born babies, nearly all African. Achmats claim that he got government to accept his demand that it spend billions of rands on purchasing ARVs from the pharmaceutical industry, and to supply them in the public health system, implies that he forced this change of policy by the South African government against its will and better judgement. Indeed so: the policy change in question was the result of enormous local and foreign political pressure spearheaded and orchestrated by him. On Achmats own version the provision of ARVs in South Africas public health system is his personal achievement, for which consequences for their victims, to be detailed below, he bears full criminal responsibility. The drug that Achmat commenced publicly campaigning for in 1998, and which he continues to champion, is AZT (zidovudine), then owned under patent by GlaxoWellcome (the patent expired in 2005), then and still marketed by the company (now GlaxoSmithKline) under the brand name Retrovir. GlaxoWellcome was engaged at that time in a heavy marketing drive to sell AZT to South Africas newly elected first democratic government for provision to HIV-positive pregnant women. The companys goal was to generate a new, substitute medical indication for AZT, namely to prevent so-called mother to child transmission of HIV, after the drug had been reported to be an outright failure as a treatment for AIDS in the biggest, best conducted clinical trial of the drug, the European Concorde trial. South Africa was targeted as a suitably vulnerable, strategic portal market for a commercial assault on the Developing World. GlaxoWellcomes chief marketing tactic was to make repeated well-publicized price discount offers, increasing over time, to amplify the moral and political pressure on the South African government to accept its solicitation to trade. Gulled by this marketing ploy and by the sales propaganda being disseminated about the drug in the commercial media, Achmat joined hands with GlaxoWellcome in demanding that the government spend billions of rands on buying AZT to give HIV-positive pregnant women, and, as a second priority, to HIV-positive people generally. About a year after Achmat started publicly agitating for the provision of AZT to pregnant women in South Africa, practically all African, President Thabo Mbeki went on public record drawing attention to the fact that the drug that Achmat was pressing on the government is in fact dangerously toxic. Addressing Parliament on 28 October 1999 he stated: Concerned to respond appropriately to [AIDS in South Africa], many in our country have called on the government to make the drug AZT available in our public health system. There exists a large volume of scientific literature alleging that, among other things, the toxicity of this drug is such that it is in fact a danger to health. These are matters of great concern to the government as it would be irresponsible for us not to heed the dire warnings which medical researchers have been making. On the same day that President Mbeki alerted the people of South Africa to the serious hazard to health posed by AZT, the South African Press Association (SAPA) wired a report that Health Minister Dr Mantombazane Tshabalala-Msimang had confirmed to reporters that there was indeed a body of scientific research and information which indicated that AZT was a dangerous drug, and had not been designed for the treatment of HIV/AIDS. Because it was unable to target only the human immunodeficiency virus when it went to work in the body, it further weakened the immune system. There was also a danger that ... mothers taking the drug might produce children with disabilities. Tshabalala-Msimang said her ministry would not like to look back ten or fifteen years down the line and find it had exposed the vast majority of historically disadvantaged people in South Africa to a dangerous drug. Two weeks later, on 16 November, Dr Tshabalala-Msimang again confirmed, this time by way of a formal statement in Parliament, that AZT is a drug that was developed for use in chemotherapy for cancer patients. It was, however, never used in cancer patients because it was regarded as too toxic to use. Tests have clearly shown that rats that were exposed to AZT [in the womb during gestation], developed vaginal cancer. This is a very serious finding. Other toxicological data exists with respect to AZT, including damage to nerves, muscles and bone marrow. All of this data needs to be assessed very thoroughly. As the Minister of Health I have a responsibility for ensuring that South Africans get appropriate and affordable healthcare. This responsibility extends to ensuring that no healthcare intervention has a long-term negative effect on people. Apropos the dire warnings that medical researchers have been making, as President Mbeki put it, in a large body of scientific research and information which indicated that AZT was a dangerous drug, as Dr Tshabalala-Msimang did, by the time these announcements were made in October/November 1999, a substantial corpus of medical and scientific literature had already been published to this effect, supporting a plea made as early as 1991 by Hayakawa et al. in Biochemical and Biophysical Research Communications 176:87-93 that for AIDS patients, it is urgently necessary to develop a remedy substituting this toxic substance, AZT. In 1994 Lenderking et al. reported in the New England Journal of Medicine 330(11):738-43 that even at the lowest 500mg daily dose then and still recommended by GlaxoSmithKline in its package insert for the drug, AZT is so extremely toxic that the severe side effects it was found to cause asymptomatic patients were life threatening in some cases. The following year, in Nature Medicine 5:417-22, Lewis and Dalakas explained why: It is self-evident that ANAs [antiretroviral nucleoside analogues, such as AZT], like all drugs, have side-effects. However, the prevalent and at times serious ANA mitochondrial toxic side-effects are particularly broad ranging with respect to their tissue target and mechanisms of toxicity:Haematological; Myopathy; Cardiotoxicity; Hepatic toxicity; Peripheral neuropathy. Mitochondria are the energy powerhouses inside all cells of the body. By destroying them or by inhibiting their functioning, AZT and similar ARVs kill or seriously damage blood, muscle, heart, liver and nerve cells. That nucleoside analogue drugs such as AZT are extremely poisonous was noted again the following year in Adverse Drug Reaction Bulletin, No.178: The antiretroviral drugs currently licensed in the United Kingdom are zidovudine (azidothymidine) [AZT], zalcitabine (ddC) and didanosine (ddI). All are very toxic. Suppression of bone marrow elements can occur with any of the three, as can peripheral neuropathy. In fact, AZT is so very toxic that in accordance with international industrial conventions for the labelling of poisons the chemical supply company Sigma-Aldrich Chemie Gmbh labels miniscule 25mg quantities of the drug for laboratory research use with a skull and crossbones icon set against a broad orange stripe to signify potentially fatal toxic chemical hazard to the handler upon accidental exposure, above the warning in six languages, Toxic Giftig Toxique Toxico Tossico Vergiftig, and spelt out in the following terms: TOXIC Toxic to inhalation, in contact with skin and if swallowed. Target organ(s): Blood Bone marrow. In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). Wear suitable protective clothing. Taking cognisance of published research findings in this regard, Sigma-Aldrichs latest version of the label also carries a warning that accidental contact or ingestion of AZT may cause cancer. A few months before President Mbeki and Dr Tshabalala-Msimangs warnings in Parliament about the dangerously harmful toxicity of AZT, Papadopulos-Eleopulos et al. reiterated Hayakawas et al. entreaty that AZT be urgently abandoned as an AIDS drug, due to what the former identified as its widespread, serious toxicity via a number of biochemical mechanisms. The conclusion of their extensive review, A Critical Analysis of the Pharmacology of AZT and its Use in AIDS, published in May 1999 in a special supplement to the prestigious academic medical journal Current Medical Research and Opinion 15, squarely supported President Mbeki and Dr Tshabalala-Msimangs statements about AZT a few months later: AZT underwent clinical trials and was introduced as a specific anti-HIV drug many years before there were any data proving that the cells of patients are able to triphosphorylate the parent compound to a level considered sufficient for its putative pharmacological action. Notwithstanding, from the evidence published since 1991 it has become apparent that no such phosphorylation takes place and thus AZT cannot possess an anti-HIV effect. However, the scientific literature does elucidate a number of biochemical mechanisms which predicate the likelihood of widespread, serious toxicity from use of this drug. Based on all these data it is difficult if not impossible to explain why AZT was introduced and still remains the most widely recommended and used anti-HIV drug. [The continued administration of AZT] either alone or in combination to HIV sero-positive or AIDS patients warrants urgent revision. And just a couple of weeks before President Mbekis statement on the subject in Parliament, Brinkman et al. emphasized in Lancet 354(9184):1112-5 that drugs in the AZT class are much more toxic than we considered previously. The layer of fat-storing cells directly beneath the skin, which wastes away is loaded with mitochondria other common side effects of [AZT and similar drugs are] nerve and muscle damage, pancreatitis and decreased production of blood cells all resemble conditions caused by inherited mitochondrial diseases. Despite President Mbekis warning in Parliament that there exists a large volume of scientific literature alleging that, among other things, the toxicity of this drug [AZT] is such that it is in fact a danger to health, a warning repeated by Dr Tshabalala-Msimang in Parliament and on many occasions in other fora since, Achmat has wilfully disregarded this information and has persisted in campaigning on behalf of GlaxoSmithKline and other pharmaceutical corporations on the basis that ARVs such as AZT are life-saving medicines. However, not even the drug companies make this claim in their drug package inserts and product information releases because theres no evidence for it. Nonetheless Achmat falsely pretends in his TAC drug propaganda that these drugs save lives and that they make the sick well, when stacks of published reports demonstrate the contrary, i.e. that they induce serious disease in healthy people. (AIDS doctors call this phenomenon immune reconstitution syndrome: as the lab test results improve, the patients physical health deteriorates as might be expected from drinking poison.) Given the toxicity of AZT, and its particular toxicity to blood cells, including immune cells, leading AIDS expert Professor Jay Levy of the University of California at San Francisco opined in Newsday on 12 June 1990: I think AZT can only hasten the demise of the individual. Its an immune disease and AZT only further harms an already decimated immune system. No less an AIDS authority than the inventor of the HIV theory of AIDS, Dr Robert Gallo, truthfully swore (for a change) in Application No: 245259 on 17 May 1994 for a US patent on a novel treatment approach: the United Kingdom-Irish-French Concorde Trial conclusions reported that the nucleoside analog zidovudine (AZT), a mainstay in the treatment of patients infected with HIV-1, failed to improve the survival or disease progression in asymptomatic patients. Indeed so, but not only did the researchers in this major study of 1849 patients find AZT useless as a therapeutic drug, Phillips et al. reported in the New England Journal of Medicine 336:958-959 in 1997 that Extended follow-up of patients in one trial [of AZT], the Concorde study, has shown a significantly increased risk of death among the patients treated early. This is to say, its been known for a decade that the toxicity of AZT is cumulative, with the result that the longer the treatment with it, the higher the death rate. On the ABC television show Nightline on 6 June 2001, Martin Delaney, director of the pro-antiretroviral drug lobby group Project Inform in San Francisco, foresaw a catastrophic epidemic of ARV-induced deaths in Africa, based on what hed seen in the US: Well, I think the dilemma here is weve got to learn from what has happened here in the last 18 years and try not to repeat it, as we move into Africa I cant overstate, I think, how severe the problems are with the current therapies. People are dying from the effects of the therapies themselves in some cases. People are suffering from severe life-threatening complications of drugs. And a lot of them get to the point where they simply cant use them anymore. So as we talk about bringing therapy to Africa, even if we can solve the problem and cost and infrastructure and delivery, I have this pang in my heart of are we doing the right thing, you know, with these drugs? Or are we unleashing another kind of epidemic over there of drug side effects as well? Delaneys anecdotal but remarkably frank and unbiased observations from a professional ARV drug promoter were formally confirmed in 2003 by Reisler et al. in the Journal of Acquired Immune Deficiency Syndromes 34(4):379-86 under the title, Grade 4 events are as important as AIDS events in the era of HAART. The study involved a review of the case files of 2 947 patients treated with ARVs between 1996 and 2001 to estimate incidence and predictors of serious or life-threatening events that are not AIDS defining, and death among patients treated with highly active antiretroviral therapy (HAART) in the setting of 5 large multicenter randomized treatment trials conducted in the United States. In plain terms, the researchers purpose was to determine the toxicity of ARVs having regard to the incidence of dangerous side effects, sometimes fatal. They began by noting: All 4 classes of antiretrovirals (ARVs) and all 19 FDA approved ARVs have been directly or indirectly associated with life-threatening events and death. And they found that more than twice as many people had suffered a drug related (grade 4) life-threatening event as against an AIDS event. The most common causes of grade 4 events from drug toxicities were liver related. Cardiovascular events, the researchers found, are associated with the greatest risk of death. They concluded: Our finding is that the rate of grade 4 events is greater than the rate of AIDS events, and that the risk of death associated with these grade 4 events was very high for many events. Treated with ARVs then, ones greatest risk of dying is not from an AIDS-defining disease but from ARV-induced cardiovascular events. In sum, Reisler et al. found the cure to be deadlier than the disease, and that ARV-induced heart failure is the leading cause of death among people treated with these drugs. Consistent with these data, the Antiretroviral Therapy (ART) Cohort Collaborative has recently reported, in August 2006, in Lancet 368:451-458: The results of this collaborative study, which involved over 20 000 patients with HIV-1 from Europe and North America, show that the virological response after starting HAART [Highly Active Antiretroviral Therapy (i.e. ARV drugs)] has improved steadily since 1996. However, there was no corresponding decrease in the rates of AIDS, or death, up to 1 year of follow-up. Conversely, there was some evidence for an increase in the rate of AIDS in the most recent period. [We noted a] discrepancy between the clear improvement we recorded for virological response and the apparently worsening rates of clinical progression. A covering editorial in Lancet commenting on these somewhat paradoxical trends summed up: The major findings are that, despite improved initial HIV virological control there were no significant improvements in early immunological response as measured by CD4-lymphocyte count, no reduction in all-cause mortality, and a significant increase in combined AIDS/AIDS-related death risk in more recent years. This is to say that irrespective of the early transient effects observed on a surrogate laboratory marker for drug efficacy (viral load), a massive review study found ARV drugs to have no actual clinical benefits for the health of people given them. On the contrary, HIV-positive and AIDS-diagnosed people treated with ARVs were found to die of AIDS defining or AIDS-related diseases at a higher rate than those who arent. It is relevant to mention that the laboratory test marker for improved initial HIV virological control i.e. so-called viral load, considered for a decade to be an index of ARV drug efficacy, was itself discredited as a prognostic indicator the following month. In a review of 2 800 HIV-positive cases, Rodriquez et al. reported in the worlds biggest medical periodical, Journal of the American Medical Association 296(12):1498-506, that in more than 90% of cases, viral load failed to predict or explain immune status. As the title to an article about it in the leading scientific journal Science 313(5795):1868 put it, contrary to popular medical belief, Study says HIV blood levels don't predict immune decline. As anticipated by the above-cited findings in the US and Europe, the following figures bear out the fact that the ARV drugs which Achmat has personally engineered into the South African public health system, and which he continues to promote reckless of the President and Health Ministers warnings that they are dangerously toxic, are killing thousands of South Africans, mostly black. According to information provided by Department of Health Media Liaison Officer Maupi Monyemangene on 6 October 2005, The Western Cape report showed that: Out of a total of 4251 patients enrolled in 3 months, a total of 207 (4.8%) patients died. Out of the total of 2715 patients enrolled in 6 months, a total of 196 (7.2%) patients died. Out of the 914 patients enrolled in 12 months, a total of 114 patients (12.2%) patients died. Plotted on a graph as X and Y values, these data reveal a perfect linear relationship between the death rate of people taking ARVs and the duration of their treatment; and they predict that within seven years everyone on ARVs will be dead. Citing UN Integrated Regional Information Networks (IRIN) as its source, Reuters Foundation published an article on 14 Nov 2006, SOUTH AFRICA: Govt AIDS programme on course but people still dying: South Africas Ministry of Health has confirmed that close to 6,000 HIV-positive people had died while receiving antiretroviral (ARV) drugs since the government rollout began in 2004 just below 3 percent of the number of HIV-positive people accessing treatment at government ARV sites during the same period. Health department spokesman Sibani Mngadi said The number of people being treated with antiretroviral therapy through our Comprehensive Plan on HIV and AIDS has increased [by] 60,000 in the past year to 235,378 by the end of September 2006. Having regard to the extended follow-up findings in the Concorde study, and the rising rate at which ARVs are killing people in the Western Cape the longer the ARV treatment, the higher the death rate there is every reason to believe that reports of the nearly 3% national death rate on the drugs that Achmat has got into the public health system in South Africa will soon equal Malawis: In an article on 1 November 2006, UN concerned about Malawis rising deaths of AIDS patients on ARVs, the Chinese Peoples Daily Online reported (but no Western corporate media did) that United Nations Special Envoy for HIV/AIDS in Africa Stephen Lewis expressed concern on Tuesday over Malawis rising number of deaths among people receiving HIV/AIDS treatment in the country. Lewis was speaking at the end of his three-day visit to the impoverished southern African country when he was briefed by Malawian government officials that the country was grappling with an 11 percent death rate of people who were receiving free antiretroviral (ARV) drugs in public hospitals. Malawi has managed to increase the number of people receiving free ARVs from about 4,000 two years ago to 70,000 at present. It is trite and beyond any serious disputation that the overwhelming majority of South Africans being treated with ARV drugs and consequently being poisoned and killed by them are African, and Achmat is well aware of this. That Achmat wants Africans on ARVs is evidenced by his establishment of dozens of TAC mission stations in the African townships, and none in the white suburbs. The manner in which African victims are selected for poisoning with ARVs in South Africa is by means of testing with non-specific HIV antibody tests designed for blood-screening and not making diagnoses followed by CD4 cell count testing. According to the Americans who run the AIDS division of the South African Human Sciences Research Council (HSRC), and who, disregarding their manufacturers instructions, misapply antibody tests to make epidemiological determinations of HIV Prevalence in South Africa, black South Africans are riddled with the sex virus: 40.7% of women in the Zulu Kingdom for instance, and 37.9% of African women aged between 25 and 29 years countrywide; whereas nationally, only 0.6% of whites of both sexes and all ages are supposedly infected (per HSRC HIV Prevalence report in December 2005). (This American junk science implies that young African women are about a hundred times more promiscuous than whites, and that, unlike whites, they cant control themselves, and copulate randomly like dogs.) Because HIV antibody tests are not specific, about seventy unrelated health conditions have been documented in the medical and scientific literature to cause them to react positively, including simple malnutrition, TB, malaria, past pregnancy even the common cold. And since as President Mbeki pointed out to the Leader of the Opposition, Tony Leon (in correspondence released to the media in October 2000), that even a child, from among the black communities, knows that our own burden of disease coincides with the racial divisions in our country, the African poor predictably show up HIV-positive at a very substantially higher rate than whites. Thus by encouraging South Africans to get tested, Achmat and his TAC are directly involved in the Western medical selektion of the poor African majority in South Africa for poisoning off with ARVs. Possibly accounting for his callous indifference to the human cost of his criminal conduct in marketing the pharmaceutical industrys useless and deadly toxic wares in South Africa, for consumption mainly by the African poor, Achmat attributes the high rate of HIV antibody seropositivity among them not to the manifold health stresses that cause these non-specific tests to react, but to their prodigious, indiscriminate venery. This racist opinion of Africans was openly expressed in the Guardian on 10 December 2002: The central problem, says Achmat, is the absence of political will. Why is the president like this? Achmats theory is this: The president doesnt want to believe that people in Africa have a lot of sex. To put a point on it, in Achmats view the undernourished African poor trapped in the peri-urban favelas and arid rural wastes have only themselves to blame when their health collapses. HIV-AIDS Research Professor Jerry Coovadia of the Nelson R Mandela Medical School, University of KwaZulu-Natal, also a fan of ARVs for Africans, expressed the same racist view in a speech at the University of the Witwatersrand on 24 June 2003: As we stagger under the massive weight of AIDS [it is the] unbridled sexuality ... of newly independent people ... especially the promiscuity of men [that has led to] AIDS ... ripping through millions of our people. According to this big time AIDS expert, the leading cause of the African massess susceptibility to TB and other diseases endemic among them is not malnutrition and other concomitants of poverty, its their orgiastic instincts let loose and running wild since the advent of their own democratic government. Another energetic ARV salesman, Supreme Court of Appeal Judge Edwin Cameron, earlier expressed a concurring racist judgment of Africans in the Daily Dispatch on 13 November 2001. They are rife with HIV, he suggested, on account of sexual practice among African men, their priapism being what he proposed as having chiefly contributed to its spread. No less distinguished an expert on AIDS in Africa than the director of UNAIDS Dr Peter Piot (from Belgium) backed these racists up on BBC News on 14 September 1999, referring to multi-party sexual behaviour deeply rooted in polygamous African societies but not sexually continent European and American societies, he implied, where multi-party sexual behaviour is extremely unusual, and where having a single sexual partner for life is the norm in those societies, being white, industrious and God-fearing. It is not known whether Dr Francois Venter, president of the Southern African HIV-AIDS Clinicians Society, also thinks Africans have far too much sex. Nor is it known whether his American colleague Dr John Moore, professor of microbiology and immunology at Cornell University Medical Center, shares this expert opinion of Africans too. But being top AIDS experts like Dr Piot they probably do. The second leg of the selection process for poisoning Africans with ARVs is CD4 cell counting, on the premise that such a count indicates a persons immune status, i.e. his health. But as early as April 1994, having employed CD4 cell counts as a surrogate marker for drug efficacy in the Concorde trial, the researchers reported the irrelevance of this laboratory measure and its lack of a correlation to clinical health in Lancet 343(8902):871-81, noting that the results of the study call into question the uncritical use of CD4 cell counts as a surrogate endpoint for assessment of benefit from long-term antiretroviral therapy. In their review Surrogate End Points in Clinical Trials: Are We Being Misled?, published in Annals of Internal Medicine 125;7:605-13 in 1996, Fleming and DeMets pointed out that CD4 cell counts are in reality as uninformative as a toss of a coin Effects on surrogate end points often do not predict the true clinical effects of interventions. Three trials, including the Concorde Trial showed an inverse relation between survival and improved CD4 cell counts. Which is to say, the better you got on AZT according to your CD4 cell count, the faster you died. And a paper, HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations, just published by WHO researchers Williams et al. in Journal of Infectious Diseases 194(10):1450-8, has yet again highlighted the unreliability of CD4 cell counting as a measure of health, by reporting considerable variability in CD4+ cell counts within and among human immunodeficiency virus (HIV)-positive and -negative African populations. Plenty of HIV-negative people have CD4 cell counts below 350, they found, a figure that would get them diagnosed as having AIDS had they been HIV-positive. And they reported that HIV-positive people with low CD4 cell counts treated with AIDS drugs died off at just the same rate as those with high counts. But in November 2006, the same month as the WHO researchers paper was published, Achmat continued calling on people to GET TESTED on the back page of his TAC magazine, Equal Treatment, that is to (a) submit to non-specific blood screening antibody tests so they can be misdiagnosed as infected with HIV, (b) have their CD4 cells counted so they can be misled about how healthy or sick they are and thereby terrified into going on ARVs, and (c) have their viral load recorded so they can be misinformed about how infected they are and how soon they can expect to get sick and die of AIDS. It would appear that the reason for Achmats enthusiasm in pressing people to GET TESTED with useless antibody-, CD4- and viral load tests despite the above-cited data is because hes not mentally equipped to understand them, having left school with a Standard Six. CRIMINAL MENTAL ELEMENT Article 30 of the Rome Statute provides that 1. Unless otherwise provided, a person shall be criminally responsible and liable for punishment for a crime within the jurisdiction of the Court only if the material elements are committed with intent and knowledge. 2. For the purposes of this article, a person has intent where: (a) In relation to conduct, that person means to engage in the conduct; (b) In relation to a consequence, that person means to cause that consequence or is aware that it will occur in the ordinary course of events. 3. For the purposes of this article, knowledge means awareness that a circumstance exists or a consequence will occur in the ordinary course of events. Know and knowingly shall be construed accordingly. Since October/November 1999 when President Mbeki and Dr Tshabalala-Msimang cautioned the people of South Africa against the dangerously harmful toxicity of AZT, Achmats genocidal conduct in pushing these drugs has been committed with deliberate criminal intent and knowledge in that, as a direct consequence of his actions, thousands of South Africans, mostly black, would likely be killed or seriously harmed in the ordinary course of events. FACTS VITIATING ANY DEFENCE OF MISTAKE OF FACT It is conceivable that when, like a Nazi at Nuremberg, Achmat is confronted with the enormity of his crime particularized in the International Criminal Courts bill of indictment, he may attempt to raise a defence of mistake of fact, as contemplated in Article 32.1: A mistake of fact shall be a ground for excluding criminal responsibility only if it negates the mental element required by the crime. This is to say, to escape punishment, Achmat may try apologizing from the criminal dock and contend that he really thought he was on a life-saving mission rather than a genocidal one. In this event it is likely that he will plead that he didnt make it beyond his first year of junior high school and consequently lacks even the most rudimentary high school tuition in biology and general science. Achmat may accordingly argue that that the reason he persisted in his criminal conduct, even after hearing President Mbeki and Dr Tshabalala-Msimangs warnings about the grave dangers of AZT in Parliament, was not because he didnt want to see his millions in foreign funding dry up and his new career as a world famous pharmaceutical industry pimp implode, but rather because he was too stupid and too ignorant to understand what President Mbeki and Dr Tshabalala-Msimang were saying. As convincing evidence of this, Achmat may cite a statement he made in the Saturday Star on 12 January 2002: It can only be Thabo Mbekis belief that antiretrovirals like AZT are toxic and destroy the immune system. There is no other explanation for the paranoia thats going on. Achmat was apparently referring to President Mbekis point in his letter to the said Tony Leon on 1 July 2000: In your letter to me of June 19, you make the extraordinary statement that AZT boosts the immune system. Not even the manufacturer of this drug makes this profoundly unscientific claim. The reality is the precise opposite of what you say, this being that AZT is immuno-suppressive. Contrary to the claims you make in promotion of AZT, all responsible medical authorities repeatedly issue serious warnings about the toxicity of antiretroviral drugs, which include AZT. However, none other than the US Food and Drug Administration provided support for President Mbekis statement a decade earlier in a press release concerning AZT on 5 March 1990: The drug [AZT] can inhibit the production of red blood cells and may reduce white blood cell counts [which include immune cells] to the point where the drug has to be discontinued to avoid infections. GlaxoSmithKline itself cautions in its Prescribing Information for AZT: Patients should be informed that the major toxicities of RETROVIR are neutropenia and/or anemia. Neutropenia is defined in the Oxford Concise Medical Dictionary as a decrease in the number of neutrophils in the blood. It results in an increased susceptibility to infections. [A] neutrophil [is] a variety of granulocyte (a type of white blood cell) capable of ingesting and killing bacteria and provides an important defence against infection. And in their standard text Nucleoside Analogs in Cancer Therapy (New York: Marcel Dekker Inc., 1997), Cheeson, Keating and Plunkett underscore this gravely harmful effect of AZT-class drug treatment on the very first page of their foreword, as well as in their main discussion. Due to their potent immunosuppressive properties profound immunosuppression often accompanies therapy with nucleoside analog drugs. they have a number of associated toxicities, some of which may be severe. Of particular concern is immunosuppression which is uniform with standard treatment programs. Each of the nucleoside analogs is associated with a profound lymphocytopenia [depletion of immune cells], with a reversal of the CD4/CD8, and opportunistic infections. Even Judge Cameron, who commends Achmat as a man of principle because he also pushes drugs, knows this, contradicting Achmat and confirming the lethal toxicity of ARVs in the Canadian Globe and Mail on 13 September 2003: Of course the drugs are toxic, said Mr. Cameron, almost trembling with exasperation. TAC recently lost three prominent activists whose bodies could not withstand the drugs. Following this clear-headed concession, the International Criminal Court may be somewhat perplexed by the senior jurists remark directly thereafter: But there is no question among credible scientists, he said, that ARVs are the only thing that keep most people with AIDS alive. This opinion may be found particularly puzzling in the light of Mr Camerons self-estimation in an interview in the Daily Dispatch on 13 November 2001: I have no doubt that I have natural intellectual gifts. But the mystery may resolve when the Court learns that this unusually gifted person said about a week earlier on the MNet television show Carte Blanche on 4 November 2001 that hes the sort of bloke who talks to his drugs and asks them to enter him: I talk to them. I say, Youre my allies. I want you to enter my virological system and I want you to fight with me against this alien invader. A month after Achmats equally stupid outburst in the Star, ignorantly disputing President Mbekis matter of fact statement that ARVs are toxic and destroy the immune system, Achmat frankly confirmed the obvious inference that hes a total scientific moron in an interview in Rapport newspaper on 10 February (translated from Afrikaans): With great honesty the TAC has always tried to understand medical science. And this is something with which all South Africans have always struggled. We are scientifically illiterate. (Presumably Achmat meant to include in this category Judge Cameron and his virological system.) Achmat admits, in other words, that he doesnt understand medical science because hes unable to make any sense of the medical literature, much less read it with any critical intelligence. However, Achmats projection of his own intellectual deficits onto everyone else in South Africa is obviously not supported by President Mbeki and Dr Tshabalala-Msimangs informed opposition to ARV drugs such as AZT and their concern about the serious danger they pose to the health of South Africans, mostly black. But Achmats foolishness in this regard may be explained by the general observation of the philosopher Arthur Schopenhauer, who once explained that Intelligence is always invisible to the man who has none. It may be that Achmat pleads from the dock in the International Criminal Court that his lack of a high school education is responsible for his inability to understand what President Mbeki identified as the dire warnings that medical researchers have been making about AZT, and so for this reason failed to immediately quit supporting GlaxoWellcomes marketing operation to sell the drug to the South African government for the poisoning of the populace, mostly African, and instead apply his TACs millions to a publicity campaign in South Africa to generally disseminate President Mbekis warning that South Africans, mostly black, stood in serious danger of being poisoned by a criminal drug corporation dumping its toxic wares in South Africa on the basis of such fraudulent claims as AZT and similar 3TC Prolong Life and Delay Disease Progression, as GlaxoWellcome falsely advertised the drugs for African children in the April 2000 issue of Modern Medicine of South Africa, whereas in point of fact abundant research data already pointed to precisely the contrary conclusion on both scores. Any defence to the charge that Achmat might seek to raise before the International Criminal Court that hes not fully criminally culpable and therefore not liable to punishment like any adult in his full sound and sober senses, because hes a self-admitted cretin in the field of medical science (and therefore perfectly qualified to be a member of the WHOs HIV Strategic and Technical Committee since 2004) and so he childishly and uncritically believes everything and anything drug companies say about their merchandise in their marketing propaganda, will be vitiated by the fact that he has direct personal knowledge of the dangerous toxicity of ARVs that President Mbeki and Dr Tshabalala-Msimang have repeatedly warned against, inasmuch as he has personally experienced their toxic ill effects to the extent that he was very severely harmed by them, and then nearly killed by them a year later: At a media briefing on 8 September 2003 Achmat said that four days earlier hed swallowed his first dose of Triomune, a generic ARV cocktail of d4T, 3TC and nevirapine in one tablet. Hed immediately suffered a severe headache and an intoxicating light-headedness that made him feel high. Within a few months the poisonous drugs had made him so sick that hed become completely invalided. An article in the Daily Dispatch on 28 May 2004 revealed that not only had the toxicity of his triple-combination ARV regimen crippled and incapacitated Achmat both physically and mentally, he had also been determinedly concealing this for the reason that he had not wanted to lose face to President Mbeki and Dr Tshabalala-Msimang over this, by seeing their many public warnings about the toxicity of ARVs publicly vindicated by his admission that they had caused him severe injury, particularly since he had been vilifying them without any kind of decent restraint throughout their first terms as President and National Health Minister on account of their aversion to the drugs that he himself had now found too hot to stomach. And more than not lose face, he had not wanted to lose the political ground hed won through his relentless propaganda campaigning, by conceding that theyd been perfectly right about the drugs and hed been flat wrong. Things have changed in Zackie Achmats life, went the report: Once readily accessible and always quick with a sound bite, a personal assistant now monitors the cellphone and diary of the chairperson of the Treatment Action Campaign (TAC) and screens visitors before ushering them into Achmats study. ... As much as these changes signify a new level of structure in Achmats life and the need to manage multiple requests for interviews, the more profound changes emerge from his first six months of anti-retroviral therapy and how this has forced the charismatic activist to review his life. a frightening setback ... occurred in February and March ... which shook Achmats self-confidence. ... Going into my fifth month I started feeling a sensation in my feet. At first I dismissed it, thinking Id done something at the gym. The second week it was clear to me and I thought, I cant let Manto win and I cant let Mbeki win, and I kept quiet for three more weeks. When Achmat finally told his doctor about his symptoms, the nerves in his feet were so sensitive that he could barely walk. A change of drugs (from d4T to AZT) has arrested the situation and his left foot feels better, but he still cant put any weight on his right foot for any length of time, nor can he walk long distances. ... Achmat, who has a clinical history of depression, says that the fact that he was immobile for a week while his doctor tried to bring the side effects under control brought on aterrible depression, the worst hes had in two years. In point of fact, AZT is no less neurotoxic than d4T: as nucleoside analogues the drugs are in precisely the same chemical class, and have substantially the same toxic pharmacology. Furthermore, the neurotoxicity of the drugs that had physically incapacitated him also appeared to have caused him conspicuous mental deterioration (an ill effect doctors call chemobrain) by late 2004. The early indications of this in the Daily Dispatch report were confirmed by journalist Willemien Brummer, who observed Achmat during an interview published by News24.com on 1 December 2004. She was perturbed to notice that His words were bats that flew into each other in the dark. His sentences ended in mid-air. It was as if he looked at you through a dense layer of fog. It was during these times that I wondered what was happening to him. Especially when he cancelled press conferences and public appearances at the eleventh hour. Between gulps [of soup and a glass of orange juice] he talks about his past and the complex interaction between the chemicals in his brain, his genes and the virus with which he was diagnosed in 1990.The HI virus already penetrates the brain during cero-conversion [sic]. ... Every patients reaction to this penetration is different. Chances are good this can lead to depression and cognitive reduction and, during the final stages, even to dementia a condition that usually only afflicts the elderly. Achmats own subjective appreciation of his deteriorating mental condition, his incipient ARV-induced AIDS dementia, was conveyed by his concern expressed to Brummer that Losing control of his mind [was] his biggest fear worrying to her like an increasingly senile old man aware that he is losing his marbles: As long as I hold on to my dignity. Brummer continued: And then came the physical side effects of the antiretrovirals. Especially peripheral neuropathy a condition that takes place when the nerve endings are impaired; burning pains are felt in the feet and legs. It was so bad for Achmat, that by the fifth month of antiretroviral treatment he could no longer walk. I was totally melancholic and dysfunctional at the beginning of the year. I fought with my nearest and dearest, and I did not want to accept that I was experiencing side-effects. Achmats phrase experiencing side-effects would seem to be inappropriately light for being physically crippled and mentally reduced, but in any event the admitted fact that he had been seriously harmed by his ARVs within months of starting to swallow them flatly refutes his blatantly false claim on the back page of the March 2006 issue of his TACs Equal Treatment magazine, I am healthy again because of them. Anxious to project an impression that he was thriving on his pills, not sinking on them, Achmat insisted to Brummer: I have been fine since June. In September I went to London, Germany, Addis Adeba and back to London, and I managed three appointments a day. I returned from Durban on Tuesday. What Achmat sought to imply was that since June hed no longer experienced the poisonous drugs as poisonous. Obviously the more likely reason is that, contrary to his claim in the caption to his happy mugshot in his Equal Treatment magazine, Achmat was in truth either no longer taking the drugs, or no longer taking them at the prescribed doses and at very much lower ones instead. This surmise is supported by Achmats self-admitted public deceitfulness, and the perfect impossibility that a mix of three toxic chemicals that had made him extremely ill, should thereafter be experienced as benign and health-supporting, after substituting one of them for another almost chemically identical one. Certainly hes made it clear that he doesnt want anyone checking up on him to make sure he really is taking his poisonous pills as prescribed (what doctors call DOT, i.e. Directly Observed Therapy routine in TB treatment) because, as he said in the 7 May 2006 issue of the Statesman, That, for me, is unacceptable because it limits the autonomy and dignity of every person. In reality, the reason Achmat doesnt want anyone catching him cheating by throwing his ARVs down the lavatory when no ones looking is because for most people they are unendurably toxic. In a novel investigation to quantify the Prevalence of adverse events associated with potent antiretroviral treatment in single, double, and triple regimens of ARVs, published in Lancet 358(9290):1322-7 in October 2001, Fellay et al. reported a high prevalence of toxic effects in a cohort of 1160 patients. More than two thirds of patients on these drugs suffered side effects severe enough to affect treatment adherence in other words prevent them taking the drugs as prescribed. Forty-seven per cent reported clinical problems like vomiting, diarrhoea, nausea, fat growth, mood swings, insomnia and fatigue. Blood tests revealed potentially serious abnormalities among twenty-seven per cent. The researchers classed a significant proportion of these adverse events as serious or severe. Kidney dysfunction and severe fatigue that were probably or definitely due to their HIV treatment led to some patients winding up in hospital. More recently, the Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis, released by the US Centers for Disease Control (CDC) on 30 September 2005, cited numerous studies reporting that as a result of toxicity and side effects among HCP [health-care personnel], a substantial proportion of HCP have been unable to complete a full 4-week course of HIV PEP Side effects have been reported frequently by persons taking antiretroviral agents as PEP In multiple instances, a substantial (range: 17%47%) proportion of HCP taking PEP after occupational exposures to HIV-positive sources did not complete a full 4-week course of therapy because of inability to tolerate the drugs. But Achmat makes out that hes taking these drugs at their full prescribed dose year after year, unaffected by their toxicity and side effects, which the CDC acknowledges prevents up to half of doctors and nurses completing a mere 4-week course of therapy because of inability to tolerate the drugs; and instead of campaigning to warn people in South Africa that they face being poisoned and made very ill by the toxicity of ARVs, as he was just as the findings of Fellay et al. and numerous other researchers predicted he now goes about lying that he is healthy again because of them. Nevirapine, which Achmat was also taking, is neurotoxic too, and was reported to cause severe mental problems by Wise et al. in the British Medical Journal 324(7342):879 in April 2002, under the title, Neuropsychiatric Complications of Nevirapine Treatment. A second paper along the same lines was published in the same year by Morlese et al. in AIDS 16(13):1840-1841: Nevirapine-induced neuropsychiatric complications, a class effect of non-nucleoside reverse transcriptase inhibitors? In Achmats case these neuropsychiatric complications were in evidence almost immediately. He told journalist Jennifer Barrett during an interview published in Newsweek on 24 November 2003: The most remarkable thing after I started taking the medicines actually is that in the first three weeks, I became so depressed Id never been as depressed in my life. An article wired by Associated Press on 15 October 2006, Scientists battle HIV dementia: Doctors cant predict which patients will suffer from neuroAIDS, helps explain Achmats mental incapacity. Though first blaming HIV, the piece noted that Today, anti-HIV medication has resulted in a more subtle dementia that strikes four years or more before death: At first, patients forget phone numbers and their movements slow. Some worsen until they cant hold a job or perform other activities, but not everyone worsens and doctors cant predict who will. many specialists worry [that] nearly all of them may suffer at least some brain symptoms memory loss and other symptoms of so-called neuroAIDS, which afflicts at least one in five people with HIV and is becoming more common as patients live longer. After replacing d4T with AZT in his drug combo, imagining this would solve his problems apparently, Achmat claims that he continued with a daily fix of ARVs until 28 March 2005, when he suffered a major heart attack at the age of forty-three, following which he was rushed to hospital by ambulance and kept there for several days. This terrible misfortune was eminently predictable having regard to the reported findings of Reisler et al. (cited above) that (a) All 4 classes of antiretrovirals (ARVs) and all 19 FDA approved ARVs have been directly or indirectly associated with life-threatening events and death. That (b) twice as many people on ARV drugs suffer a life-threatening toxic ill effect than what the researchers called an AIDS event. And that (c), induced by toxic ARVs, Cardiovascular events are associated with the greatest risk of death. In the same month that Achmat was falling down having his heart attack, kicking and groaning on the floor, McKee et al. were reporting one of the several ways in which AZT damages hearts in their paper Phosphorylation of Thymidine and AZT in Heart Mitochondria: Elucidation of a Novel Mechanism of AZT Cardiotoxicity in Cardiovascular Toxicology 4(2):155-67: Antiretroviral nucleoside analogs used in highly active antiretroviral therapy (HAART) are associated with cardiovascular and other tissue toxicity associated with mitochondrial DNA depletion. The reason, they explained, is that AZT is a potent inhibitor of thymidine phosphorylation in heart mitochondria. What this means is that AZT wrecks the synthesis of cellular DNA and thereby poisons heart tissue. And in a press release on 5 February 2001, when the US Department of Health and Human Services was announcing its abrupt renunciation of its hit early, hit hard approach to AIDS with AZT and similar ARVs, a year after President Mbeki had formally drawn the worlds attention to the dangerous toxicity of AZT, National Institute for Allergies and Infectious Diseases director Anthony Fauci explained: We are very concerned about a number of toxicities associated with the long-term use of anti-retroviral drugs. We are seeing an increasing number of patients with dangerously high levels of cholesterol and triglycerides. The bad news is that we now must find ways to deal with unanticipated toxicities, including the potential for premature coronary disease. Premature coronary disease like Achmats exacerbated by the dyslipidaemia found by his cardiologist, being what Fauci would call dangerously high levels of lipids in Achmats blood. Achmat consequently cant successfully be heard to plead to the International Criminal Court for pardon for his crime on the basis that hes what primary school teachers call a slow learner; that hes an extremely stupid and ignorant person; that he honestly didnt know what he was doing when duped and co-opted by the pharmaceutical industry into helping it push its useless, deadly drugs in South Africa; and for the same reason couldnt make sense of what President Mbeki and Dr Tshabalala-Msimang were saying when warning the countrys people that they were in danger of being severely harmed by AZT; and that although at the end of his Parliamentary statement about AZT, President Mbeki said To understand this matter better, I would urge the Honourable Members of the National Council [of Provinces] to access the huge volume of literature on this matter available on the internet, so that all of us can approach this issue from the same base of information. he, Achmat, didnt even try following this advice himself, because as hes said, hes a scientifically illiterate person, so the huge volume of literature on this matter available on the internet would have been complete Greek to him. In the circumstances, it obviously behoved Achmat to ask someone intelligent to explain to him in simple terms what it all meant, instead of turning a deliberate blind eye to it in the manner of the Nazi war criminal Albert Speer, not wanting to disturb his brilliant career by investigating evidence of the atrocious abuse of slave labour for war production taking place under his jurisdiction, much less putting a stop to it. In the premises, it does not lie in Achmats mouth to pretend to the International Criminal Court that he did not know about the dangerously harmful toxicity of ARVs that nearly killed him, and which are killing thousands of Africans in South Africa. He cannot claim a genuine mistake of fact as the basis of any defence excluding criminal responsibility, as envisaged by Article 32 of the Rome Statute, because he subjectively appreciated, from direct personal experience, that his criminal activity in South Africa was leading thousands of people to their deaths, mostly black, mostly poor. FACTS EXCLUDING ANY DEFENCES BASED ON MENTAL DISEASE OR DEFECT As he witnesses his defences collapsing under the mass of evidence of his crime led during his trial, Achmat may resort to applying to amend his plea to claim the protection of the special defence set out in Article 31.1(a) of the Rome Statute. This would provide him with immunity from conviction and punishment if he could show that he suffers from a mental disease or defect that destroys that persons capacity to appreciate the unlawfulness or nature of his or her conduct, or capacity to control his or her conduct to conform to the requirements of law. In this regard, Achmat is on record repeatedly claiming to be mentally ill, in that he says hes suffered from severe depression from childhood, for which tragic medical condition he is being chronically doctored with mind dulling psychiatric drugs that alter normal brain chemistry. But whether the extent of Achmats endogenous mental disease is advanced enough and/or the compounding slipping clutch effect of his psychiatric drug treatment on his cognitive abilities is sufficiently pronounced to legally excuse his crime will only be determinable upon a full, extended medico-forensic investigation conducted in a suitable lock up mental hospital. An obstacle to Achmats reliance on the Rome Statutes mental infirmity defence will be his own doctors cheerful assertion in an affidavit filed in the Cape High Court in 2006, in Case No: 12156/05, that Zackie is currently in complete control of his mental faculties. Rather clouding the picture, however, Dr Andrews also noted that Achmats ARV treatment had damaged not only the nerves in his limbs (grade 2 peripheral neuropathy being treated with neurological pain adjuncts) but his brain too, caused him sensory, motor and proprioceptive disturbances. The learned doctor leaves open the question as to whether as a result of his ARV intoxication he thought Zackie was previously not in complete control of his mental faculties. At all events, whatever the court-appointed psychiatric panels findings might be, Achmats further deteriorated mental condition, apparent to several journalists after he commenced his ARV treatment, cannot avail him as the basis of a defence under Article 31, because its onset appears to have occurred after the commission of the principal act constituting his crime, namely coercing the South African government, in collusion with other pharmaceutical interest groups, to announce on 17 April 2003 that it would be providing ARV drugs in the public health system for provision to the poor, mainly African. Although Article 31.1(b) provides that criminal responsibility will be excluded where The person is in a state of intoxication that destroys that persons capacity to appreciate the unlawfulness or nature of his or her conduct, or capacity to control his or her conduct to conform to the requirements of law, and Achmat may fairly contend at his trial that the neurotoxic effect on his brain of the ARV drugs that he took for a few months caused him to become so intoxicated that he no longer had his wits about him, as all the journalists who interviewed him seemed to think, Article 31.1(b) disallows the defence where the person has become voluntarily intoxicated under such circumstances that the person knew, or disregarded the risk, that, as a result of the intoxication, he or she was likely to engage in conduct constituting a crime within the jurisdiction of the Court. Given President Mbeki and Dr Tshabalala-Msimangs repeated warnings about the dangerous toxicity of AZT, and the latters specific mention in Parliament on 16 November 1999 that AZT attacks nerve cells, Achmat was on notice that he might become even more stupid on drugs of this type when he commenced to take them, because even the most dim-witted person knows that much of the brain comprises nerve cells. Achmat therefore cannot competently rely on the defence created by Article 31.1(b). FACTS IN AGGRAVATION OF THE CRIME In the International Criminal Courts deliberations on what suitable sentence to pass on Achmat following his conviction for genocide, several considerations will operate as aggravating circumstances. Not only has Achmat deliberately disregarded the evidence of the grave harm that his continuing conduct is causing, he has also venomously attacked President Mbeki and Dr Tshabalala-Msimang for warning about ARV drug toxicity and for emphasizing poverty and malnutrition as the principal causes of broken health (i.e. acquired immune deficiency) among the poor African majority in South Africa; and he has strenuously sought to discredit their due warnings for the protection of the South African public they serve against his toxic ARV drug agenda by attacking and insulting them personally and working to destroy their reputations. Achmats marketing of the pharmaceutical industrys ARVs has been conducted in a grossly dishonest and misleading manner in several respects: He has puffed ARVs in a manner so at variance with the known facts about their debilitating, unendurable toxicity for most people that it would be illegal for him to have done so in the US, and would have exposed him to immediate arrest and prosecution were he to have marketed the drugs in that country on the back of the false claims that he makes in South Africa with impunity. On 12 May 2001 the British Medical Journal 322(7295):1143 reported that The US Food and Drug Administration (FDA) has issued a warning letter to manufacturers of AIDS drugs cautioning them to tone down the optimistic tenor of their antiretroviral ... billboard and magazine ... drug advertisements. Thomas Abrams, director of the FDAs division of drug marketing, advertising, and communications said that current antiretroviral advertisements directed at consumers are misleading as they fail to depict the limitations of AIDS drugs and also feature healthy looking people sexy and athletic models in the prime of health who were climbing mountains, sailing boats, and riding bikes. These are pursuits which are quite difficult for people with HIV infection, who have to take drugs several times a day that have debilitating side effects The advertisements therefore violate the Federal Food and Drug Act. Noting this move by the FDA, South Africas governing party correctly predicted in ANC Today on 18 May 2001 that Achmat, his TAC, and other pharmaceutical interest groups would disregard this information and persist in enticing people to their deaths with misinformation about ARVs and false promises about the benefits of swallowing them: Most unfortunately, there is little chance that the politicians, corporate, medical, non-governmental and media people in our country, who are involved in a campaign that is not different from the one which the US FDA seeks to prohibit, in the public health interest, will listen and respond to the message of the US FDA. In the consequence, innocent people in our country will continue to suffer, even to the point of death, thanks, in part, to the wilful behaviour of these fellow South Africans. Whereas the toxicity of his ARVs had crippled Achmat within months of starting treatment with them, he is currently pretending (in the Cape Times on 17 February 2006) that the drugs are now giving him a zest for life that he never had before, to the extent that he is even climbing mountains. That is to say, hes now presenting himself as a poster-boy for ARVs in precisely the bogus terms and images that even the drug industry friendly FDA has outlawed as misleadingly false, namely of healthy looking people sexy and athletic models in the prime of health who were climbing mountains, sailing boats, and riding bikes. Just as Achmat fraudulently pretends to be so invigorated by ARVs that hes now climbing mountains, the November 2006 issue of his TACs Equal Treatment magazine features a back-page ARV drug advertisement with a photograph of Judge Cameron grinning in his cycling gear, riding bikes, and claiming falsely, Antiretrovirals keep me healthy, alongside the caption: In 2006 he rode the 110 km Argus cycle race. As the British Medical Journal has pointed out, this sort of dishonest and misleading ARV advertising is illegal in the US and would get the persons involved in it thrown in jail. Since he acts beyond the jurisdiction of the FDA in the criminally deceitful manner in which he promotes ARVs in South Africa, Achmats next ARV advertisement in Equal Treatment can be expected to feature healthy looking sexy and athletic models in the prime of health sailing boats around Cape Point. Not even the pharmaceutical corporations manufacturing ARVs claim that they have the medical benefits that Achmat and Judge Cameron falsely allege. For instance, AZT manufacturer GlaxoSmithKline says frankly about its new state of the art ARV Ziagen in its Product Information: Ziagen has not been studied long enough to know if it will help you live longer or have fewer of the medical problems that are associated with HIV infection or AIDS. About Combivir, a combination of its drugs AZT and the chemically similar compound 3TC, GlaxoSmithKline concedes: COMBIVIR is not a cure for HIV infection and patients may continue to experience illnesses associated with HIV infection, including opportunistic infections. Boehringer Ingelheim says about nevirapine: VIRAMUNE does not cure HIV or AIDS, and it is not known if it will help you live longer with HIV. People taking VIRAMUNE may still get infections common in people with HIV (opportunistic infections). Merck is no more encouraging about its protease inhibitor drug in its package insert: It is not known whether Crixivan will extend your life or reduce your chances of getting other illnesses associated with HIV. Gilead Sciences is equally pessimistic about its drug tenofovir, which the TAC is currently trying to ram through the Medicines Control Council approval process; its Product Information reads: VIREAD does not cure HIV-1 infection or AIDS. The long-term effects of VIREAD are not known at this time. People taking VIREAD may still get opportunistic infections or other conditions that happen with HIV-1 infection. Opportunistic infections are infections that develop because the immune system is weak. Some of these conditions are pneumonia, herpes virus infections, and Mycobacterium avium complex (MAC) infections. In marketing the pharmaceutical industrys ARVs in South Africa, Achmat has consistently underplayed their potentially fatal toxicity. His TAC pamphlet Immune Reconstitution Syndrome (IRS), for instance, features a smiling healthy looking black man in a sparkling white print shirt, looking sexy and athletic and in the prime of health, announcing: I got sick with TB after starting ARV treatment. The perverse, infantile, magical reason provided in the models voice bubble for this health downturn is that its because the TB that was sleeping in my body took a chance to wake up as my immune system began to recover. Since ARVs are potent general metabolic poisons, as Lewis and Dalakas (cited earlier) have pointed out, further comment on this inane explanation for why healthy people fall severely ill when poisoned by them would be superfluous. No manufacturer of any ARV alleges, as Achmats TAC does in its propaganda piece on IRS, that its drug, alone or in combination, will make and keep a person who has fallen ill with TB well and healthy again. This is because theres no reported clinical evidence supporting this untruthful, wholly fabricated claim. On the contrary, numerous research papers have reported and Achmat explicitly confirms this in his TACs IRS article that ARVs actually induce such serious diseases as TB, Pneumonia, Cryptococcal Meningitis or generally [make people] feel sick. The TACs unbelievably stupid allegation in the IRS piece that When you start ARV medication you develop TB, Pneumonia, Cryptococcal Meningitis or generally feel sick because your immune system gets stronger on the drugs would seem to be par from an organization led by a mentally unstable and intellectually challenged person who brags of being scientifically illiterate. As mentioned above, Achmats dishonesty in marketing ARVs on behalf of the pharmaceutical industry extends even to deceitfully concealing from President Mbeki and Dr Tshabalala-Msimang, and from the people of South Africa, the crippling harm that these drugs have caused him personally (mitochondrial myopathy, peripheral neuropathy and mental deterioration) and that nearly killed him (heart attack). A particularly deplorable aspect of Achmats criminal activity in hegemonizing the pharmaceutical industrys ARV drugs as the only permissible treatment modality for AIDS has been his campaign of cultural genocide in denigrating and undermining centuries-old African healing systems and medical knowledge in South Africa, generally referred to in the West as Traditional African Medicine. Achmat smears as unethical any traditional healer who treats people suffering from AIDS-defining illnesses with natural indigenous medicine, and who warns against the toxicity of ARVs; and he implies that such healers should be criminally punished. In an editorial under the subheading Stop unethical healers in the May 2005 issue of his TAC journal Equal Treatment, he wrote: Some traditional healers spread dangerous messages. They claim they can treat AIDS and antiretrovirals are toxic. Their behaviour gives other traditional healers a bad name. This shows that regulation is needed so that the traditional healing profession will serve patients better. This is something traditional healers should support. If we modernise traditional medicine, it will benefit everyone, traditional healers most of all. By modernise Achmat evidently means that traditional healers should abandon ancient indigenous models of understanding and treating disease, and should adopt allopathic, capitalist, pharmaceutical bio-medicine, centring on the use of ARVs in cases of AIDS, thereby not healing but killing their patients. Carrying on Achmats attack on Traditional African Medicine, TAC treasurer Mark Heywood repeatedly demeaned it at the 16th International AIDS Conference in Toronto in August 2006, both in his speech before the plenary session and in a statement to newspaper reporters after his TAC colleagues grabbed the vegetables on display in the South African governments conference booth, threw them on the floor, and stamped on them with their shoes. In both cases Heywood falsely contended that African traditional healers are useless in the treatment of AIDS; that they kill people by treating them ineffectively with traditional natural remedies; that treatment with the pharmaceutical industrys ARVs instead would save their lives; and that only the pharmaceutical industrys ARVs are any good for treating AIDS. It is not known whether GlaxoSmithKline paid Mr Heywood to promote AZT and other ARVs in this way by paying his conference registration fees for him as the corporation gladly did TAC lawyer Fatima Hassans in 1998, shelling out R5000 so she could go around earnestly telling everyone at the 12th International AIDS Conference in Geneva that ARVs are a human right. Even though he says he takes vitamin supplements every day, because he knows theyre good for him, Achmat aggressively assails advocates of nutritional medicine, who point out that, being natural and non-toxic, essential micronutrients are much better at restoring sick people to health than synthetic, dangerously toxic ARVs; and in this manner he works as a craven servant of the pharmaceutical industry by entrenching its virtual monopoly on formal-sector healthcare in South Africa, particularly in the treatment of AIDS, with wide-scale fatal consequences, described above. Achmats repeated vicious attacks on the democratic government of South Africa (for instance, referring to Dr Tshabalala-Msimang as this criminal on 25 March 2003, and filing vexatious criminal complaints against her with the police) have been carried out under the guise of a public benefit organization, with Achmat and his TAC claiming to represent civil society, as if he and his TAC do, rather than South Africas liberation movement, the African National Congress, elected to power by an overwhelming majority of the popular vote, increasing with every election. Achmats pretensions to speak for the electorate (for civil society), however, are laid bare by the fact that his TAC is entirely a child and tool of foreign commercial and political interests, has no genuine grassroots base in South Africa, and would be nothing without colossal foreign government and corporate funding R38 million in 2006, according to a report on its website to keep its otherwise unemployed staff in paid jobs and to finance its ARV marketing operation for the pharmaceutical industry. The basic theme of the Achmats vilification of South Africas democratic government is that by not promoting the use of ARV drugs, it is criminally neglecting its responsibilities to govern properly, with catastrophic results for the majority constituency it represents a charge epitomized by Achmats accusation, shouted outside the Cape High Court in June 2005, that Mbeki is responsible for the deaths of thousands of people. In other words, to Achmats mind, although he has successfully got ARVs into the public health system in South Africa, for pointing out that they are dangerous toxic and for not encouraging people to use them, President Mbeki and Health Minister Dr Tshabalala-Msimang are basically mass murderers. APPROPRIATE CRIMINAL SANCTION In view of the scale and gravity of Achmats crime and his direct personal criminal culpability for the deaths of thousands of people, to quote his own words, it is respectfully submitted that the International Criminal Court ought to impose on him the highest sentence provided by Article 77.1(b) of the Rome Statute, namely to permanent confinement in a small white steel and concrete cage, bright fluorescent light on all the time to keep an eye on him, his warders putting him out only to work every day in the prison garden to cultivate nutrient-rich vegetables, including when its raining, in order for him to repay his debt to society, with the ARVs he claims to take administered daily under close medical watch at the full prescribed dose, morning, noon and night, without interruption, to prevent him faking that hes being treatment compliant, pushed if necessary down his forced-open gullet with a finger, or, if he bites, kicks and screams too much, dripped into his arm after hes been restrained on a gurney with cable ties around his ankles, wrists and neck, until he gives up the ghost on them, so as to eradicate this foulest, most loathsome, unscrupulous and malevolent blight on the human race, who has plagued and poisoned the people of South Africa, mostly black, mostly poor, for nearly a decade now, since the day he and his TAC first hit the scene. Signed at Cape Town, South Africa, on 1 January 2007  Anthony Brink Advocate of the High Court of South Africa Chairman, Treatment Information Group Complainants Contact Particulars: Postal address: Adv A Brink Email: arbrink@iafrica.com Treatment Information Group Postnet Suite 273 Telephone: 0027 21 426 4513 Private Bag X1 Vlaeberg 8018 Telefax: 0027 86 6720776 Cape Town South Africa Internet website:  HYPERLINK "http://www.tig.org.za" www.tig.org.za PDF copies of this draft criminal indictment may be downloaded and printed off the TIG website. It is also available in Spanish, French, Russian, Italian, German and Dutch.  8 February 2007 To: Trevor Ncube, CEO: Mail&Guardian Grosvenor Corner 195 Jan Smuts Avenue Rosebank Johannesburg And to: The Office of the Prosecutor, International Criminal Court; African National Congress; South African Government; other interested parties; media; and online at  HYPERLINK "http://www.tig.org.za" www.tig.org.za Dear Mr Ncube Media Complicity in Genocide: the Case of the Mail&Guardian In Guardians of Power: The Myth of the Liberal Media (London: Pluto Press, 2006) David Edwards and David Cromwell make the point that If there is to be a way out of the nightmare of history, it will begin with a waking up to the complicity of the corporate mass media in mass murder. Last month I  HYPERLINK "http://www.tig.org.za/pdf-files/icc_serviceconfirmationletter.pdf" served a  HYPERLINK "http://www.tig.org.za/pdf-files/icc_achmatcomplaint.pdf" criminal complaint on the Prosecutor of the International Criminal Court (ICC) at The Hague against Treatment Action Campaign (TAC) leader Zackie Achmat. The complaint was presented as a 59-page draft bill of indictment, systematically particularizing the actus reus and mens rea elements of a charge of genocide within the special extended meaning envisaged by Article 6 of the ICCs founding charter, the Rome Statute. The complaint anticipated and refuted Achmats possible criminal defences, detailed aggravating factors in consideration of sentence, and concluded with an ironic criminal sanction submission in the form of a conceit charged with multiplex meanings and allusions. I appreciate that at first blush the charge seems absurd: it flies in the face of Achmats media-sculpted renown as a national hero who has bravely and selflessly devoted his life to the redemption of those unfortunates in our country whose physical passions have got the better of them, nearly all African, proffering their salvation from a dreadful early death by dint of certain patented chemicals sold by multinational pharmaceutical corporations under the name and style of antiretroviral drugs (ARVs). As a newspaperman youll know that news of colossal crimes is a hard sell when it contradicts deeply piled prevailing wisdom in a given propaganda climate, and threatens to collapse the readers reality. Or when it concerns the less favoured races. The New York Times, for instance, initially showed scant interest in early reports about the social engineering crimes of Stalin and Hitlers regimes in which millions died. And suburban white liberals in South Africa like seeing the servants and their sexually transmitted diseases taken care of with strong, modern, scientific medicines from overseas (rather than all that voodoo stuff), and dont want to hear a word said against them or those plying them. The ICC complaint was founded on the following core facts: (a) by common agreement among the experts whove studied them, the ARVs promoted by Achmat for the treatment of the diseases of poverty among the African poor in South Africa, nowadays called AIDS, are extremely toxic as President Mbeki and Health Minister Dr Tshabalala-Msimang have repeatedly warned; (b) a massive review study of 22 217 clinical cases published in August 2006 in the leading medical journal Lancet (but mentioned nowhere by the commercial media in South Africa) shows ARVs to have no health benefits in terms of saving lives (to quote the expression used in the TACs press statement on the ICC complaint, and the basic lie of its ARV marketing campaign) and that, contrariwise, they actually accelerate the death rate of HIV-positive people taking them; (c) these recent findings are consistent with reams of previously published research reports in the medical and scientific press over the last two decades concerning the dangerous toxicity of ARVs, to which literature President Mbeki and Dr Tshabalala-Msimang have both called attention in Parliament and elsewhere; and, (d) figures released in November last year to and by the United Nations, and by the South African Department of Health the year before, show that in South Africa and neighbouring Malawi ARVs are decimating the African poor. Broadcast media took news of this enormous atrocity seriously; and I was able to inform South African radio listeners about it during prime-time interviews on all the major national and regional radio stations SAfm, RSG, Radio Metro and Radio 702/Cape Talk as well as on numerous stations serving local communities, and on Indymedia in Chicago. I was invited to speak on e.tv too, but Achmat apparently had a failure of nerve and refused to meet my proviso that he also appear to talk to the above-stated facts. (The likely reason for this he gave in an interview in Rapport on 10 February 2002, declaiming about himself and his TAC with remarkable candour: We are scientifically illiterate.) Of the countrys newspapers, on the other hand, only Die Burger reported the ICC complaint in a professional manner, and apart from a couple of minor inaccuracies properly conveyed its gravamen. Other papers contrived to ridicule and discredit it by quoting only the ironic sentencing recommendation, missing its satirical sting, and by headlining the TACs response: rubbish from beginning to end; truly delusional; the rantings and ravings of a madman [that dont] deserve comment; laughable; Brink had taken everything out of context Almost every single quotation in his report was out of context. A news poster here in Cape Town billed the complaint as a BIZARRE CHARGE AGAINST ZACKIE. Despite timeous notification by press release, your Mail&Guardian (M&G) ignored the complaint in its Friday print edition, and more importantly failed to report the crucial facts at the heart of it. Thus were your readers kept in the dark about them, thereby perpetuating the fable that ARVs make sick Africans better, when the opposite is true. A cursory mention of the complaint appeared in the Mail&Guardian Online on 11 January, followed by a piece posted the next day making a pointless story out of the TACs refusal to address the contents of the complaint substantively, and its derisory response in its press statement that it would not waste public resources in dignifying Anthony Brinks lunatic call [for Achmats prosecution in the ICC]. Anthony Brinks actions serve only to insult the rationality of all sane people and the difficult experiences of millions of people who live with HIV/Aids in the world. It wasnt as if your readers werent interested in what the complaint was all about, because the M&G included a note in its print edition on the 19th that the mention of it in the M&G Online was the third most read story the week before (although only by the lucky elites with internet access, and certainly not the target market for ARVs in South Africa, the African poor). I write to you because although your M&G is a commercial newspaper just like all the others, it has billed itself as the countrys conscience from the time it was founded in the apartheid era, speaking truth to power and all that, even claiming the original Manchester Guardians mantle as the voice of the oppressed. So by rights the M&G shouldnt stint at causing a serious disruption of the international business climate by reporting a vast and murderous swindle by an immensely wealthy and powerful Western pharmaceutical corporation such as GlaxoSmithKline, selling AZT, a purpose-designed cell poison, to Africans under the pretext that its a beneficial medicine. The M&Gs self-conception of its intellectual vanguard role in our country was displayed in an editorial on 11 November 2003, deploring commercial media coverage of the American invasion of Iraq: Embedded is now a thoroughly filthy word: it signals wholesale journalistic capitulation to interests that it should be the professions job to dissect, not embrace. The question arising then is why your journalists should be conducting themselves as pharmaceutical industry embeds, lovingly embracing the TAC, wholly uncritically hawking the wares that this pharmaceutical industry interest group touts for it, and showing no interest at all in their professions job to dissect Whose interests does the TAC serve?, as ANC Today asked on 17 December 2004. In the May 2001 issue of Umrabulo, the late Peter Mokaba MP pointed up your newspapers power to inform and shape opinion: In South Africa [public perceptions] are informed, mainly, by the media which forms part of the most reactionary forces among those offering consistent ideological resistance to transformation. It is a powerful tool of manipulation, information and propaganda. For example, in the 1995 Media and Market Research of Jocelyn Cooper it was indicated that 70 per cent of the people north of the Parktown Ridge get their information from the newspapers only. They normally do not consult other sources of information. And John Braithwaite commented on the effective deployment of this power to expose pharmaceutical industry abuses in Corporate Crime in the Pharmaceutical Industry (Routledge&Kegan Paul, 1984): Investigative journalists played a more important role than health regulatory authorities in many parts of the world in saving children from thalidomide. Recalling the German pharmaceutical company Chemie Grunenthals indifference to his desperate efforts in November 1961 to persuade it to remove thalidomide from the market in view of the deformities it was causing, Dr Widukind Lenz confirmed that the drug was withdrawn, largely due to reports in the press. But this tradition has collapsed in the Age of AIDS. In the Spectator on 14 December 2000, John le Carr lamented that in the matter of bad drugs and pharmaceutical industry corruption The mainstream media have failed us completely The subject is just too damned uncomfortable to handle; too complicated, often deliberately, too scientific for the layman. Many hacks who should know better have been lunched, holidayed and bamboozled into silence. Fake nostrums are taken as gospel. Part of the reason your paper has failed us completely in this subject stems from its reliance on bamboozled junior reporters such as Belinda Beresford, unable to handle the uncomfortably complicated scientific minutiae of the ARV drug controversy (e.g. the  HYPERLINK "http://www.tig.org.za/pdf-files/openletter_gsk.pdf" nucleoside analogue (AZT) triphosphorylation problem to which President Mbeki has publicly referred) because theyre too complicated and too scientific. This goes some way to explaining why your M&G is selling fake nostrums like AZT as gospel (Miss Beresfords imagery and tone are frequently Christian), and is not reporting compelling indications from research reports in the medical and scientific journals that a fundamental rethink about these drugs is overdue on account of the deadly harm theyre causing African people. The M&Gs failure to convey to readers what the ICC complaint was all about was solidly in keeping with its overtly pro-pharmaceutical industry, pro-ARV drug, pro-TAC line, and its avowed anti-government, anti-dissident and uncritical bias in reporting the AIDS treatment controversy which, as you know, has raged here ever since President Mbeki alerted the people of our country to the dangerous toxicity of AZT in Parliament on 28 October 1999, a warning reiterated by Dr Tshabalala-Msimang in a detailed statement in Parliament two weeks later. Indeed, the M&Gs active marketing of AZT on behalf of its manufacturer GlaxoSmithKline, and its protection of the product from any criticism, lest readers start worrying about it as they should, is a matter of formal editorial policy. Youll recall that there was a tremendous uproar over the M&Gs publication of an invited contribution to its special AIDS Day supplement on 26 November 2004, co-written by my  HYPERLINK "http://www.tig.org.za" Treatment Information Group, under the title Why should South Africans continue to be poisoned with AZT? Theres a natural answer to AIDS. It was two particularly objectionable statements I wrote that caused all the trouble: Hundreds of studies have found that AZT is profoundly toxic to all cells of the human body, and particularly to the blood cells of the immune system. Numerous studies have found that children exposed to AZT in the womb and after birth suffer brain damage, neurological disorders, paralysis, spasticity, mental retardation, epilepsy, other serious diseases and early death. These statements made your readers very angry, not because they werent precisely true, but because they contradicted what your white liberal journalists had been writing in their columns about AZT as a life-saving chemical eucharist, a holy token of Western modernity to save a dark continents aboriginals from the deadly disease theyre tragically spreading among each other by rampantly joining their privates every five minutes. (The paeans theyve written to the drug could fill a book.) One outraged reader, along with the TAC, complained to the Advertising Standards Authority, and actually got the  HYPERLINK "http://www.tig.org.za/pdf-files/tig_response_to_asa.pdf" statements banned from ever being  HYPERLINK "http://www.tig.org.za/pdf-files/TIG_to_ASA_reminder.pdf" repeated in the media again. Print shops are now forbidden from publishing them too. And we thought apartheid mind control was over. Can you credit this? Many of the hundreds of studies referred to in the first objectionable statement are cited in a book I published in January 2001,  HYPERLINK "http://www.tig.org.za/pdf-files/debating_azt.pdf" Debating AZT: Mbeki and the AIDS drug controversy, and heaps more have since been reported. An early draft of this book, then subtitled Questions of safety and utility, moved President Mbeki to investigate the issues himself, to order an enquiry into the safety of the drug, and then, when the useless local experts botched it, to convene an International AIDS Advisory Panel of scientists and clinicians to debate the questions Id raised, among  HYPERLINK "http://www.tig.org.za/pdf-files/affidavit-aug06/BRINK%20AFFIDAVIT%20WITH%20ANNEXURES%20HYPERLINKED%20AND%20TYPO%20FIXES.pdf" other issues. At the first meeting of the Panel in May 2000 no one disputed pharmaceutical biochemist Dr David Rasnicks statement that AZT has killed tens of thousands of people. Clinical pharmacologist Dr Andrew Herxheimer, Emeritus Fellow of the prestigious Cochrane Institute (and an orthodox member of the Panel, not a dissident), also noted at the time that AZT has killed a lot of people. I presented a brief, updated overview of the toxicity literature on AZT and similar drugs at a meeting in November last year conducted by the KwaZulu-Natal Department of Health, under the title  HYPERLINK "http://www.tig.org.za/pdf-files/azt-mbeki_tshabalala-msimang.pdf" Why do President Mbeki and Dr Tshabalala-Msimang warn against the use of ARV drugs like AZT?   HYPERLINK "http://www.tig.org.za/pdf-files/introducing_AZT.pdf" Introducing AZT: A World of Antiretroviral Experience cites the toxicity literature in greater detail, includes research papers published after Debating AZT went to print, and quotes many revealing statements by experts and activists for and against the drug. Unlike Achmat and his TAC, I like giving both sides. The principal research papers reporting the foetal and neonatal toxicity of AZT and how it maims babies in the womb, as described in the second objectionable statement in your newspaper, are comprehensively reviewed in a compendium of submissions to the Medicines Control Council under the title  HYPERLINK "http://www.tig.org.za/pdf-files/poc.pdf" Poisoning our Children: AZT in pregnancy. A few of these shocking research reports are baldly cited without any gloss in  HYPERLINK "http://www.tig.org.za/pdf-files/azt-achmat_geffen_heywood.pdf" Why do Zackie Achmat, Nathan Geffen and Mark Heywood want pregnant African women to be given AZT? What AZT does to unborn and newly born children. You wont believe your eyes reading the horrors in the appendix. After agreeing to publish a reply to your readers fulminations against the unspeakable heresies about AZT uttered in your newspaper, editor Ferial Haffajee spiked it just before going to press. Your chief operations officer Hoosain Karjeiker explained the reason to me on 9 December 2004: We are proponents of AZT. Yes [its objectionable to] cast aspersions on AZT and nevirapine its dissident. A couple of hours after my illuminating telephone conversation with Mr Karjeiker, Miss Haffajee rang to enlighten me further. Imagine my amazement when she told me that The position of the Mail&Guardian is that everyone is entitled to treatment. Our newspaper has been at the forefront of the push for antiretrovirals in this country. Our brand has suffered [from publishing the facts about the general and foetal toxicity of AZT]. Publishing [another article mentioning the side effects of extremely toxic pharmaceutical drugs like AZT and nevirapine] will continue to damage our brand. Which is to say the M&G has a brand tie-up with GlaxoSmithKlines AZT like the one the TAC has got going with Levis jeans. Meaning that the reputation of the M&G is married to the market fortunes of AZT. Since thanks to the TAC its now groovy and progressive to be identified as a proponent of the drug at the forefront of the push for antiretrovirals in this country. And its verboten to cast aspersions on these drugs by stating matter-of-factly that loads of studies have found them to be very poisonous. To babies especially. Particularly if you dont want to be called mad like me. (Miss Haffajee says Im loony; her minder Drew Forrest reckons Im a buffoon.) The M&Gs commitment to promoting AZT, and to shielding it from information that its defective, goes back to the beginning. Whereas Etienne de Harven MD, Emeritus Professor of Pathology at the University of Toronto, thought Debating AZT: Mbeki and the AIDS drug controversy excellent the best, most comprehensive review on AZT currently available Harvey Bialy PhD, founding scientific editor of the leading science journal Bio/Technology (now Nature Biotechnology), and scholar in residence at the Institute for Biotechnology at the National Autonomous University of Mexico, considered it Absolutely spectacular superb ... the definitive refutation Peter Duesberg PhD, Professor of Molecular Biology at the University of California at Berkeley, member of the National Academy of Sciences of the United States of America, and author both of review and original research papers on AZT, described it as superb, extremely well researched, analyzed, written. I could not have done a better job. Are you a scientist or do you collaborate with one? How could you survey so many scientific publications as an attorney? Could you publish your article or a variant of it in a medical/scientific journal? It would strengthen our case no end, if scientific papers of that quality would come from several sources, not only from Berkeley and Perth. later remarking to a journalist in my presence, I still cant believe he wrote that. Hes really a molecular biologist pretending to be a lawyer. with many other gents at the top of their game in similar and other disciplines at divers splendid academies wowing alike, and none other than the very inventor of AZT, Richard Beltz PhD, Professor of Biochemistry at Loma Linda University School of Medicine in California, who first synthesized AZT in 1961 as a cell poison, confirming to me that I was justified in sounding a warning against the long-term therapeutic use of AZT, or its use in pregnant women, because of its demonstrated toxicity and side effects. Unfortunately, the devastating effects of AZT emerged only after the final level of experiments was well underway Your effort is a worthy one. I hope you succeed in convincing your government not to make AZT available and such top-deck investigative journalists as Martin Welz (who wrote the foreword), the late Donald Woods (Deserves serious treatment; more strength to your arm), and the late Paul Foot in London (Very good, convinced me completely) all going with these scientists, the M&G took a corporate view of things. Taking half a page to really rub it in, David Beresford summed up in his weekly column on 22 September 2000 that the medical and scientific literature Id cited in Debating AZT amounted to no more than the ravings of [a] drivelling conspiracy-theorist, loony, crackpot fruitcake. Im a professional at spotting weirdos. Even though the more he read it, he said, squinting through his addled, glazed-eyed Parkinsons fog, the more it made a strange kind of sense. Still, he threw it into his rubbish bin humming a happy little tune to myself. Before inscribing this demented effusion, your Mr Beresford may well have solicited the expert scientific advice of M&G board chairman Professor Malegapuru Makgoba PhD, then president of the South African Medical Research Council, now Vice-Chancellor and Principal of the University of KwaZulu-Natal, and world-famous for repeatedly accusing President Mbeki of dabbling in pseudo-science, lacking understanding, likening him to a Nazi, and charging him with collaboration in the greatest genocide of our time. If so, the highly respected, most eminent scientist (with the shaky CV) would have advised Mr Beresford along the lines of what hed already told me: I do not intend to engage in nonsensical debates on AZT ... I find the issues you raise a total waste of energy but perhaps more exciting for ignorant people in the field. Remember that I am the scientist and not you. Small wonder that in certain quarters Loyal Natives like these are considered a national embarrassment. In an article in your newspaper on the 9th of last month, Mr Beresfords simple daughter Belinda was still claiming that mass antiretroviral therapy (ART) has potentially life-saving effects several months after the publication of that massive Lancet study in August last year, which found ARVs dont work and that they increase the death rate of sick people given them. Ones left wondering whether Miss Haffajee and the journalists you employ, such as the Beresfords, Mr Forrest and the rest of their white liberal sort, champion AZT and other drug industry merchandise for Africans out of the goodness of their hearts, or whether its because your newspaper is receiving a big fat payoff from GlaxoSmithKline and/or other pharmaceutical companies like the one it got (before your time, to be fair) from Shell Oil Company (but theres another story). Since its express M&G editorial and management board policy to punt AZT for GlaxoSmithKline whenever it gets the chance, it may be arguable that no one has any cause to moan when the newspaper simply carries out this policy by suppressing research findings brought to its attention about how bad the drug is and the lethal harm its causing the African poor. Following this tack, the M&G would seem to be quite within its rights in guarding AZTs market reputation, considering that its inextricably tied to its own in a commercial brand match, and that any damage to the former will inevitably redound negatively on newspaper sales and company profits. So that if Miss Haffajees darling medicament is exposed as a deadly fraud like Bayers arsenic-based Salvarsan injections for syphilis between 1910 and the mid-fifties (endorsed by the Health Organization of the League Of Nations in 1934), causing brain damage (dementia, paralysis, as with AZT) and other terrible harm (including dead and crippled babies, as with AZT) in hundreds of thousands of cases the M&G will take a terrible knock to its credibility, and might have to suffer a change to its popular nickname from the Mail and Garbage to the Mail and Complete Garbage, with Miss Haffajee maybe even getting sacked over it. As she said in an article in the M&G on 17 December 2004, following the embarrassing fuss that my revelations about AZT had kicked up, This newspaper has always supported the need for an effective antiretroviral programme and will not in future [publish anything] which dilutes this message or creates confusion in the minds of readers. The provenance of this excellent principle can be traced to US General William Westmoreland, who wisely pointed out that during controversial wars, especially criminal ones, Without censorship, things can get terribly confused in the public mind. This is why it was necessary that a supine and compliant commercial press should also have supported the need for an effective American military programme in Vietnam; although in the case of that particular war it didnt, eventually quitting the censorship, dispelling the lies and ending the delusion, thereby getting the Americans to stop murdering the Vietnamese people and to go home. In the circumstances, it may be arguable further that in doing battle at the forefront of the War on AIDS the M&G cannot be expected to publish information creating confusion in the minds of its readers about whether the antiretroviral programme in South Africa really is effective; nor can the newspaper be expected to dilute its message about the need for ARVs, by ventilating recently published data confirming previously published reports that they are ineffective as medicines and that, just as cell poisons can be expected to do, they are poisoning and killing thousands of people in South Africa the most vulnerable and voiceless, the African poor. I hope, however, now that youve been apprised of the horrible facts about AZT and similar drugs, you might see things differently and tell Miss Haffajee to stop behaving like the US military. And like Tony Leon and his DA too, whose DEMOCRATIC ALLIANCE PUBLIC HEALTH WARNING! issued in October 2005 ranked me No. 1 among the countrys AIDS DISSIDENTS (like a listed communist during the old days), and said that because Im so dangerous the media [should] deny [my] dissident views publicity; particularly since in making known the research literature on the lethal toxicity of AZT and similar drugs, I merely hide behind the excuse of promoting scientific debate in order to promote views that are false and dangerous. South Africa cannot let this continue any longer. Although the Press Code of Professional Practice allows that A newspaper is justified in strongly advocating its own views on controversial topics provided that it treats its readers fairly by not misrepresenting or suppressing relevant facts. youll surely agree that the M&G isnt treating its readers fairly by suppressing relevant facts about AZT and similar drugs detailed in the ICC complaint, because this stultifies what the Press Code says is the primary purpose of gathering and distributing news and opinion which is to serve society by informing citizens and enabling them to make informed judgments on the issues of the time thus breaching your newspapers most basic responsibility stated in the very first section of the Code, namely to report news truthfully, accurately and fairly in a balanced manner, without an intentional or negligent departure from the facts whether by misrepresentation [or] material omissions. If youre with me on this, you might consider calling a meeting of your editors and reporters pronto to advise them that youre no longer willing to be party to the slaughter of your fellow Africans in the name of modern scientific medicine and multinational corporate profits, if only because your newspapers continuing conscious complicity in this crime, now that you know, exposes you and your employees to prosecution in the highest criminal court in the world. If it ever comes to this, though, you might get off pleading that as a company director rather than a journalist you have no legal duty to tell the truth, to inform your newspapers readers about anything, and even less to serve the general public good. Your sole obligation is to the investors in your newspaper enterprise, which the law constrains you to discharge by doing whatever it takes to ensure maximum stock growth and the most pleasant dividends possible; and any other high-minded public purpose dampening company profits is actually illegal. In short, to put it bluntly, corporate law requires you to act like a psychopath, and nothing less; and spreading lies and getting involved in the killing of thousands of innocent people is a tried and tested way of swelling newspaper sales, as the American corporate media found yet again when recycling the Administrations fake, planted stories about imaginary Weapons of Mass Destruction in Iraq to mobilize public opinion behind the invasion. In 1994 and again last year the prominent American AIDS treatment activist Sean Strubb (probably a good personal friend of Achmats) privately conceded to New York journalist  HYPERLINK "http://www.stopsmilingonline.com/features_detail.html?id1=740" Celia  HYPERLINK "http://www.stopsmilingonline.com/features_detail.html?id1=743" Farber that AZT had killed a generation (of American homosexuals) and that her work to expose the drug, for which shed been pitilessly vilified and abused for nearly two decades, had saved countless lives. I protest against your M&Gs suppression of the information provided in the ICC complaint about how toxic ARVs are killing African people critical information that could save countless lives and at your newspapers continuing complicity in Achmats deceptive and deadly propaganda campaign for these drugs, which recently released reports cited in the complaint show to have killed a generation, or more precisely, according to the figures revealed in these reports, are literally decimating a generation of South Africans diagnosed HIV-positive, mostly black, mostly poor. During a telephone chat in October 2004 you told me you support the publication of controversial viewpoints, so Id be grateful if youd let me know what you intend doing about this. Yours sincerely  ADV ANTHONY BRINK CHAIRMAN: TREATMENT INFORMATION GROUP     PAGE  PAGE 3 *+456y{|}ضؑo]K9]#hXBhv(5CJOJQJ^JaJ#hXBhs5CJOJQJ^JaJ#hXBh,5CJOJQJ^JaJ hXBhO&)CJOJQJ^JaJ hXBhE;CJOJQJ^JaJ hXBh,CJOJQJ^JaJ&hXBh^95CJOJQJ\^JaJ h,5CJOJQJ\^JaJ hXB5CJOJQJ\^JaJ&hXBh,5CJOJQJ\^JaJ&hXBhE;5CJOJQJ\^JaJ+56]yz{|}~  $dh7$8$H$a$gd2a$dh7$8$H$a$gd, 7$8$H$gd,$d7$8$H$a$gd,     " # $ . 4 5 6 7 L Q R S T m s t u v ƲvvvbvvQ h55CJOJQJ\^JaJ&hXBhfgl5CJOJQJ\^JaJ&hXBhlE5CJOJQJ\^JaJ&hXBhK[5CJOJQJ\^JaJ&hXBh,5CJOJQJ\^JaJ&hXBhS5CJOJQJ\^JaJ#hOA5>*CJOJQJ\^JaJ#h2a5>*CJOJQJ\^JaJ)hXBh,5>*CJOJQJ\^JaJ $ 7 T v  C j m x   7$8$H$gd% 7$8$H$gddhx<7$8$H$gd2adh7$8$H$gd~]Adhx7$8$H$gd2adhx7$8$H$gd2adhxx7$8$H$gd2a      9 ? @ B C a f s_K:_s_ h|[5CJOJQJ\^JaJ&hXBh>vp5CJOJQJ\^JaJ&hXBh,5CJOJQJ\^JaJ&hXBhS5CJOJQJ\^JaJ#hXBh W5CJOJQJ^JaJh|[5CJOJQJ^JaJ#hXBhlE5CJOJQJ^JaJ#hXBh,5CJOJQJ^JaJ#hXBh2a5CJOJQJ^JaJh~]A5CJOJQJ^JaJ#hXBhS5CJOJQJ^JaJf g i j m t w x    ʹ۹ۗrr]r]I&h: h2a5CJOJQJ\^JaJ)h2ah2a56CJOJQJ\^JaJ h5CJOJQJ\^JaJ&h2ah2a5CJOJQJ\^JaJ hOA5CJOJQJ\^JaJ h: 5CJOJQJ\^JaJ h2a5CJOJQJ\^JaJ h,5CJOJQJ\^JaJ h|[5CJOJQJ\^JaJ&hXBhu5CJOJQJ\^JaJ  f m   &)*+@۹۹ۧۖۈwiXGGGG hXBh;aCJOJQJ^JaJ hXBh^9CJOJQJ^JaJhb2CJOJQJ^JaJ hXBhb2CJOJQJ^JaJh[CJOJQJ^JaJ hXBh4UCJOJQJ^JaJ#hXBh,5CJOJQJ^JaJ hXBhX[CJOJQJ^JaJ hXBh0^CJOJQJ^JaJ hXBh,CJOJQJ^JaJ&hXBh,5CJOJQJ\^JaJ     *+@go% hh7$8$H$^hgd[7$8$H$^gd% hh7$8$H$^hgd[ h7$8$H$gd[ hh7$8$H$^hgd[$7$8$H$a$gd%<FVYͻududSBS1 hXBhF>TCJOJQJ^JaJ hXBhlCJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBhn ,CJOJQJ^JaJ hXBhl.CJOJQJ^JaJ hXBhw*CJOJQJ^JaJ#hXBhK[5CJOJQJ^JaJ#hXBhfgl5CJOJQJ^JaJ#hXBh,5CJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBh;aCJOJQJ^JaJ hXBh_CJOJQJ^JaJ6E`d?ORUgޚxxgVggVg hXBhVCJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBhgCJOJQJ^JaJ hXBhuCJOJQJ^JaJ hXBhZCJOJQJ^JaJ hXBhAgCJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBhF>TCJOJQJ^JaJ hXBhlCJOJQJ^JaJ hXBh CJOJQJ^JaJ! oDE  !"#5It~F|kZI hXBhy/CJOJQJ^JaJ hXBh-CJOJQJ^JaJ hXBhtCJOJQJ^JaJ#hXBh,6CJOJQJ^JaJ hXBh^CJOJQJ^JaJ hXBh!JjCJOJQJ^JaJ hXBh$J|CJOJQJ^JaJ hXBh,CJOJQJ^JaJ)hXBh,B*CJOJQJ^JaJph/hXBh,6B*CJOJQJ]^JaJph%r/ "1$%&>')#*, /s/0(12x3 4$ ha$gd% hh7$8$H$^hgdm  hgd% hh7$8$H$^hgd[$7$8$H$a$gd%FN ./=kst   ޼ޚxgVVgE4 hXBhjNCJOJQJ^JaJ hXBhJCJOJQJ^JaJ hXBhqeCJOJQJ^JaJ hXBhB|CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBh*eCJOJQJ^JaJ hXBh,MCJOJQJ^JaJ hXBhjnNCJOJQJ^JaJ hXBh_6CJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBhWCJOJQJ^JaJ/38JTwy  " # $ 5 > C X b c ޼ޫ͚xgV hXBhiCJOJQJ^JaJ hXBhOHCJOJQJ^JaJ hXBh'w'CJOJQJ^JaJ hXBhECJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhqeCJOJQJ^JaJ hXBhjnNCJOJQJ^JaJ hXBhJCJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBhB|CJOJQJ^JaJ M![!!!w""""""f#l#&$($%&&&&&'޼ޫޚމxgVgEg hXBhv_OJQJ^JmH sH  hXBhOJQJ^JmH sH  hXBh,OJQJ^JmH sH  hXBhlCJOJQJ^JaJ hXBh|CJOJQJ^JaJ hXBhoCJOJQJ^JaJ hXBhjnNCJOJQJ^JaJ hXBh SCJOJQJ^JaJ hXBh1`CJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBhSCJOJQJ^JaJ'6'='>'?')#*,#.%.].a.i.n..... ///0000ͼ͚͉͉͉wc͚Q@ hXBhjnNOJQJ^JmH sH #hXBh,6CJOJQJ^JaJ&hXBh,6OJQJ]^JmH sH #hXBh,OJQJ]^JmH sH  hXBhfOJQJ^JmH sH  hXBh,CJOJQJ^JaJ hRwh,CJOJQJ^JaJ h[h,CJOJQJ^JaJ hXBh,OJQJ^JmH sH  hXBh],OJQJ^JmH sH  hXBhj%OJQJ^JmH sH 00011!1(1223323;3D3K33355̻̪wfRA hXBh_sCJOJQJ^JaJ&hXBh,6CJOJQJ]^JaJ hXBhMOCJOJQJ^JaJ hXBhX)CJOJQJ^JaJ hXBh .CJOJQJ^JaJ hXBh?&;CJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBh?&;OJQJ^JmH sH  hXBh,OJQJ^JmH sH #hXBhjnN6OJQJ^JmH sH  hXBhjnNOJQJ^JmH sH  45&788;6??SAjCEFGGHI_J hh7$8$H$^hgd} hh7$8$H$^hgd{vr$7$8$H$a$gd% hh7$8$H$^hgdcP$ ha$gd% hh7$8$H$^hgdm555#5&5,51525m5555:6@666778/8;8;:?>???K?????B+CBCNC޼޼ޫޫޚޚޚވwfވUw hXBhk`CJOJQJ^JaJ hXBhz-CJOJQJ^JaJ hXBhMf CJOJQJ^JaJ#hXBh,6CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh_sCJOJQJ^JaJ hXBh,ROCJOJQJ^JaJ hXBh .CJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBhCJOJQJ^JaJ!NCiCjCtCCCCCD D\D]DaDkD}DDDDDDDDDDDD EͫxgV hXBhLCJOJQJ^JaJ hXBh wCJOJQJ^JaJ hXBhhCJOJQJ^JaJ hXBhMf CJOJQJ^JaJ hXBhv7CJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBh^ CJOJQJ^JaJ hXBhADfCJOJQJ^JaJ hXBhcCJOJQJ^JaJ hXBh,CJOJQJ^JaJ EE6E8E9E?EPE]EdEfEgEyEEEEEEEF&FjFpFtFͼＫ﫚xgVgEg hXBhJ_CJOJQJ^JaJ hXBh)'LCJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBhMf CJOJQJ^JaJ hXBhhCJOJQJ^JaJ hXBhqSMCJOJQJ^JaJ hXBh}CJOJQJ^JaJ hXBh wCJOJQJ^JaJ hXBh-CJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBhKCJOJQJ^JaJtF{F~F)G.GcGdGtGuGGGGGGGGHH.I/I2I@IIII˺˩˩˩˩ˇveTeB#hXBh,6CJOJQJ^JaJ hXBh4&CJOJQJ^JaJ hXBhiCJOJQJ^JaJ hXBhqwVCJOJQJ^JaJ hXBhLCJOJQJ^JaJ hXBhqCJOJQJ^JaJ hXBhMf CJOJQJ^JaJ hXBhUCJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBh\jCJOJQJ^JaJ#hXBh\j6CJOJQJ^JaJIIJJ"K+KKKJONOgOpOOOOOOOAP`PoPpPPܹܨܗܨ܂܂kZI hXBh41CJOJQJ^JaJ hXBhMf CJOJQJ^JaJ,hXBh,6B*CJOJQJ^JaJph)hXBh,B*CJOJQJ^JaJph hXBh)OCJOJQJ^JaJ hXBhUCJOJQJ^JaJ#hXBh,6CJOJQJ^JaJ hXBhgCJOJQJ^JaJ hXBh,CJOJQJ^JaJ#hXBh,CJOJQJ]^JaJ_JKLOPQsR S]TUULVVLYYZ\]d_` hh7$8$H$^hgd\0 hh7$8$H$^hgdc hh7$8$H$^hgd}$7$8$H$a$gd%PPPPaRjRmRpRUUgVhVVVVVWWLYdY޼޼ޫޔ}d}SBS h\0h}CJOJQJ^JaJ h\0h,CJOJQJ^JaJ0hXBhP6B*CJOJPJQJ^JaJph-hXBhPB*CJOJPJQJ^JaJph-hXBh,B*CJOJPJQJ^JaJph hXBh QCJOJQJ^JaJ hXBh)OCJOJQJ^JaJ hXBh|CJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBhCCJOJQJ^JaJdYjYYZ [[[0[1[_[n[z[[[[[[\\ \%\\\\п{jYjHjj hXBhZCJOJQJ^JaJ hXBhvCJOJQJ^JaJ hXBhe8CJOJQJ^JaJ hXBh 9CJOJQJ^JaJ hXBh|CJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBh,CJOJQJ^JaJ h\0h,CJOJQJ^JaJ-hXBh,B*CJOJPJQJ^JaJph0hXBh,6B*CJOJPJQJ^JaJph\\\\\1]?]]]]]^3^E^J^^^^^^^^__(_)_c_ǰǙǙǀiǙǀiR-hXBh;GB*CJOJPJQJ^JaJph-hXBhdB*CJOJPJQJ^JaJph0hXBh,6B*CJOJPJQJ^JaJph-hXBhwtB*CJOJPJQJ^JaJph-hXBhMf B*CJOJPJQJ^JaJph-hXBh,B*CJOJPJQJ^JaJph hXBh,CJOJQJ^JaJ hXBh'|CJOJQJ^JaJc_d______`````]abcccQdf h/hͼ͖͖ͫp_J(hXBhDCJOJQJ^JaJmH sH  h\0h,CJOJQJ^JaJ$hXBh CJOJPJQJ^JaJ$hXBh,CJOJPJQJ^JaJ(hXBh,CJOJQJ^JaJmH sH  hXBh/CJOJQJ^JaJ hXBhf:jCJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBh)(CJOJQJ^JaJhXBh,6CJOJQJaJ`]abcQdI= $a$gd%P$EƀSlF.[$\$a$gd%V hh7$8$EƀSlF.H$^hgd\0$[$\$a$gd%Qdf hh-klmpt vvwx}yz|~ hh7$8$H$^hgdI hh7$8$H$^hgdk J$7$8$H$a$gd%$[$\$a$gd% hh7$8$H$^hgd\0/hshthuhhhhhhh-k8k@k[k llllll!m.mCmPmo^o^oMox?x@xx}y~yyyyyz zʹq\G\2\2\(hXBhCJOJQJ^JaJmH sH (hXBhJmCJOJQJ^JaJmH sH (hXBhz2CJOJQJ^JaJmH sH  hIh,CJOJQJ^JaJ1hXBh"r B*CJOJQJ^JaJmH phsH 1hXBh<_B*CJOJQJ^JaJmH phsH 1hXBhEB*CJOJQJ^JaJmH phsH 1hXBh,B*CJOJQJ^JaJmH phsH 1hXBhH%B*CJOJQJ^JaJmH phsH  zzzzzzzz;{?{M{a{d{g{l{p{{{{ҹҠoZA҇1hXBh1B*CJOJQJ^JaJmH phsH (hXBh_CJOJQJ^JaJmH sH .hXBh,6CJOJQJ]^JaJmH sH 1hXBhD^cB*CJOJQJ^JaJmH phsH 1hXBhz2B*CJOJQJ^JaJmH phsH 1hXBhaVB*CJOJQJ^JaJmH phsH 1hXBh,B*CJOJQJ^JaJmH phsH (hXBh,CJOJQJ^JaJmH sH {{|}}~.~B~a~~~~~~~~~ͼxgVE4 hXBh1CJOJQJ^JaJ hXBh-!CJOJQJ^JaJ hXBhbCJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBhE_CJOJQJ^JaJ hXBh9xCJOJQJ^JaJ hXBhD^CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh,CJOJQJ^JaJ1hXBh,B*CJOJQJ^JaJmH phsH 1hXBhFB*CJOJQJ^JaJmH phsH ~~~89TUadfjptͼxgVEVEV hXBh9xCJOJQJ^JaJ hXBhtVCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh~9CJOJQJ^JaJ hXBh5 CJOJQJ^JaJ hXBhmCJOJQJ^JaJ hXBh-!CJOJQJ^JaJ hXBhbCJOJQJ^JaJ hXBh1CJOJQJ^JaJ hXBh"CJOJQJ^JaJ hXBh8CJOJQJ^JaJ *BILMTUYq΀ӀԀ߀DGHNag޼ޫޚޚޚ͚x޼xfTx#hXBhq6CJOJQJ^JaJ"hXBhq6CJOJQJ]aJ hXBhqCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh5zCJOJQJ^JaJ hXBh9xCJOJQJ^JaJ hXBhJ`CJOJQJ^JaJ hXBhmp[CJOJQJ^JaJ hXBhtVCJOJQJ^JaJ hXBh'tCJOJQJ^JaJgxÂ|΃':R]^_„DŽфԄ޻ުޙwfwU hXBh 9CJOJQJ^JaJ hXBh/yCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh~CJOJQJ^JaJ hXBhjCJOJQJ^JaJ hXBhfCJOJQJ^JaJ#hXBhtV6CJOJQJ^JaJ hXBh9xCJOJQJ^JaJ hXBhtVCJOJQJ^JaJ hXBhDCJOJQJ^JaJRNNJ͋ U hhxx7$8$H$^hgdrn[ hhx7$8$H$^hgdrn[ hhx7$8$H$^hgdrn[ 7$8$H$gd%$7$8$H$a$gd% hh7$8$H$^hgdE$%&*.4}~Ά$Lͻ滋wfwUUDUDwDUD hXBh'hKCJOJQJ^JaJ hXBh 9CJOJQJ^JaJ hXBhKCJOJQJ^JaJ hXBh{@CJOJQJ^JaJ hXBhbCJOJQJ^JaJ hXBh~CJOJQJ^JaJ hXBh/yCJOJQJ^JaJ#hXBhj6CJOJQJ^JaJ hXBhjCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhiCJOJQJ^JaJLMNS} =H‰ͼwwfwUwD3 hXBhBCJOJQJ^JaJ hXBhKCJOJQJ^JaJ hXBhE?CJOJQJ^JaJ hXBh)eCJOJQJ^JaJ hXBhO^CJOJQJ^JaJ hXBh^CJOJQJ^JaJ#hXBhu6CJOJQJ^JaJ hXBh#CJOJQJ^JaJ hXBhuCJOJQJ^JaJ hXBh)CJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBh)CJOJQJ^JaJ‰Éɉ.KNUXstͼxxgxVVgVE4 hXBh$CJOJQJ^JaJ hXBhGaCJOJQJ^JaJ hXBhuCJOJQJ^JaJ hXBhfg:CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhQCJOJQJ^JaJ hXBh|?ICJOJQJ^JaJ hXBhP|CJOJQJ^JaJ hXBhO^CJOJQJ^JaJ hXBhBCJOJQJ^JaJ hXBhKCJOJQJ^JaJ hXBhj1CJOJQJ^JaJƊNJ_iqˎΎҎӎԎͻvevTvCevCeC hXBh93!CJOJQJ^JaJ hXBhVCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh 8CJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBh,CJOJQJ^JaJ#hXBh,5CJOJQJ^JaJ#hXBh,=5CJOJQJ^JaJ hXBh@2=CJOJQJ^JaJ hXBh)CJOJQJ^JaJ hXBhGaCJOJQJ^JaJxyz;ȕ8 ә5z hh7$8$H$^hgdNO hh7$8$H$^hgdrn[$7$8$H$a$gd% hhx7$8$H$^hgdrn[ /6SwxyzďŏƏۏ܏ＪzhzWFW5W hXBhCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhYCJOJQJ^JaJ#hXBh't5CJOJQJ^JaJ#hXBh,=5CJOJQJ^JaJhrn[5CJOJQJ^JaJhRw5CJOJQJ^JaJ#hXBh,5CJOJQJ^JaJ hXBh 8CJOJQJ^JaJ hXBhVCJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBh'tCJOJQJ^JaJ[\];aglpx!&8>?BcͼxggVgEgEg hXBh@CJOJQJ^JaJ hXBhmBiCJOJQJ^JaJ hXBh#0\CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh1CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBh5CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhnCJOJQJ^JaJ hXBhX9hCJOJQJ^JaJcȒɒϒԒ !&osy͓ՓܓͼxgxggVEV hXBhwCJOJQJ^JaJ hXBh(CJOJQJ^JaJ hXBhp&gCJOJQJ^JaJ hXBh0CJOJQJ^JaJ hXBhAOLCJOJQJ^JaJ hXBhL@CJOJQJ^JaJ hXBhFCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh#0\CJOJQJ^JaJ hXBh$CJOJQJ^JaJ %&-./X\ɔʔϔͼމxgVE4E hXBhCJOJQJ^JaJ hXBhHCJOJQJ^JaJ hXBhmBiCJOJQJ^JaJ hXBh }CJOJQJ^JaJ hXBhUFCJOJQJ^JaJ hXBhFCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhAOLCJOJQJ^JaJ hXBh@`CJOJQJ^JaJ hXBh'FCJOJQJ^JaJ hXBhL@CJOJQJ^JaJ hXBh0CJOJQJ^JaJϔՔߔϕӕ֕ݕ8QR St՛$4mq`O hXBhNCJOJQJ^JaJ hXBhDCJOJQJ^JaJ hXBhyjCJOJQJ^JaJ-HhZhXBh,CJOJQJ^JaJ hXBh#CJOJQJ^JaJ hXBhLCJOJQJ^JaJ#hXBh,6CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhUECJOJQJ^JaJ hXBh,CJOJQJ^JaJmp,EŞƞݞ)@N޻wwfTC hXBht-CJOJQJ^JaJ#hXBh,6CJOJQJ^JaJ hXBhUECJOJQJ^JaJ hXBhkCJOJQJ^JaJ hXBhYncCJOJQJ^JaJ hXBhA"CJOJQJ^JaJ hXBh" wCJOJQJ^JaJ hXBh,CJOJQJ^JaJ#hNOhN6CJOJQJ^JaJ hXBhNCJOJQJ^JaJ hXBhVfCJOJQJ^JaJe,ġڤ ϵлR3hk hh7$8$H$^hgdLV$7$8$H$a$gd%$1<enow{,18FRͼxgVE4 hXBhZ2CJOJQJ^JaJ hXBhPCJOJQJ^JaJ hXBh?EWcͼvveTC hXBhj'^CJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBh^6CJOJQJ^JaJ#hXBh,5CJOJQJ^JaJ#hXBh8O5CJOJQJ^JaJ hXBhLCJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBh)!CJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBh{%CJOJQJ^JaJ hXBhaCJOJQJ^JaJP  T OH6 "#I%}& hh7$8$H$^hgdLV $a$gd%cqw  +2v~޼޼޼ޫޚޚމ޼xgggxx hXBh|CJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBh-NCJOJQJ^JaJ hXBhP}CJOJQJ^JaJ hXBh\QCJOJQJ^JaJ hXBhD|CJOJQJ^JaJ hXBhU^CJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBhPCJOJQJ^JaJ"$,/9<EFKQV\]^aeoͼͫޫͫͫx͉g hXBhxyCJOJQJ^JaJ hXBhXCJOJQJ^JaJ hXBhn}VCJOJQJ^JaJ hXBhU^CJOJQJ^JaJ hXBhWBCJOJQJ^JaJ hXBhG<CJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBh|CJOJQJ^JaJ hXBh##CJOJQJ^JaJ&12APwABbo         D ˺ܺܩܩܩvܩeTeT hXBh6CJOJQJ^JaJ hXBhZfCJOJQJ^JaJ hXBh&/CJOJQJ^JaJ hXBh<CJOJQJ^JaJ hXBhDCJOJQJ^JaJ hXBh*CJOJQJ^JaJ hXBh%CJOJQJ^JaJ hXBhX'ICJOJQJ^JaJ hXBhxyCJOJQJ^JaJ#hXBhxy6CJOJQJ^JaJ D g q      p      c x z      ̻̻̪̙wfUUC#hXBhR6CJOJQJ^JaJ hXBhRCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh5CJOJQJ^JaJ hXBhbCJOJQJ^JaJ hXBh%CJOJQJ^JaJ hXBh+,CJOJQJ^JaJ hXBhJACJOJQJ^JaJ hXBhxyCJOJQJ^JaJ#hXBhZf6CJOJQJ^JaJ hXBhZfCJOJQJ^JaJ      $(8FGPdestܺ܇veTC hXBhuCJOJQJ^JaJ hXBhSCJOJQJ^JaJ hXBhi@CJOJQJ^JaJ hXBhbCJOJQJ^JaJ hXBhzCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhJACJOJQJ^JaJ hXBhRCJOJQJ^JaJ hXBhxyCJOJQJ^JaJ#hXBhxy6CJOJQJ^JaJ#$o&̻wfUDfDf3 hXBh~CJOJQJ^JaJ hXBhzCJOJQJ^JaJ hXBhECJOJQJ^JaJ hXBhYCJOJQJ^JaJ hXBhPCJOJQJ^JaJ hXBhJACJOJQJ^JaJ hXBhvCJOJQJ^JaJ hXBhzCJOJQJ^JaJ hXBhuCJOJQJ^JaJ#hXBhh6CJOJQJ^JaJ hXBhhCJOJQJ^JaJ hXBh*CJOJQJ^JaJ&HKZ[vDﻪwfUfUfDf hXBh cCJOJQJ^JaJ hXBh> CJOJQJ^JaJ hXBh"CJOJQJ^JaJ hXBhxyCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh{CJOJQJ^JaJ hXBh4CJOJQJ^JaJ hXBhaCJOJQJ^JaJ#hXBh~6CJOJQJ^JaJ hXBh~CJOJQJ^JaJ hXBhJACJOJQJ^JaJDIObj  *BKMQS`fnͼ͚͚͚͉ͫͫxgVgVVEV hXBhAJCJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBh0CJOJQJ^JaJ hXBh.!CJOJQJ^JaJ hXBh_CJOJQJ^JaJ hXBh'7CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhhCJOJQJ^JaJ hXBh"CJOJQJ^JaJ hXBh[CJOJQJ^JaJ hXBhECJOJQJ^JaJnopqs@AMNO_~ͼ͚ͫxxggggVE hXBhS|LCJOJQJ^JaJ hXBhsCJOJQJ^JaJ hXBh~CJOJQJ^JaJ hXBhv+uCJOJQJ^JaJ hXBhFS$CJOJQJ^JaJ hXBh.!CJOJQJ^JaJ hXBhhCJOJQJ^JaJ hXBh%CJOJQJ^JaJ hXBhk#CJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBh{CJOJQJ^JaJfbcowblͼ͚͚xgVE hXBh{CJOJQJ^JaJ hXBh*cCJOJQJ^JaJ hXBh*CJOJQJ^JaJ hXBh_bCJOJQJ^JaJ hXBh.CJOJQJ^JaJ hXBhE:CJOJQJ^JaJ hXBh.!CJOJQJ^JaJ hXBh:CJOJQJ^JaJ hXBhhCJOJQJ^JaJ hXBhS|LCJOJQJ^JaJ hXBhYncCJOJQJ^JaJ 56x9Zhͼ޼xgVV hXBhCJOJQJ^JaJ hXBh.!CJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBhhCJOJQJ^JaJ hXBh$wCJOJQJ^JaJ hXBh.CJOJQJ^JaJ hXBhhCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh' CJOJQJ^JaJ hXBh[4CJOJQJ^JaJ *<Idetuͼ͉xgx͚VE4x hXBhOCJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBh{CJOJQJ^JaJ hXBhhCJOJQJ^JaJ hXBhq CJOJQJ^JaJ hXBh~?CJOJQJ^JaJ hXBh0CJOJQJ^JaJ hXBhC;TCJOJQJ^JaJ hXBh1CJOJQJ^JaJ hXBhhCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh4NCJOJQJ^JaJ   N g h m q      ＫxggVE hXBh' CJOJQJ^JaJ hXBh)DCJOJQJ^JaJ hXBh'CJOJQJ^JaJ hXBhiCJOJQJ^JaJ hXBh~?CJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBhhCJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhq CJOJQJ^JaJ hXBhOCJOJQJ^JaJ   !5!>!L!m!x!|!}!!!!!!!!!!!""޼޼xgVE hXBhbY4CJOJQJ^JaJ hXBh_B^CJOJQJ^JaJ hXBhguCJOJQJ^JaJ hXBh;3vCJOJQJ^JaJ hXBhZ/\CJOJQJ^JaJ hXBh%CJOJQJ^JaJ hXBh0CJOJQJ^JaJ hXBh'CJOJQJ^JaJ hXBhC{CJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBhcQCJOJQJ^JaJ"&"'"("7"""""""""""""####T#|#####͉͉x﫼fU hXBhxCJOJQJ^JaJ#hXBh\6CJOJQJ^JaJ hXBhguCJOJQJ^JaJ hXBhX[CJOJQJ^JaJ hXBh|eCJOJQJ^JaJ hXBh"QCJOJQJ^JaJ hXBhzCJOJQJ^JaJ hXBhvCJOJQJ^JaJ hXBhJ[CJOJQJ^JaJ hXBh\CJOJQJ^JaJ##)%I%W%_%f%%%%%&J&T&d&z&}&&&&&ͼޫޚމxgVgE4E4 hXBh.ACJOJQJ^JaJ hXBhZ/\CJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBhmSCJOJQJ^JaJ hXBh-SACJOJQJ^JaJ hXBhvCJOJQJ^JaJ hXBhzFCJOJQJ^JaJ hXBhECJOJQJ^JaJ hXBhMCJOJQJ^JaJ hXBh3CJOJQJ^JaJ hXBh\CJOJQJ^JaJ hXBh]!CJOJQJ^JaJ&&&&& '/'9'<'u'''''''''''''''( ((( ($(6(wfwwUw hXBh}CJOJQJ^JaJ hXBh|CJOJQJ^JaJ hXBh3CJOJQJ^JaJ hXBh#CJOJQJ^JaJ hXBh]!CJOJQJ^JaJ hXBh[CJOJQJ^JaJ hXBh*CJOJQJ^JaJ#hXBh|eCJH*OJQJ^JaJ hXBhM.CJOJQJ^JaJ hXBh|eCJOJQJ^JaJ6(E(L(M(U(d(((((((((((((())0)4)5)=)B)S)T)Y)^)ＫxgV hXBh6CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh[CJOJQJ^JaJ hXBh~RCJOJQJ^JaJ hXBhoCJOJQJ^JaJ hXBh_\CJOJQJ^JaJ hXBh.ACJOJQJ^JaJ hXBh 2CJOJQJ^JaJ hXBhm5CJOJQJ^JaJ hXBh*CJOJQJ^JaJ^)))))))* ***2*:*=*F*O*P*W*Z*[*e*s*޼͉x͉ͫgVE hXBh -CJOJQJ^JaJ hXBhXsCJOJQJ^JaJ hXBhzCJOJQJ^JaJ hXBh%CJOJQJ^JaJ hXBhZECJOJQJ^JaJ hXBh:yCJOJQJ^JaJ hXBh12CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh}CJOJQJ^JaJ hXBhk1CJOJQJ^JaJ}&)+X-/1 3I3u4v449*:+:-:;:f::::$a$gd%gd% $7$8$H$a$gd%$7$8$H$a$gd% hh7$8$H$^hgdLV$7$8$H$a$gd% $a$gd%s*u*v*}*************++ͼxgUgD3 hXBh=CJOJQJ^JaJ hXBh%CJOJQJ^JaJ#hXBhCCJH*OJQJ^JaJ hXBhCCJOJQJ^JaJ hXBhQCJOJQJ^JaJ hXBhXsCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhS$CJOJQJ^JaJ hXBhZECJOJQJ^JaJ hXBh\CJOJQJ^JaJ hXBhA5CJOJQJ^JaJ hXBh CJOJQJ^JaJ++x++++++++++,3,9,D,P,V,Z,[,n,﫚xgVgE hXBh^CJOJQJ^JaJ hXBhdCJOJQJ^JaJ hXBhTGYCJOJQJ^JaJ hXBh5iCJOJQJ^JaJ hXBh{CJOJQJ^JaJ hXBhZECJOJQJ^JaJ hXBh:CJOJQJ^JaJ hXBh>]CJOJQJ^JaJ hXBhsCJOJQJ^JaJ hXBhUCJOJQJ^JaJ hXBh 7CJOJQJ^JaJn,o,r,},,,,,,,,,,,,,!-(-2-E-F-V-X-ͼͫͫxgVEޫ hXBhmsCJOJQJ^JaJ hXBhfICJOJQJ^JaJ hXBhLn3CJOJQJ^JaJ hXBh"cCJOJQJ^JaJ hXBhyCJOJQJ^JaJ hXBhwvCJOJQJ^JaJ hXBh 7CJOJQJ^JaJ hXBh7!CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhZECJOJQJ^JaJ hXBh CJOJQJ^JaJX-`-a-j-r-y----- ..B.C.v.}......ͼޚxgVgޚE4 hXBh\CJOJQJ^JaJ hXBhI +CJOJQJ^JaJ hXBhBCJOJQJ^JaJ hXBhsCJOJQJ^JaJ hXBhQPCJOJQJ^JaJ hXBh`XtCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhsCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh**CJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBh_B^CJOJQJ^JaJ..._/`/o/s////////////00050N0W0X0Y0w0ͼ޼xxgVgV͚E hXBhNTCJOJQJ^JaJ hXBhjCJOJQJ^JaJ hXBhfCJOJQJ^JaJ hXBhv^#CJOJQJ^JaJ hXBh#CJOJQJ^JaJ hXBhdCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhI +CJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBh\CJOJQJ^JaJ hXBhpAeCJOJQJ^JaJw00000000000111"171@1C1I1M1N1Q1R1Y1[1ͼ͚ͫxggVEVxV hXBhmsCJOJQJ^JaJ hXBhiCJOJQJ^JaJ hXBh]ICJOJQJ^JaJ hXBh.\CJOJQJ^JaJ hXBhjCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhLCJOJQJ^JaJ hXBhS?CJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBhNTCJOJQJ^JaJ hXBhv^#CJOJQJ^JaJ[1\1]1a1j1k1111111111222!2ͼͫxgVE4E hXBhoCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhPCJOJQJ^JaJ hXBhcCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh&mCJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBheCJOJQJ^JaJ hXBh.\CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhNTCJOJQJ^JaJ hXBh42tCJOJQJ^JaJ!242V2^2_2`2y22222222222233 3 3(3G3H3I3Y3ͼͼxgޚVxgVVV hXBhdCJOJQJ^JaJ hXBhjCJOJQJ^JaJ hXBh}XCJOJQJ^JaJ hXBhBnCJOJQJ^JaJ hXBhd$CJOJQJ^JaJ hXBh3V"CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh0kCJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBhCJOJQJ^JaJY3Z3b3i33333333333333344444&4,41484@4W4Z4[4ޫxމgVVV hXBh>pCJOJQJ^JaJ hXBh;?CJOJQJ^JaJ hXBh}XCJOJQJ^JaJ hXBh*CJOJQJ^JaJ hXBhddCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhjCJOJQJ^JaJ hXBh6CJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBhZmCJOJQJ^JaJ[4s4u4v4444444444445͹raP?. hXBhVMCJOJQJ^JaJ hXBh2CJOJQJ^JaJ hXBhqCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh8MCJOJQJ^JaJ hXBhACJOJQJ^JaJ hXBh7{CJOJQJ^JaJ&hXBh,5CJOJQJ\^JaJ&hXBh,=5CJOJQJ\^JaJ hXBh@`CJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBhRCJOJQJ^JaJ55 5%54555;5H5W5X5[5x5555555555޼xgVggE4g hXBhn90CJOJQJ^JaJ hXBh?{CJOJQJ^JaJ hXBh#,CJOJQJ^JaJ hXBhoCJOJQJ^JaJ hXBh`CJOJQJ^JaJ hXBh}CJOJQJ^JaJ hXBh_CJOJQJ^JaJ hXBh7{CJOJQJ^JaJ hXBh63CJOJQJ^JaJ hXBh/CJOJQJ^JaJ hXBhACJOJQJ^JaJ hXBhXZCJOJQJ^JaJ555555666666626_6k6s6w6z6ͼޫ͉xgVE4x hXBhnCJOJQJ^JaJ hXBhoCJOJQJ^JaJ hXBhoCJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBh?HCJOJQJ^JaJ hXBh#tCJOJQJ^JaJ hXBhAC<CJOJQJ^JaJ hXBhXNCJOJQJ^JaJ hXBhu!\CJOJQJ^JaJ hXBh\=!CJOJQJ^JaJ hXBh63CJOJQJ^JaJ hXBhn90CJOJQJ^JaJz6{66666667777#7(797:7F7G7M7Y7a7޼ޫ͚xgVEg4 hXBh9mCJOJQJ^JaJ hXBhIECJOJQJ^JaJ hXBhmCJOJQJ^JaJ hXBhnTCJOJQJ^JaJ hXBh"CJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBh?HCJOJQJ^JaJ hXBh;CJOJQJ^JaJ hXBhXCJOJQJ^JaJ hXBhnCJOJQJ^JaJ hXBhoCJOJQJ^JaJ hXBhJXCJOJQJ^JaJa7g777777777777777788+8,8-8/80818޼xgxVEVVEVV hXBh,CJOJQJ^JaJ hXBhbW0CJOJQJ^JaJ hXBh![CJOJQJ^JaJ hXBhcICJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBhmCJOJQJ^JaJ hXBhw@CJOJQJ^JaJ hXBhIECJOJQJ^JaJ hXBhb CJOJQJ^JaJ hXBh9mCJOJQJ^JaJ hXBhnTCJOJQJ^JaJ1878O8X8Y8Z8n8o8u8~888888888ͼxgVgE4 hXBh_CJOJQJ^JaJ hXBh#,CJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhcICJOJQJ^JaJ hXBhIECJOJQJ^JaJ hXBha CJOJQJ^JaJ hXBhb CJOJQJ^JaJ hXBh/ WCJOJQJ^JaJ hXBhnTCJOJQJ^JaJ hXBhh CJOJQJ^JaJ hXBhmCJOJQJ^JaJ hXBh}CJOJQJ^JaJ888888888999-9<9B9F9J9T9ͼ﫚xgVE4 hXBhwTCJOJQJ^JaJ hXBh<2zCJOJQJ^JaJ hXBhLCJOJQJ^JaJ hXBhuCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBh$+CJOJQJ^JaJ hXBhe6CJOJQJ^JaJ hXBh63CJOJQJ^JaJ hXBhnCJOJQJ^JaJ hXBhiJCJOJQJ^JaJ hXBh\WCJOJQJ^JaJ hXBhJXCJOJQJ^JaJT9Z9r9s99999999999999ͼxgVEVE4 hXBh,CJOJQJ^JaJ hXBh3wWCJOJQJ^JaJ hXBhCJOJQJ^JaJ hXBhJCJOJQJ^JaJ hXBhXCJOJQJ^JaJ hXBh,CJOJQJ^JaJ hXBh`CJOJQJ^JaJ hXBhR CJOJQJ^JaJ hXBhoVCJOJQJ^JaJ hXBh&/CJOJQJ^JaJ hXBh$+CJOJQJ^JaJ hXBhXZCJOJQJ^JaJ9:::$:(:):*:+:,:-:::;:f::::Ｇr`Q=&hXBhqs5>*CJOJQJ^JaJh;[5CJOJQJ^JaJ#hXBhC5CJOJQJ^JaJ#hXBh+W5CJOJQJ^JaJ#hXBh,5CJOJQJ^JaJ hXBh_CJOJQJ^JaJ)jhXBhCJOJQJU^JaJ hXBhCJOJQJ^JaJ hXBh:JCJOJQJ^JaJ hXBh'9kCJOJQJ^JaJ hXBh!CJOJQJ^JaJ::::::::::;;4;K;U;g;;;ȶraP?0a?h\5CJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBh"SCJOJQJ^JaJ hXBhlCJOJQJ^JaJh%5CJOJQJ^JaJ#hXBhl5CJOJQJ^JaJ hXBh'CJOJQJ^JaJ#hXBh 5CJOJQJ^JaJ#hXBhmX5CJOJQJ^JaJ#hXBh,5CJOJQJ^JaJ#hXBh;[5CJOJQJ^JaJ&hXBh"S5>*CJOJQJ^JaJ:::;#;g;v;;;5<6<<<<<<<<<<<<<<<<<<$ $ a$gd%$a$gd%;;;;;;;;;;<#<$<%<3<4<5<6<;<ϾϜv^vM< hXBhp+CJOJQJ^JaJ hXBhlhCJOJQJ^JaJ/jeh\hlhCJOJQJU^JaJ h\hlhCJOJQJ^JaJ)jh\hlhCJOJQJU^JaJ h\hlCJOJQJ^JaJ hXBh CJOJQJ^JaJ hXBhlCJOJQJ^JaJ#hXBhl5CJOJQJ^JaJh\5CJOJQJ^JaJhqJ5CJOJQJ^JaJ;<H<I<O<X<b<<<<<<==#=%=&='=(=3=5=д¦}n\G)hhv1B*CJOJQJ^JaJph#hv1B*CJOJQJ^JaJphh:bh%CJOJQJaJj&hBZh UaJhnICJOJQJ^JaJhLVCJOJQJ^JaJh<.&CJOJQJ^JaJhlhCJOJQJ^JaJhzCJOJQJ^JaJh%CJOJQJ^JaJ hXBhlhCJOJQJ^JaJ hXBhBCJOJQJ^JaJ<<<<<<<<<<<<========= = = = = ====$a$gd%================ =!="=#=$=%=&=(=E=$xx^a$gdN $xa$gd%$a$gd%$a$gd%5=\=j=N>O>r>s>t>>>>>>>>>>?ꜹq\E-E/h\Ph%6>*B*CJOJQJ^JaJph,h\Ph%>*B*CJOJQJ^JaJph)h%h%B*CJOJQJ^JaJph#h8VB*CJOJQJ^JaJph0hh%0J>*B*CJOJQJ^JaJph8jShh%B*CJOJQJU^JaJph2jhh%B*CJOJQJU^JaJph,hh%6B*CJOJQJ^JaJph)hh%B*CJOJQJ^JaJphE=j==>>>>X??;ANCKEHKH}IXKLzM5PR hhxx7$8$H$^hgdLV $xxa$gdN$xx7$8$H$a$gdNxxgdN$xx7$8$H$a$gdN xx7$8$H$gdN?X????K@L@M@S@T@W@X@@@@@@AAAAHFVFeFfFKHzMOOjPtP)S6STꢿlUUUUUUU,hh%6B*CJOJQJ^JaJph8jThh%B*CJOJQJU^JaJph0hh%0J>*B*CJOJQJ^JaJph8jShh%B*CJOJQJU^JaJph2jhh%B*CJOJQJU^JaJph hLVh%CJOJQJ^JaJ)hh%B*CJOJQJ^JaJph!RPT|UVXZi[\]^``zarbbjcdfgkvllcmBnq $xxa$gdN hhxx7$8$H$^hgdLV$xx7$8$H$a$gdNTT|UV!W#WBWLWYYi[\{]]]]^````zarbbbbjcdeeeeeffkkԬԒu\Ԓ0hh%0J>*B*CJOJQJ^JaJph8jUhh%B*CJOJQJU^JaJph2jhh%B*CJOJQJU^JaJph,hh%B*CJH*OJQJ^JaJph hLVh%CJOJQJ^JaJ)hh%B*CJOJQJ^JaJph,hh%6B*CJOJQJ^JaJph$kkkklllBnppppppp q qRqSqTq\q]qsrͳlO8j Xhh%B*CJOJQJU^JaJph8j+Whh%B*CJOJQJU^JaJph hLVh%CJOJQJ^JaJ0hh%0J>*B*CJOJQJ^JaJph2jhh%B*CJOJQJU^JaJph8jVhh%B*CJOJQJU^JaJph)hh%B*CJOJQJ^JaJphsrtrrrrrr=s\svtwtuuuuuXwYwwͯ̀fIf0f0hh%0J>*B*CJOJQJ^JaJph8jYhh%B*CJOJQJU^JaJph2jhh%B*CJOJQJU^JaJph)hh%B*CJOJQJ^JaJph3hh%0J6>*B*CJOJQJ^JaJph;jXhh%6B*CJOJQJU^JaJph,hh%6B*CJOJQJ^JaJph5jhh%6B*CJOJQJU^JaJphquvxy|}~~i#n`TIˋ΍FxxgdN hhxx7$8$H$^hgdLV $xxa$gdNwwwxxx xJxKxLxxxxxxzzzzz{{`{a{{ƬƕƕwƬƕbbƕDƬbƕ;j\hh%6B*CJOJQJU^JaJph)hh%B*CJOJQJ^JaJph;j\hh%6B*CJOJQJU^JaJph,hh%6B*CJOJQJ^JaJph3hh%0J6>*B*CJOJQJ^JaJph5jhh%6B*CJOJQJU^JaJph;j [hh%6B*CJOJQJU^JaJph{{{(|7|?|@|}~~i"#nȄ΄`TIˋ΍FƬƀooXXoXXooooXoo,hh%6B*CJOJQJ^JaJph hLVh%CJOJQJ^JaJ)hh%B*CJOJQJ^JaJph-h8V0J6>*B*CJOJQJ^JaJph3hh%0J6>*B*CJOJQJ^JaJph5jhh%6B*CJOJQJU^JaJph;j]hh%6B*CJOJQJU^JaJph"F*ey̜zÝM]<ͦ  hhxx7$8$H$^hgdLV $xxa$gdN03̜zÝ]<ͦ "#nopuvwxït[0hh%0J>*B*CJOJQJ^JaJph8j^hh%B*CJOJQJU^JaJph2jhh%B*CJOJQJU^JaJph hLVh%CJOJQJ^JaJ,hh%6B*CJOJQJ^JaJph,hh%B*CJH*OJQJ^JaJph)hh%B*CJOJQJ^JaJphs hh]h`hgd &`#$gd $dha$gdlh$a$gd% $xxa$gdNïįů˯̯ɰɛlWF5-)-)hBjhBU hXBh%CJOJQJ^JaJ h:bh%CJOJQJ^JaJ)h%h%B*CJOJQJ^JaJph2ja`h%h AB*CJOJQJU^JaJph)hh%B*CJOJQJ^JaJph)hh%B*CJOJQJ^JaJph0hh%0J>*B*CJOJQJ^JaJph2jhh%B*CJOJQJU^JaJph8jt_hh%B*CJOJQJU^JaJph  ʹʦʹ hXBh%CJOJQJ^JaJ%h|[0JCJOJQJaJmHnHu hh50JCJOJQJaJ)jhh50JCJOJQJUaJh5 h50Jjh50JUhBjhBU   $dha$gdlh< 00&PP:pXB +!S"S#S$S% eDd-+L  C A"`bšț?@KDInț?@KPNG  IHDRw{MPsRGB pHYsj-IDATx^gW{-)!KR!XŐЊޛ&/(|#?T20Ou- , , |< ɏEEE_S`EEJtW-XXXA~u{Q`Q`EEJtW-K ^Y _D2tQybQȔ qjT𕨢J.{: #BeVjd-W_F.0/._՝ V¬BͿ7d m/FoUNT ӂԒ"_pt_8 =VW =?bXw1RNL 􀘟_#L%v3HoȘw$G6m-wIpV](UWo/G (5t+mp<5dZŽL;j)'Ѕ)IpsTUջ<=`}V*2ːGӞtVªJCGe.A.VQF/߽jo(t,ܯa_zZk7¬ 8^i˜ݰ4@ Bl|=*ڻ_!_WIK;կ~߰5y3pP`I Ž/8E|Sh[I-~^}Y!<KsZQ!#wND6%,b/Cd! x}Z0@ 2$pktfrD.cڠI(s+P9F%T{}^a[$)^3HX!.nIo$v hARNXMM}6RprOm2zȉ_XЄwcnP!6 T oŃŬ3!:%hssOuŶ. r K Xw%¯j8&N\q˟~>\ƒOj!=!DJ$&%+0׎7O;8_(V:b&kС;U@QCF8>Px^kd{ݦ@hmJV⑸\++A53 9e{F+hQTmn+b~L`43SxL] C]\ѡtd8 }X1"#!fs zĵV4{3ۥK{ԑ=qr͇.}vm+O7.ܻLNGTYNm %eۜʗ;g~4 }~# ;5,9\RKμa{S0-HnnYRC'jr\[噽7F#w7. DybꢩKI1{N;y}\ƷW[WI2X?hsӎ û.\lݜ} P`\Z6PW;.$V<*sNͤ1^#'bIPW>VI^>tٞN}2LOSIoHvW>ߝ\:ig%؂ M\?'!ڳ̈́ Y1$S?f 8 F|jY k.@Du}٫ `qiZ;e;b7 >A'L$Z}M_wl}Ӊo`agaj u>li(QɆ"wÙojI8"6+ם=vw1{9-М7O*92>bi͙Z"WH|DjLiVL2MvNƫَͷ;\qτr]Ǜ ^fG& q'PpttZ"{Xq/;x J ;)BJ)DapR ۼ2 b*Z2}QbmNHfsRoHc-ϋ7; 7Ș$́7׹lw[/66@RӢ=9#jQټΣb73}=$ I8XciXLL2+iL `Xhq;ߢk8Lbk[RZ1"2wƤL~ㆋ(Zsmv i%W1O+DX7qTK /5=Ӧ sna"З_pa&[|#:FpMV1m/sDktg|E89.x~GYuŸ7z=Y2zG!]&ts$5ª}З S8Օe0YER+CxbTi Dx4V8$4,Θ:<;!QHLCBFhB9b _#sU,= x6OM*s% uT|2/$e+7W9yNxz{k,Ƈ3mɴtaEqMg#M0iHv~QnQTiPC ( "ZlsRp0{侜NBP Ihr8γ;oFw)+ g2g, 1Ǹa2]*hB,V>(K0-'+ 5baI|o^Qo<7_n7.=T-t䳞Wk]jf`tD^hV5R@̦h^fbp1!ecϷ6K;-=_)-ktǤeX\E,6r2Gd7bFl}~lY׌^+kv3.y' x˝[bGy'YuQScj5t&&aep/]߅w;+NK~e`w'ib#W"^ضl^Treyf dzz_8)6sިQ [ p;,t-1^ܾ e`_C},3bl^\l.T[3{̇lOG:Fx(sl~#`&ŅVm ;WnjPp,>\xm6Uf0OjҸkNR*Q۽ \Q#ˋ._  i%]仰l5ǟ4UJإ_a" *$XFЋϘφ{Vpd7!N/Ʃ63U)쳤&Pا\ Ւ1o9$ԸBx- eĺvIn6P)P`IZqu_qw׬mh]P.Kݫ J!WeZ(J wNU"ڱK-!43d}Mb8f[AdmosF\=캟oO狥M4@COƻ9_"/.(P2 V\$8W1 13H,[uٶg{M 7 dac xS&i ?+e5pdyؗob9sPXb^xBTU LL<eaKav^&3)mEb'tp^~G%IVQߢxoi.+\=(tؑ^F=dk[O4S=l/p]C >2@It+a0r,9=V㘳ҍ]LNlNB1y v45l4N8FcA# $>BatM!uaYu K # \~QX;yȬCkpqf~MT=(߷ҭ!qv!n eMVȊ+&$2x+4u&`6f/ZWjO2<ԟ^eDN^)O7a.6q9z8;k+ sO?u =QlۥK+1HĬ9ܶS J(C@X6Yй<$e;7{|Fd˯E9Hĕ6L^9 ^2K@ֺ͋PKz*jv8)1p wm}/[REaO %]~,W@3bER?4]jBfIH4Nؼe{BIօzX5b&ٳы8XbC9aKݘpb.a6fnR'uPQD*0tA%̷LcfMHtJЛ6̲‰m^'fz.7.yki-O ]CկipG.X+Q})o$-gy$1zz`Ua}jn4?cS>98㢫B>EMZiXU#(.cK:r@VA14$;1olFs o\m!gƝdl8Jw}8s10зT`H{d>xzNRXv&x@- k~ױ;qUoE|=ZXlr8  $hk~VA̙VpѪG#0G.o&lpf#|iG+󊂉Ě!1E,#Spa|ݼb_m nhrk~uj__87bDFe:7F"".[A>K0xEP瑫s.@,y:nJ;Ʈu^xX?qn:e/rP˜c.?C>F YZRa7|WXNDČwmk;6_Ek4AbSAD_xm!y\DfBU/R W0΁ z. n>8s %5v/ Sr1+ťjo1 s| -q+⇃,FH<^sL:>K&Wf#_I0MucUٗAפ-NNDx.LW@QAؖ<¢mw&\5f MgEpw|Y/st?Q4r,#YOH9Nʶ us*fb-~Nٸ.7R69(pEF":U[`Tp*rN#ܠC(f֭ Kytꇃ?9B-e(V 'o# 9z$ψ$1q&mvBVwl;FWiuwtCF7+$ :HQA9oLth5jD!8p\+ݤbV?pʩץ'P+quK8Ѱ Tt2'Mlpyd~6Q݃z!#?utͱxev={Nhj#z G/G|u01ޤf =(!GmaKBp\ь*fikY#lC{ _A0Gz7:a)$Q(X?z*o7)]m,*0 &8*K8- V,k#Iѧ gg*Dk0C؃*1hn1*6c_QƾM8RI%^0%ķ}-2յ8>蜗QNh:SM8$5sZ>UR63<o7{,nF'Tn_٭#4ʾYN D }{aD层mŋLv S]-}}DZ᫝ӎ *B2hUt泿^#5RzǙnf 蘱~_ p(4} 8~F۶*nS{6k0d7KQ}j Њa6~uP0S~C:f~\:f5ۄ9Nw4ol*8sjV1|SX60o]sW;ˆ]_¾ֻYj[KLqCd1,TAW@\E `AXۄ:icKp'6wӔ& أ6ܤn R`cjη`{ڤ oLjcЌujO? TQ+^fZx+$hОuZ#d48+6c]97-XV\m)x8=֠6o-n,shMwAq=浌{-c@NCcjɿZl3|%@?KlZOԙf̈́#'1{X<&=yV\ClO8rY7ۘ`P|julG{fd žloLRE *bh78 W"ua7 7௶6 j mj%fqsQ⇌{i̘zrhA<jKhYnZVCĔx4! պ 17ya4Wg&>ф\ [l|At7|@Ykqm/mٝbק0oK㊝-"˜D{4QqADXOK и lCp Qj,/ffl>7oI|ŦdZ*B.n q2WE1͎WM']iX }z͟vFiԯљ$5xt{;>fN 4plU(5ƋL3ʻٖHn2E@}s>jɗ0zB鹎Y^Hol_R8-&Ds:Avn@+.G^g͕mֳQk#3볔m.kGA~ VqNӻ> Lh|E%t\ڑ")@?==+A@>9s; TZUD͝v4 .A^G hlݭe_dXsv6? ڐƁDAI Aʣon6p6~Y9 z& i13G62!8N>+i)@ʣ2NV :e>;q c~c>;F$&ش4y"ĞSWQ q;miIcZ#ʬCf&6ႨP.T,]{kFgYZ2M*L_1:;զт)6JN8 FT294/Zh5YߥrU%ٖ;(NHШYq]G 4'?IãKq,;1jL+t5^ҵֈJhM!` GyLcrF1GYEo`F򎳿n˺PBHLI-%] LI|6Wiqf:1nIQĦlUlڌش9'jx׬qb@i4Xkd+]D7}oZqs0J!K6Jtc-]DЙ|C =UJ;cfUtQ k%Њ+ff i9mI7A@]b{|;O*6ZeZX5@ݺC7N9yk6cƚ{վ b&CGTܰۆiq|YvǩK?|Si[j@Z6˙%7S]ߑ&COQsRvM,n*Sd-x\Z5U (n"uXMMX E2<Ƌ:Jv੿Zm).XKT<$CmӾHAöװ:(\z]|пAoa)wh6xDj͑ZXxutC6? ~ccV[͗i~'R ȰYj w0[.smL*մv/'BwL=W9gi}ͬtvh{jByb`oPRyBvHKv [;7m i4CRt+JksNʋ N[YƣYe_C[_ׄYQc\ӌ,s!و#L i0ҍtڙ3g+z󺱮#U17p x m&4ș@l1P:R]lKReGbo±égNunz41ƦY3yTo}aj0%dviζ;F4Fu0BUw[Hro|}MR47"2>gnh`*p9loQF&uAV β{Υ[HhёzͮЄ,uzQ]{/jw0ACѯ)=8~|[1 B-٨Q,[7uI4#igrMfv_%kԃ;?1b6p(ֺ5`GVqX;qʔ\A׍'A֘bű X3kzv(pM5f5h7m1?]@[A3@>~0ކS [PA&=tul޵~̭\zf~ 4F[nuU@G:V(7B/Z3[@nvD-WJ/l %? 4ӵFn2gXzaʙf߭6[adH?Xmp­@ۢLnFC<j@R̿q6-ecԤF*޵ 4[o8^<ٱ'NջfJ4rkL=凕h 4ʭ8V!ښFrP-}}Xg%,tom$j ^6>U-A"w5_W]J+΄~+tmgʽ/!mNKR{ԣQ*ETM d-xLd4kU a?yjٸ q&3s/"LCAatm]ԇn=!}8;쎨&6$ڌ8 &O p4qY֪؇6Xgs[M3eot[QX=`L 2O[ GWo‘tJɏXhQfee ق* J"?A$c;~kHssg0G$lC| FiBnó;{D~$FJ '|D"^Thw͚Gӯ3q0cny2֤[:"d8FA~v6Pz=b}G,Ϸ mX-@{r0m'a 0?ľ+H" Mbf]p&l;b#[L|׶{V!@76nTiQYU;5@֞x ^~D>lQ0Nag6% ฿#} s7r>bʙbz}V``.Lt@@wqzTPٛuN S;Kv02|1G* To`w *͘n=Ag_Mq]VQZn3m5eēpWh)^ikHׯ8é2ֈsiG/%``+kQ?F9L}ܱ1{JVͪ#gL6A0q+sDav ^mK۳\bғS`@GW8ls:QhĖo l:KԊl*ƮIT}Y2$,;Iqcq{O B&n>2:26OK3 ξ#v|ޮOEYn㺝PVd5T`M v&@g ^Pa%tL'k#g-g>x\#ogOӼymt _CfuЪ%-xuFx5i`7Kn2w-zz1rvfϞZU_pSaq7n>UԷ*pT.^ef! ͍Iy{Eͷ6CH5_\K&ʦix*6^81V9ݧEیW,c3k*(fŪΨWxUx=3g>fkV`9BUi)Y ˌ1w|ƕ$%jS rax+X nXb;`R#Sstԯ^ X n|/Hj7DHTi©@N-|*c08"^":A88WW)@Kx3e/l5| lǭ+_<' K0<'8gj̞h=.{̍fN詈ʹ<foxKyc)6f1McBJW"L!m 9/DᆦqL;&΋Vcj,;A샘]f眣u]Ow,./ÄX}GB ]ܶ4\qVAO&؍1G/ϼow||90H:ږ&"/ _'ȳž=EȘ-Cwh$2ZT%kF [kkU#r`TUrO`ǦQ"LBS;m׶#'! D~Ex8|gܣ2ٙmUpAp:ȧO@pSBo7u$W'tԪ QW'!; 44,njCqk7a#i>ns{gl''N5AJ͞ 4+l"ʑCc4^"\Ns~"=Ⴈ;fD ʫRCCz9GM']ЫMprT ilMqμ[¤dH8G NEWʙ߸:6T2f]Ra;ܱVc;"DTuՀnn jи.$KRNé0O>99P3xB=y?N;g/)9IMʱs{B-WTclke)Vc`scM[j^m#k̞RwJ.]-g1 qڶC=:4~!;|=0OH6oWbKQM'`Zw!sn [Ae 'r2Tґ`fdS{=PƦ={lmb/KI8O6zV)zkywtl ^` ]= J!Ũxɀf "}CQ: NEW1!9Yغ`Ks-gmF5kk~=3 8 26Fi#D̔f_MǮ[N1<+x#nnmbB4pZJ.i鹯4A$ۏQJFYʮ֖UWbD;iL4jŮ#rQu[Xv<ːnIoOߑ8x%v-=U]* 1)$<+#ڊJ~`[H=7e gW;67ጞ.&ŵ0"B=UY;Nm2Qm/Щ%]ȿB\3Bli3oe֪&1o_[֘cAO~%w&>6GƄt_ *bBalk}GScX8bfl}kP &\"׻2.A۸5Fw 3_<^ t0k+IΑA kbnL 4BVv"\]$^Qp㟑b(~yfx,p83Ɵ#ZEy7f4MCԩrsT<ĵ\DKTXIvnj)"dk |#e<|P>2(@i=;i>?w6E|+INxÜkAo- r+8D~;WMZX]!,α k4d8pϞM^H;BHۭuK]RXTu~w.g;\ID5"qy+ab <cިܔf]u/fA[ÑSPwdž6"W/B^d;Z / &k4̠ꠝUi7]30|-<n;vn}Q{QN+V: MeFOdؓ#l$Es/AxԪ#r.dx$ј7^MU~MH]i^!ꚱ!Lu1rw&ЧZT~Guq G]W&TeHTt2ܣ6S]TޝunƨѱX>gh!q.`c]{\3M.-xDsJȈe./` 5Bj2|;upJE^>OQH_42E&G7ьs%T ]^rх\ӣ: (_eXw91R;z[=RbfZ (:ݜ]5c&9Wo&|7VLΜeCggq1L;r8gV,3Wdp 0 p-WʔDs18(O#eVOKCA؉(?I h)lȻuNWc-? A1>-l;-]/Urñ障3?s wb \1cApo;QHqp{ ,IB a !adPZ[{dgJ?< JІ8#];1<♌'3^(Wjd)Fahݸaa!Д=/ƃ1Oif]L%n4|ưLrH$`w)SlEؐ^=!yq#z!F Vmƴ8&-5>E=:87Ԗ>?^Mm Bd{>E/OR־1 |PTƗ0mF햱6/ϯr+>bo7iɳM@n|^;@)0Wd [yj?̻fO{7=UM2R>ƾm9*S,$:B/|l5|f̄zhgU {+UlyQHԗ:]ttqr}DW[V }WY>`lFA #1ȉRb.LoEiO˹Ad04zzMjGBs# 0L%NܑF㛳՘;ɼ鷿mt= I5X F(p1KWܱ҄NFdF+ j;|H@8]HLlU)u}۾#u`Aܾ}]4sƻ8V2S~}YH}뇅&Vp֪۹]h,_ /nYZLl&Uk~L\kݿj5]ȺS }ʼPCz+\`JaH!uʐGU}M0'3i8U{M5&*)@UrBE,Wk1yݯ'|@rF%^pqz-*Y"Lu ([f^nkψ`YPO}v93Y8JK_0T8^ӈE GuӀ k0.kmP*B 9[d<r^T}67ʫٖＫ˔nncY}PsAb؆0@%,V5w>"osCݱٕ%E{\/ֳr-;Kec4fvH]K1nzYJ)rh"WVHOZ%䪋n/'RwƊ* K^w!~\T[h&Xck3^ i '2oEf:s^Q=:#BG".^ئ 1\EՈ.vdaSCC:U otYΚQUz6gaik@=ɡĹ .:.7ʿgD70vę7fl(e Ia$&vƙR4Jti`<K /?rԠQmq,nAg28vDЊRLAUِG ջB d:Xԅ2- ]c.Sj2 Vl&ۛ7"՘(ÃY:8YmCUvVv7Bߖub D>3q6ҟ@Le)KT5 8C-xo!Vv3-rxo 3 UZ/y衤>U<5K`q3M5!83;F+S*T e,V U4fOȞnc\}95 A {~X?X&Lc(s[,UT/&脺5M"LT8UBmȶ2ι# RF#}7w߅(5< E>i|.9*r[N|c ]ٲQ#y^֝p񗮲AzWٷ[\Q!qe8rl֒]kv $$,tEK'Itm.B {`g0zّ*0TXO19 f[ >1t1d1u)0s.{ _C4H>d4Av,QW#uP`){ѾG[+`x5NsxL?$}MHc<5BIc>hBj:g3 0Q{:tl*v< ^z~Z*=  hw *5@K+Ucq$\"﬇Ifk7/7Бg 8fiӕ>2 싂nHag(iKzi=DvQrN%"~VukWgȳW- e*gzѝ UT} |*  Yc`+pSt@*gzwЕ U{xcߨBn03N>oTG|Dw~@ @ȫvʥtx]NB3@p+Q2`Qw_jq.n;GZ1PJ߸>kg% 6O^l ۷PO)@sH% !1(hby[{DbTu,W}sl=@]ĖWm+_ߑo4-E \Qa7(dy鿶jQ ٬B}-,OvJ\2,а=3-Sr?Ӫ&<<^䅲J?zf7#Ւ| 1V{-u:i#4@%   =Vu)mB=B[vpM4/ycIA=8X0 S໺lBg' l *z4.Y`z8C*{hۉs*jC߈7;R?%GUN)$3 ῝]S"* /D#מmt (RB7rTX‹SF} V(tq4WB("T􋁉iP8ɏ5(D8L@\ge '@|FFPG^%sFO\b 2F䒭9T5? r+ӯcv lw8Q`{ja˸+s0kw;RK|^Ijˏ&-G`[pw@;9466]n0U.rf+F␘xw.ȗr ȄWvt",yoxxsܞ`G|h,tKiKʹMG< ;52넍Fs+P%?P#=ƺe6mzcFۭigruqWٴ<$f½u51}CRL 1x q&J"Ypm齿azJp86xWmrso9-;MN;)GaAjg=D?h6#bbB:mTmڴE)Lr;L$=c|(ZG5s+PrGGWO |] yckFkl3Tzt[ Viwǻ-x·tt77V?gXaO5nѷrDLfvf 6`/Nդ>XXUGӐl%b6)9p&lBI*J}y3Kգr{ll?C+t N)vWx W,3đL;$Sm76;aءzy >mSy*Ӳ|~P3diKzZPiC팕Wp9Fai?RKs+2biˉC[{ӎgn90q:Z?Dqs^C9q[Hi0ux]&CVqVup[nP0qo#{"9P+:Qߛ q4D7\Sm&lu.;F|إg%q{[GlwdE῱ã~γٻ >XmؚA'ϳ3a4q"Y(_cٹ#W?s}xŠn(tkD!}`:Ք_bɟM[D>{lNi" ڨ" ]ƞ=bܓ e״MLلJ2ʯm[O6nt3sHL/\^BvuV5B(YԻgG80ˮec6(˫?U*pc}[NXf {ܘ@=6f ~-#Ӝ&7)oʄ}6{[m ylK+(H=UQ cIqHmY!ÎRlp9fI^*Ƕ[EN?#8,]`dT8_J ha_efsi]>q3|&& '21èyf.c?qmbGG:h4Nt>1?HpݏXf2sUt438X :i173`;0:.: m!㫹:; Ku&X&zk+STgK٧"DxV|.X3JF*sI b夒45‹i\2I0' +E5U )%\VN|^LFz]|_`7Xo/oiUEN `',qo}噍C$QѹlO) # c#zVlX3E YiXY=[̫kMh`Mm2_}U6($Z߭7hڷ߷p Hԝ(fl-gʱ;~U J`q,*\lc~c7icvR(e(i4pNC&17%eު[ N0tW *m$8Ll(/|0KK=kŖu4$κ=FÓK0Y#LEv*wa-OEXկ2Z-쪂jv $,KC=1H7/?#͢jZvPrrJt[N̪>Ue59  Xyp߷KXN5A8 0'7i`up?u01WAZۊ^94ǘbGoCp~'뫵_+_Y)Qm06ǩK>ÑQQ/a1o(_*bJGF`.A@U5\:14TMI,CV9/ %4G`2x&δѰo&Z1~7R>-غރO O7!C|]F=h̭QGl ؽZs;+uNu9,+|++^+PZBXgD,'źpPE {)79頤՛n]Q.JFA<~Y*'쳝#p܋~icѤ.|<5a_Mqޕ!{BMmI)B;;'Y cˈ}zq/ |SdHCg{>Hng&ZmZ~Smfu ҈6|>6{xVt"A<$lN3f~z%{AASO:`CG;yYX|dۢƚ81mS/>Ms\ŘJIYtfvuROֆX:K ?U;o|t -a\F௑c:BMPBC1OyOǔ ︵>=/Q CZN%h5Y,Nv}P"VpaƐhv)Qp>%ɑWeO?q8huUn핃O{ A/7LX^HnmVzd3S?a$jn9>'@:ˀ7-+XwzsCdF>&# $GO eim&ta89'^;#m[.z#n2 $[#86N aͅ%E|:^!M2Ol,Ot~g=b{ +;"ŻsC_q;\G|.~ q`hpg"vzyğ\_> kDsLhփN¸Vtq9ZL!VNXo#x \ 7guG7Hckd1^%lY6WWm=@CFpggxoP@- IP͕i$Ayg> CXLgb44#=v QH%f{?9X:/ ɩ`sgFvT0<+A>B_vc53Ksp?,\Iu"&a;X+B'MY1g Ѕ{hI̵M8֞?UT(>5DL,@T>HGAv7 d'F؋8=b /:ξEg ю EdU.z :딟vQO#%,_ܮ1h$å9g'.mAy7H{{b'53is$Bєb\\=(\-3X 4ʇYHʹ%W~w\}C5|!AÐg.g*!{|DoGxS/]Gc>&B<=A|h@ݓTmo0FM;@+4'g dW`miG a-$[#gcF5h#UWH]_(5m\SHtUc+']FX-\ګ\tc|W7e[m@KCaFK:@a֡MK~9^zC@qGz 7*/m7{f/+੃fk)8Y#xP^ѿ?-b⢃ _ž0"ijt@lBG#ʌG=wKҟOUY/I IKnTr# @TfXZD&%+HU&߱XȨ`s\o(}t #fKqeueE1kagte}l@<}Y%9k0G4k]5YG-I# 噓rGM6,!b|]{(ҹ찖âs x-ez4^8m A";. :BekRCj<-UZ%vjDXtv46A]{đu;yGtuT=TH<0s;^sx6=hPV0c$n%1S霋( `ʘ`/$yJ6n4fyJd |Q<϶JM/# GVQ va)SEmcN&ͦYQAo$6t8:qQzZBpRNq|Ĉ1ǸnNY-N!pÅ8zZ~_&̂*}еg&Pߋia_ptTpu5J 75ID}/lVJ ɝu^Dar O{d=b':wx{(1<%MI0CnX׍d9oķ$fF 59KzHg'o}\N~Ö]|J+GԤ~&WKS厇ԩNm`nL^b}UBRD}/8USoKdoFDwAy :ܜ򻟬d6r@@LiݡIe'ƢiVKb;I&j`ew,W[72s Y oB [{`O|T3&ݜRoX[Hdh }Q KO7IH {mi_hѤ.V,{XQ}K~F$QN8'amqۺY6%?Z*|º!}(&k¯xAyN\iI+z ֒^˗bWzM6b(jj.R,?b,&,2}T|C-{[sm7-T )0N "l5 L#shsԏ^)>'ը8/"tsgW_Ɩ!'Wcl=qI?pfw"$ҜYgF5'PA4NlBG4ifY": M"{DٔutChM~I-Mq.S8Ye9H([|`\h]rZ~#<(j,{h&?ի] Bć'g:`-*]"wD;A^&x5]"<(/6zp4]/g<§I7TϦPCO("'2n`czB] ߲4Du7c$]'noOϛ fdac\i75p Dqh`)c%wz0#qRrIׇZ'sh4Ύ &n07>m>v§ 8e):ѫ-y4SP{tbsdcYsb'kW) ӒS/|}[ {>!޷zâ"$6i`\Lv׈-tg '4YM钰/13QHmM\W'J#[zi Ϥ|+ۅ.;w33J'8gay#gqn~?6kxQ(t>m7M[Ɲ‡E/0~HtS kn:Px*2[NXR1S\V8{ͩY;o8xwvh nߗY\{L ^H bFKgYkit/mOG#YۼRA+qNހ@o|xWfҧ #84m jā l96q&ly; M(YXV<mXBRl!ұH#L8*`n\+k:srƖhf/GiŁG,7gI(Қ &% Z!Xv&Jck:=t:m몍 sqqi|1G(c֜K >v،s \X׾ Z3O7dE*X )dBUsp :=Z{kI-Y<LJRvk8U{1JޚzdjcdIj69aYOsӏEG)y`Z-o-/h--h]Sh+bi78LDa+՘"E/k`<0/]8uBOesZ2n? x^0G(ͰȘ&mGfĢ=zV7Mmj)Y ;)LΕ'kΒ ">5ᇏZoMsX@abB!%9Gq(AڡOYV?_ߡNҕfv.<6@7n;q'zEӚO +گzHK2ݱo`>6S޽;ERQk$l᥿GrZgE`|}; +> ݐ2K,gs{@i[K`HkЬz)0 \zcx.;}b>QBʰx#<Q+}aΡe ms }Bs 8Ηߘ3Y+Ʋ?Eg!!Ӎ{:{+Y7lMA[@G@+t9DVX#+f>%Xwcb#-[$O?t#~rp"sJxG R!5<1<Fr+ g[\8&%}]G=_ӂxkl)}-3L/+h~ߜ&Բ,Q Α]}0 l*we8eW{*[߉>^Ub׷::&[]pM"6wh #$:9qOVqJB液CHl/cֶ[\'q,"*F .A+"{:O ]7u3-i_(nuzPC`13F|K#0|jfk |6Cș:124H uقWI(8"Ө9[w=6Mͅy/yuSimme&uӣ8ҧpS42X,b50O^yz^hVX;3}ky~/7d=_\pmSdi΋d'źB27;VDFNjb=tk$gN .ΉrvP~qd !ZIJ\ (\h٢׍2$17;PcxhJoB|Q.uk/EC/}#D5sibQƻNɿP7V5C[ :W:VNY9n KXY:@v g]"+5$\'[Kjv63M~X.B b86dqw3o{nnkwcйBx?؂鈠$K ZzI|t]s99/kGNV't+! ٮa'#=D&k }RKMYTte)LYc%:vd쳉خ!ֳ rb'~4ِJ{ݹd#wIj?_W1;`8--tL~D~[CTc_ VߍՂkPOk"RZ8=KX|3DKnt2le&p1;)owάGp)/Km^o%]yH,@^!~l]Ba_wuqWƪJ|c,Jlv,fu@#)0cbb愅dbȌ'_W똆l}fbKŖ'njN_8(إݹX `goR}~3 ω %L̷> -Y qAJf kn` ;6AZ,LrK-X-2$ c سǣD(I$aXܟUe)}{ /j}̍{deݵnC`zVmIbq+| z#F\׫XWItsxE͍H1 <*77h,`h@]~l+D] uCٲ|uz@0}>KeGaS%kQ~l|oFV^7)Iw^U_k%s'٧sL#J8" 08^lZe('|,{? /Z` j8 JlwsHL;7ap'\g? >s16 AkX+_nz$o]Q`)jo9#HsyiA%l RH"*:9Ф,;T,` =̜PۊZa3e X;t6t\sū {(A؃9l扯2{:/] !3ӓ u3gVLyݰL vZF1"yOIhYNOvVMrGb! 4mlhUNUف[˭#u%Bٹ/_QɢlPzdnѮeqzK+Siկ&<8>췋/`a6G[>8Qi%-Z<|s2zv2c/m]0u%+ V80.;USHyT'=q|f8[iyr+c=:OUD7* zlr6FWX \an4:IS|0ef07 M[<\xb;WH{)hbmdȳw ͼqIj)j} 3?9v@UVHՕf*f" ALtsޕs;DsE:Ev'VZH/}%]gQ8vZYT8IҦӦ:U4Z"@zրD}%Nvk_^f6jo7hw3,OA!ฏXDWB:ԔKHAӰO|AWZf}mvtڥ'|Sgk%}>tԩfIdF(cwĨbXH}ފԄ&B) stTJ(֔@q6Ժ-L{y3K஽t:O$ yKW ELS>q/;/ҟP`߃0kv78ַik1]Bȋ麍<# "$6GO/c L^$ m=j-;^g=ߋAOEբB:orwDhb+gK |ΐ sдXBw p߻t`ݬ%&}M- *z2'%xk-8-iF^;"I REl#9&e8Nui:0$e/{2~S7;1}`Q'hM;WO8xxsn رN$DPm.\_)hTG&#*Em'-ݙ z-ڮwze;Tvڦ=0ةȋN!fc5"t+:74uXIu] .FTD A+@fBҚBNJ?抔&H TUSj,0DBtRw˥Ȥ-~f]2;va3 8J6 rln=<74;in29I^΂y,m6 ?`C KN:Z}߆V$5R-d׀DN8ҋ<#;`AM hݽ8ЦrxTw8g<(f4n`Z#XI|\L! HOU(mt\a . 0ȓҴ8I_w-k@̂ ˧ V~Sa=N{OZvݚjRc@)һnnLw߇1S_׾F­IUl]#fޔR=Uł YJATQ_Mat#l:llOw=NRl(-,1Bdg''яo}[2YcS3)z ՝(Veͱس#;|v ,{;23]~giw_w~wj/%ou^-pzwoswzЖ&¦bGsEl|AM< B7 Kg٪QQ-P6  ކyWToBhs e$#.Ws%$D\y?Q@)]%dVVݴ "l7 g7ЋQ]<Ԍz8F:X $2Ww`.ToTN/=@SYjٹQk׻,BUtBG#GL;c)k&0ƙf<"ʜA]JvAi V@(EV$;L`VB; ,OПުq=xg:hOjS'c5)ݯTD^MG_ wmL0HH ݮ FN"Tb", -/X϶ԧqsjiH0/?P(\ ~4$2$n/Ѐ&ɌƆG|t*6Ŗ>!@'u',+ޞb5}<ΐ @66D,^,ƓP`I'!c@,leS F6ΓtesTZ(,h~M(~ҜTP7'ƞ~m8SQPuU >4'4a+|O~:Ja l ]&xeLf|3*Xt'X/up~'rWH7!D̩uƁkԻ.@[#&tLatG8Ox XƝZ+d&r?ۺqNBvdv8\q|+pZ" HM9Da!W:l)"f wé؇'[DSi~-jz}cuB{ /mnh ۯFU0 4\&:yz2+G +>.S^ .KmNnDLU>NrxɆ~0vAjȀo*qeZ6]{Z=g`fOEDg P3qsH^ zXi~5:,/P'z0h̻jG>h|a C&/4tTl> ^wԿ^]8=D^'/v߇ւ ,ѷ" ?Vgo nvha|| @0ٰ[HwӷЇw.7")/4{!`_1SߢUâ[)\o~g_ا ڈY{CH[h?iOJYWsK}FWxBtTkqչ(<8]]ݑna%a7 .rOJ%0瞎o@/0 R/#s8Fu-  G]2_.'ktZLec\Ŕ(O4h`JgR~LZ|6@!%C Ц~gcV|'$U7vbBlcO IR`)g%-< 50@-r=.ï~+%N~\q"=_E+ sn;q0v "3r=]s/$c7k/pD¾9%LNt Bd8@|Ai ~LXw1R2j-0AHD?J[r& Yע(L]F11fSJWUKA^6Èr@.ָ z̑ a=0H1 7Ո;;j~D/B\4D8Tfu- K}'맡@ƾT<7q$H5pAu- K{ֻ'8>Nv~?Q NF]В>L5-4a3#毆%wxNK%#wCdi\xX=<wy@HAa~ }IB\~@SQr((pgX j(T\, , ـ. ,  NEU΢Q`ߝ j(T\, , fR6IENDB`DyK www.tig.org.zayK .http://www.tig.org.za/Dd!R  S A?"`bR$gb v<Z.jIn&$gb v<ZPNG  IHDR=YsRGB pHYsodIDATx^׏ekމ}HoO_HjHt1ds: @A IK] Id3$Rd?Uu\I#w=o&OdWw 튊sk}kr~~>%bq<O\!?rB$)$N&$ӿ$7|7^Do_U_ ƶż9!ͯ\CXN6z}F+u{>b!V܈#m:dM&68BO&"7]Fo039gj>KV틏U f+OnvMa,eVe ҥ T+ffnSXzO_CNE5'BqFϙ+xq\J)ފ r#oTk{ e֎s$?a*C ~Uj㗝mӿzX*F#[q9[U=!+\=,~n^K7.|IkN+/\vruJxqV}A2wϼ%~Yn.lVoE˾._Kg]_|*$&ÙrB[:S+ ru~z]._>NqHr8_$UoNxƹ]oZ%IQV>衼2*ۮ[KBk>]KAo vtdz}SnwP|+z^EWoK[Yf5a\ouP]Ӥ:di7?ov=;;|0>JeEGX.%'2yZr{pRC`oˇF)3 ~ ~]Z.@~jvm4Vد~3{~AT7([2}ϢutVz+6skJ_#1qmm=d Ho1Vo#\,R~Y[ F,ka]WN}г5b)doʾGgm,_yR@ /8(┗mx&C~i7SzPGK2茆Ge,:[dw(y@/aiKMoHnʟ/־^W/P(r+1}Yŗ1re=oh==ad4Ul/)=Po>|7>wj*K~K˿~ڋUR蹗ݜKǟyAU~ɗshO~K]P,FnF8byt}LJn|0JZk$ceZJ잣ٝf jʟ!=Y6Rz6[4>oa2~j7XUǗ(5\|}m $s!#[4)s៾QnӶ"! [8a_4&oݭ:{:y2?^2 fǼ.\~bos❳F0Y+sT5C[K7f_˟O9`>˅<gtɪZ oYuNE3Gp"4KKO'!·'m0d^5Y$}c),5.sE ' '[oI p{Pf8|R GhTjPleU@n~r|+>]oXzRȗsׯ2#x2q]h#8nVQ£=Q.̍wbqS>.x! [oj_V;h[Do;Ut7W{G?ZP0ZwgRBuyKXw!f\T?_`-}.G-Q#8/&w}kdnu],=&&?Y|K !Șé7WL!)0ӕ4Rd$W+V?o[oM8CbȥzwV *W_rGB(.fF]*%7u\ n! / o<kEZZoߤ(YTh2jV]9N=\efًΛb˶-9sΑ\śIk}~- m©-yZg}+~ňMb8So^M:ye3ׂUWj8ף.^;fR\ʯg/gV4\ife죶Ҟ Dwʽ.ܯ42ǐCV&0".ŷ&7?_]O!'҄sXv曳ɒ>|%qJJ D\*~tT]bIHQYLVJ.uiѮ_U{2|$hvC ;;N'?5ejTInre.5JW \*kaf]/cϮd˔eZHR XƳVe\%>' }knryPm1.:qKM0y8KY ì㻒}9ȴX>tHZkOXBesyL;Z%+7&L3[ŊeƟ-F% !6r'IfsY &cG"0 Zz<͆Rt}7ץ|ȺZnu[uU:`8>\_ĝAl ~޽@j)=)8_z`Jc WA.jb]:D[&V1\ֲfo[wr\}\ *9zxs6|.OSRw]w3}pk}H"i{9QS+&{R-ی/>wxsYsYԐQ0rUeLO y[[8!zIo Z+!~4"H:lEsܪUN.+1$F1zD̒TW?ev2gkqފfUwKLU)syo-|V#o0 AErťEd?YdR<ՊyK1VRLp-^Goy| NX/W7R NJ+%AGpJTd"Qz{[3z#K56CHɝx~@)s=Î7\6]y0fcpĉ}֔KËrjH-xa Y-8>0B[( c<\$YN8`&=p[JVʁ 軜ZF;KdzƭIfԡאX0Wu Po𥸁9آ?+jdFm-C BO~}wpl("1jp-fOfz Cop1n1˘   į]mHֵDT ݚ@T/nb7kKH#{KZsymM H@&e-݅}]Di~uz[} CW%k).(!ɾQ@dkߧq}Q6jι*xylO┑ǃl[û9K)4ap z⻸Ϻ[RenʶX=0-G0,KNIMU$ae) .BÛ$?#|$ n~|)LIe`Ī@ ectq$i> XRҴ~`K4Mړ`gݔ!5FCg4L@H$ܼk߬~?輴Yzk~ZkM 2eHf<_vOB$it3[M$>dː FMܑh9bhGpBnDg8IV=FEd(44C䡁 2ΫS=LAu16% \9ISO'UCj ^e).g,/u2nS`Rs,#y* 5X=D6qօ#_[cPӪY\]ϋ_P*B>ӲQzC7݀"M{7I@ &ٚt[jxRN%Usy8В1Ml2t_fۂ'lL{3%:Aˆ>!Xq\7OaZCՕh-y[d {$ΑD8"m_4!H@}"CX%ĖGX3,ygb,]znMo1$Xn%:hL(1 sybQ J2K )ÃiX슈=<9+͛w2cBFsHDZI_oWaNm->⅁j&z$dlڰMeERىJLQbizK~2;asa!G3eVf& RmSĤL z$#3 TՅ1(V4p7q$M'm@b7, :l]yY5 !3$RvI$E(IVLuNJTt$20b@^Am$Ůim:O0`D{xޙAsoR|9%Ŋl,}jݠJp4lP)Ѡ{UkcԭP!"B lKѫ[D2I*!hHws2Mzbs+nfdɏInr49@u"}9hxo2Sr\l˔2FXe+s_#K_ P#8@ڈXe 8GvF1REOȾdMM)$AIִ:UjviIdQ^.!:_<5f -C2[f>Ռ`q>̈(S%$.0[%' h zhlV/ʈ'(R3fb\;exVNϮL $ #iZ$X!P>e\[ߝ[oyVco*ttJe]ez[o1q$+k/&gJq.sl|u P!7*־O֋/d[^6^ai&q6NinIJHl0l*&{l܆X6rͿI޲Ȥ Q$ Uy)QT@nJ}1w-{-zk$XlmdfܐkX̞d|)Ĩ4Ql̥N5:ˡǓ[F &<ָ/umx4SѦ2VAuAk-Ww[i`zf+$Yy)RFLmƊA3LHdVLJe k)0|sZ~Ŷ]oA'a4NV` 6[0-UK,&#yMp/ɠj.gluI<[1 k/b0s܌]iOup>m襹nK9Nh{iĵD%muWsЩNrG:4-8aME6e4RG>O)3%z-y-SMKo !=*RZύ˖i3 qcTcAoI%*L:-lc-T(u/0 ݐnd |m<’tɈ$۶D6 jl%nf#F@VDy'#dz .#Rq 1x\e>⒣Z$@[VCQ[Vؾs%a0M\03  0Ɗv/^"5ֱ2\sjGa뭗E 6->7i5%2ί4H!# _ ^ۺmk\3~[f=EcȰ4ݚ3_Xn\W`K,d,I6x 9g}nƔoNDw4Mw~OFHEnnB8x94% nzhO*@G8Gv2up*y`SZ6;K&6Ll<m׻/%i&Z[ )׎WJoH({on  MmԷha(,ְ21RBowZ N7<|Mߛ΃p0O)[e\_]o +xov]qq4 (#HƖ8Fi]Xp2Mb "8OaÃN3v N[[m>[7˿qBo8M{ɸN\Xl؂?L3|xOiY 'L ЌsP6";"(2OVH1ߕ8.$yKR;k2ukswALP3"rR\ea=p{ ebP ۶_4d7i Md(ێhl}9+¯sr-Hqm0)84]GiS粍r8}P8d.="zaIӬT[--wE$XEْ;bjZ2ե[)rIOs/N"3%F >%{,Ev >UrP}sv!xՆk|Kq,(W*#Wr` 8'2+L[ % p(%q(W3@ԭ,gfS> }`x]6(Qcfg^2LafZ\ ;.XNWO;z]{EJH4;*M*gT^),J܆37V|έ1b-pP1edjBlc_ Xd J,QD`19lu| ,ff+û%X[hY?KYʤ@HBb2(MSTi_w"m7¤`IIM]pTlN0ʼn,\`s%d@`研S JJlnۚeg2De옗m2JpWVQobLL|9Q18e'3k%,С-Y3)Mzk4M ]z>޺OH^Q4e> ?4PK奷˅=R ݜLC3Z51zF"t0^83MLϕ%2B1N l`?p|/3ADw1j`eA YFTZ^0HǾ.64'I/ʰKQb*2=F;ҸreC((F`JZDhL[h5-y ZTGKqֳI%E !|1Z7%+u" @\D\vGи=WX&/b sVvVԌSnnNJH[`_b^BU,,0B2>41N1KG41e߾\'m4D&ƤaZ[$3 {tt8bhC-DyJЬx_RFяR f"XR]0 x}E2 fC͉7M`K!kHza*ƶ/VuRWCJ-Q;ޒ(&=U"*"#XYc~gr]SB4vN87ޤxT7.fvA^|кøż: A?lRY*3D̛%Qu{It-a1&p˅ mKc竬Q7S2Ajh2rq1,T?FY~+bE,CDr{ dI=y[fG{- a7<,# k 5ƲiA4AˎA 6TI:`irjS#Sٳ`nfӹ{u\LЍ0} .X7[ɘV]:uiҧ#MbJ@>QV9) Đߣ% )AUu@BHjWĮғkцCjCY0r 3%KR|g6%Bb67DδC[r^v)efPK[&Yd(W(H ֤X#J2:'WfR_I'q[f 2oʒG4gvZ{sڂ+Y/Tڴؘʞ`v~rVJ.iȒcS"O&&-0ͤ"ȸ7ŸޔunMTV~. B/y%%=l TWG'x%wV=O;+gl.W2f;(^f+vհoYJb)[gqЎWp IɎ!Rnh"a`Ǒ3|,KGzSDP)M0q]Zk (eYK{ύ!i]trN4BN&_i=F r\>qT׊prۅQģ {6iG=6\jcƳJY8_i,Gm+d%cEr핒ף.4`1eSKS l\^QrR7TiJ1Q^|8JSKh/J {n)aqӏ^aNPZ-RiedX2ߪ3z!'D]U*WF+7wDžA~3'˭F+F)~>նZ_˅Y^zn0~x;f&!fDQ?{ z'v:ZD [ƅ(]Hq<zԫǟ|듃"R?0be[•X/?~_^_o0`HVZ*tbxrmwkm+,b?(U+Oh1{اۣΒrPVno_{蒟}˳ƃj?l׾޷ܮ0ώΏs$d!VdR"߃ZyƝk[}MJԙ k}^wOşsܾa񽵻ݼOi>}hZ;:8u?B?gsLΰWD0!Fjrok%ZcPL~\ nSJ-9ne,Ad*ul*;Z/~C$/z1Wt&b#VA+_փ[7W|ŠY,7߼ys~zO}y(-Z&5Q?nU|e :CT_/7~q˗O{gJ; ĭ!aDQ}Ruk@m; GϿ6˃ʵ~;d4"/5ב/o=_<~lT/ YNj69 ~ݻ;q15 ]D 1rQ9t~^}5) zo~UO?'Ϗ^l#=Lk)wBwQ޽zmj\U!~Ջ~g[ 'pP.'C啢޿fmY}uw?X-;oܹެ5/ۇ,!a^{VoEU]Q[AxksF\ݭ4?u. [KO^/'jүv TҖo\, M7xeKHj~?=z08jRin6}eo2.ꧽ|?]"ӗO~ԪH6Ap~/?~Y/* e(o "yJn@nw/:=>?9yݺsTׅ-Lf$EƓP-[=m?}?*߀^e#'-'-vbF6\kTzrƍ+뭫W۝/=߯\ĮiXF'{Wn<ظ]ZUY[߭l66u9*$)ĀfJbZRzkׯVֶvW֫[kQm|t|y 2lj|FJl I+c@_Vb+6 ?u7n6kVsjuU_RݫZ7c(rڭz^nzrTXa}#>mAY"s˓b+_u^qkҼRٹZnKe\U&x*D]ɗjrPsjxڔ Gj2r;;\U|h,T< ZcHx潻HNGV,WoGX(kzyNio޺Ym]imն7{RNg''OQqѽwZyB'=cևJ뽽[flwz\EuaP{2eS@*pm}{FX@@ in|GWJ[JիvͺtF]vj-~;Q!Ks,ΝU֝U6>kw?}pUinU6v*[/gTx oE`QZ(T|nuZu{.7FIW0_T' 9G^ެm{Ƿܮ]ۨ4[Fl4]Ӆ̈́HS FT"kga\24޹ݺ*4{}h5O7ͭjwna)_n6oT4n5nmZOzP,蕱`t(WC[i2~excYsɰ?arJ+ W& kI}3ic<('VR]w\۪5ɳd5X!VO kFRo!Չxc3$'49vc`{P|&R)$U®JLhٽds;iKm0-!d@CD-!;9$d8V@n^ΌMs\{Ṩ4vHޱe &`/FM6˵PZ:IHIqpc`j܍'k%g^G 9Bdd@ FRLjWW[[XIo UNZxc Ѡm䜊jGg%<9ne#YzE̳`(7NQk ôդЀclk^+ ' Dh@Zp\錮^OZWxꕰ5V(UR;|B,+n[I,= I_sllLƝ~ :߼`fWKJUh3", ( 0DUؑkɕAl-`"*K] T|DNַ*BE!wNv l%du>4Dj#>N0Rmچ$k{&+k$/?a$QsLn8GYHftbe3C{F8j?/IwRʓqF=1χumcыx|r|<7R*~dsĴ¸iεz7>{}œ//:Ƌ(PvYB9^鷑!qZK AJn$×^xr@\*RMIV:e\U⍵ۍ TaɫJFcy^"6H*۽٤ʨ)T˧/<9xӃ1QaZCoF '[?xz{ǟ?ѳ'GG  Nͤ6) '^G("F-%?{g zxzɳ =6}p\o;TFҾ09Rrkvc8<e`XXSy2yq td *ސH{C)ry hP?iM1r-$aţ/_+@QlO~ϟ=z~٨T IE%R0+#+7zr|v2! PrpIl݁y=/_7YkҙvOuY\ZP wx3:xu+f: uzq,W *] %n񷜪=Y7bkw>ܽJ*'@_|z:h֫ L􍔴L LJLݧ_>yYZ6=O;xB%{ìU{Y|+,賓=zbhcG(z==>\)VX"*fp!ڴ|oZ<9xv~:ԧݭ^|&A1̂IZk˲~_1VY5O_V4RPuzYez @rK-Kp_2/v~zW_>U'O^}է_ڠW-Bey<1ӗOrLb}ěMInɧ e sZذId%n uʎrܩzXKa4HS@/>:|=b&r8$p)IF=SϕvP X!J}QK*WxvA :b XOO_>>z˯_tKu&$B^~Bu]eR$EV5)om7XFQz-NO\34v!TX>z]L^+?g@ս1 rdD)M~%J` ˑSvאҠePK*:k*%l474tR.Udͳ 1SLYuJժ }stם`ޓdx 06O/xW?|,i3Np+U .խq)2Q%篞?}qr~ER-U7 ˻i'R'HS-x}J8s2J6ǽz5C/d/!A& L1+u/ ZTRQEiQo*;sWO?C& JW;=:x_<;ipUS+Wg%?^TJ5< )9oolo" ~z?{Ϟ<0kĐ*6M|nAJɠOyZ/DxgO E4Ӕd#>DzoM^bsڍM|_?񳟟x::RDK%?DV!QreI}!u͈)#P>a }mͨM1-Bz255nCBrz59ِU3 Rad[ArAVmF⣨jWWX!,t .^5 RIَ5UL|T/&# PxPvjXPO\ߨo )HWnb('iTCɤ,]e0clI4,O=,!2acPXg7+HZ6sXXJS; J@-N*L<я[Zy(r!Wݮ4"rA)o+&B'YQ*Ɠp ڡц gqV+V( >oNZ*Zkbɗ@))PWRMJ2Ĵ.h}tcA[5$LaH*%E,U."&pqR6JZ,ֱ0(->8wBHAM Q6BGj `l|9!B2V9>&S+!VjPst(8ިVmll)ch@ʿYf!炝Sۅil%Ka/4E-( GҨ(t Gg~1z/^%)#;WiXL="g 䫍ڤ$Cj @6+e&Mmk/l69tzl%k>:NzYWq$⼁6(YB`ӹDC3:,KgNBp{N |"TШklIg m,Ha{F{1v b~T.AL^?9II]JFd1H~J]㑕û򧭄-oHR*zI9-<+ kQ6#~$ )X#= ;m:@^\ p |*mUVK'LfO6P/NջFX`MX4?2JyەBMFUZ5G0qj>!`TI* K i<_iJET89'ɸ6%jX˓H OHm1w'2 \P.#Ƅ YB$3֬]mO^8ɖ$}v4?>ΫrBcrr]5LJy{Q̻UIUI0 Lakپa5H%s<AVG*Ln)̔V#avJ,MKjʃpssQSZɍ+E/Sf{1r0N/k% { Ig4> ;lW0= N{+#Y(,+E0ֺ.޻_[/%hдՓZ cӏ]p8K5VJ]M1`pF(,`c"L%XġbFQuaAXb Jv{ !j L(vJn<6A <+G[Iva!Z7 P]+P(孞-JRvЄ趦DJ4W@3vyo1/$N-NAMERP,fV' OA9浱(Ż x (r@ pZnc$Ҏ ^?~O~zp~D FU krѢ?[2Vu'ʘ [Ԛ;(q)r1< #79WF*B$L2n0h^nj k&k}4Ѭ}ZL2B&lLm̶y歩h=R)dc E;&")v0xV0 acJⅤqj`bIib4CAx_MlyXj$~E M2dTKGbꆞ!nT\4UlFǒLʺ[DK EicSm a@E,J:;YG. Ժ'վc|H0jRLjRgP ')5♕25xAR[fUANS2ddCHR\4CUd)<[7kASCJ0^rb3K1-3GN1V6<#@SZD ЌJ*rKF.T`kZCr5SPw8BK6!F YJ1N0"ң >QyvcmPH4A&hUY! ⨨Ԓ2sEVC{bm܅O q|ҡRud&AK>!$pxyەQoժ~a<.([8\Ʊf̪D1\mqpJ4P{FSbv^ :JPV*HmhV'|ܳv9 (Ҭ4P &n&XdALdot"d;sk0=53x *} U*L^7ZgMJm̃:*bR I0k*j ԃVҪlT;Z^HQ7 HҮ:B*R[2$aQGg/_QSY2ZWw%k֥RKVb*kDzlrA (.gXšA8-<ıpx*3+˪˔ t^#ۙ+'t%Z[*aGtZ# Ԋ*Hv^+L)ȡMpT(bPHelP4-5m׶Q<ђMukJuPq\)KӀE]˖kKB!aTJLMXON \}ʓB?TP#!' A2JH%99w QŮ+dK57jh69f $VvH ˛k{x:،OԊtTLKIcX$ C]P'd+*ńɦڰ/ _S QqvexqU6"[$4P2r;zT(DZ$B T$IR*5/J ˏ jt/|bʛ2J|H:,LCm)MB#}s1EX!¸o 7 3rHJhE`YjőT Nk%*HɡYTB&ڬd|XpspEj+Ī1L(աNuF50&jBWsTujy0CȔq\-IIw8h[Pu,}HAmlǽ'7M\ C 3*T_Tru89(;(Y!M) TGJ2\OJ D<\",Ql ,"AfM^8e:8RGZ%NJoZv(SE05=V+M^nQ TvvJJReEDLJjXm51 fIjcf?YG7y'/#<šꥯSG .zbOAOSuݻN/Ӊfu+5R@G`SnlfApS-p6w(%YY l1h<ʒxኘaERJ6Xzx )ޘHPysqVd|6pBTA9M\7{{j ZHa"`w5&&6G_7 W:y(b*JB@o3.HTK$ }$P]:Ijլb`H(/m%)~ fm90疐k3,gex;gޒ)VE=Vf#JSxL$OT0yCU 4$Cw^PP-v -JFtsg<zDЌʃpT뛫>j juh*b,C3xqm)=ƚ#i $rTֺDwHAD2+h$Q<@ eMS}f Ɋ7r:g\C7:K%N}oWF`Nh%e?-kdZߕjL%GHLz嘇d4 oIRxSANvfESP²]ޘ":_4" ]kYrE@yY au10a>VwɨŅ(ϧ_QOT#JdO%Aԃ~ Ym-[ K%h]ܹskJ˝J{nT_+^b9jPH=OW&LԬ١4niGA7⢹!l J6`DO$ P帙^2%r{hkk{Nc;#uБ1`B)NDѴ6fUzx aggVİtb|R/&k:]ߊl+)vز\$͔)]i(kL3IM C1vpEd1HK[&{ɴ4'xںvș|{'dEe͝5 ȍO+$_"O ʨ໐Hwͨ ߑN4 kXIOIP2%4.//V_R{턷2jo LoKe(}94Y-ct~_o{x}kHFS66 ֔m5 .zg4bH0VBNGe- _KyaggBAYTL5 iA V&-[|5 (w;·{DFM ~f:!Je"r5;a˟S$-RDDEKZgHZނxiו^;Sl+zks}CY$f"&L rtQ7?{p"`MKҰ:Y!4Mq2KAkRHOhr̬L:޽{ݸ$WAnTemܠ,n*b ݂NOtOasm٬SB"pPM%Q;Ư}I =}}r- ^vO3.{[[;Pl 㰕?-^׮oi^{_<='2,O[X9vx)3lyR[Bdc;Yk|X\#HDRLB_zMZɈN>62e^*Sx, M)e$}CtNKDM֞ZiuWCl,[{kZd2E1Re~^F& =Jr,-EY.?k7SZLN2`h#NAUshywj8hSί_+l_+IPb> 1í[vuX<7q[9r.AJ7]!>z68{}c]K)ilRG8ц nY,E)GFXH;A;e*v.tr7T{^竒K/|o5.+b$йRTZDl &A7{+;։a|YՓcZ%C2Ӧ:?[):bܼ -{;{[߻}ݻ25hieO)B|ͫd 7뫗O@-aCq#[fYj7-jR~3.$Evpͪ8ǥ@鏈'_%5 %xx6KCQ {_}Y9G6p_@cyo"RWdh`I= XWeNIUWጴ۰JsU[=U.09J'tW#Txgew;}IggϺ M4kNrh3I1Ub_| .tQǜ8襋6w[{TH _$gOU&e?ǜ!nDEs.zοT zc):ȎA'W鹰efw+37ɧEMgHI%!C"0$MS~"ɆkC-uEh *IB+뫣4 xi#i%O5-ePEZԠqA]a/ QE֭lfi' `SkdBߤ~%yFpQS' )T3*[MhBe8G4} N<ōK(%9h|}A+8}8O0D~n}š 4DmUI Vw-\9yQf ge:2D&=Oϓs/jk3ї}^oxoLOw?aG8, >Kj V,3* -nUr<#vJ`#JS"Xըr+cBuQcaOӣ_xe$HdRˠӾqQUUR|}%kjL6g܂,C!;~!iX%xB *zkH*NcBDGC!#`pz?9Nz̸t¬2dO8Kڃ.RP@\Kdx9}:^>FmEupLePVf͑LQe/bQRjaYr1HI,KhqZGSDÉKCXPO8dմs]/ا:@gg㝻8šR1E~ikkKAb3#R +*`1HiǤxu2e!Y_@*VW8RY1 UdX>(^f~ eB:gM1mu ײ$_{T0hP../u@W.*?rjCSfS{o*Ss,'kԫ?я=y&2:o( 4 1;ZT&ښ;4Ao1ӵI:߲ Vv˖![oY'o'!ơ<7g|=g=WZf&i˯^?Ǹґ4$:Y>2td{ف&R{[}$<O2h{BQY-^@!30u'4ϦSյO621h^Q5 Q9K47nV8G|&@֬^:(һרj&zJdJ֏> }=69ԙ0b}*\,5&Uئ4=ޗ5p=5G+$gGM,1p 2сJ4P4ć2iiQ%|ȏӓ)eJEԷNÝ߁Uq{PZt$ؐBxGǽԧfB-_D2_%ФZXk[ *Ž==bey[ͱR T{!-s:y(YTƓ)E&>@z=O֮@BqN#B#Orjv ʢUUgqYGx9Vq>+*l.I8 RIj/芖J*nATS+ ЍA#(PX'S"v,IZPX ̀h=Wi>i褝m>S!;ǔi: 8+;;P Iq;c:,,Gz0)FZ]+P/d H(  *[?j  e wN*,?6#̡~'xpF !m%@bmCke]jJhPz*yGgQƋW1368ZCv*>31sG'G> !cfRHK8Lm%淝$^+Sq0S6SPMC6s!/0'~HzO@w*@1nyBmvOjg+U \*0p8>2Xz[ndO)RD<ŗV4F| dњ v,)H‘1HV$2a?@|,vX's˭5x^܆g 8rr&)5P *ڪŌ^Zyڵ;;OTt&OA]ic`}}oꅗ̴4E::FԃJ_Þ*Z%Vi_JZ{N8O1""d;AFMP,a.boUhI\HMXVYξ>}RtȆ A&XE Osdl4')]of#1.,g+ǙIN4]M>xDa>bgN`-W%$FǢb{W[Jgx7=em >V?D9N5+Չʡ6O14XMb,Ӑ|y|7|eM}+:CR Aޑᐰ=ZUP%]bAV#0?qW]R>3l2N(x/A; 1z+2nvMx+p0$=*.=wdؐNF.p<"WS6o9ˣ\JxlurfWYbHEfp`䳗r_xQfj5hiQG,K[;H%!Y6 Oi(SiBK\NQXt2#4ܹq烏?yfUo6(#C@jo3Me֤ӿэI*!x:>ӮgyV4p!BG\XA3NɠHnA|8!}_2hg&iyu5~ǟ8PbXݡVLU':kO$̹0ԋDr~Œ.j26Оr!br7LwڤrZfʲox4e,2U b*~>Hyv^F̧9L($RhGAGfq%B⬪Tނi1VE$vNeJ鞟7uyДr-rv>? mA s!T1a4nܢBYZRߠ AAiJd"m޻?pq~H;ЂVA$K~K`djޗ}NI^['T,xgIg5OfDJO,֗JjcI#NLtj&Hˤlƞ,vnxSkF[\)̹VB5oR;1z:6_4 ydpQ\QXkpٽ!4&.JmhY3 2J) 0FEvNcS9 }K@4,ZwJrnC6BxnKi H0#g9s&>Rr&]adE:D-"bU9v/9#= tp6s]PPk?b͍UV?kXc4yT*)v(Fu4!OA05Z ^|1k ᱧp_Guiv;zI_$JcNxT6Ĩˑz*Hs}S-fwO4;ޛQ XQoݿv>H , Nt!CDQPno`K$4^R$|j>ִ-ƧZrtTµǃGbpԞ,|!) o5U nb+kB1\I\Iiֱфv:]!1&Z2-Ie:+dA >:Fl,eHWN[ k:{TUjc r4Pހ, :˶D@QX .pF+X{Xdg_H * }j:ю2_*|y–!%^AOS,NƸ8=E[G!S#v3pZ^dOD>ӥLS9]d}`Ƚ>{d!+9nԘ Q,LGdDjơbBMp<,*@2!W'Gݕ+dC%GBP-7ij4,R !8]z mZM*>v {d EɬqObIX̌oͲ-kk#H%U]lOҏ6T)x笜 &)k$] gSL)I&(ڠadL`65K 3ci, Y}QWBwH0鑵S#";g(Uo@CDSblf` H'e! %aGowvìKJ%͜!nF{XHz;=S3z[N0*6 2=HO&Oft+EN. G.1<x.Xд`/Z:X1[6fLyLX8pr]7-jbujQsD B_~^o< ʷ)V~~g?|{~ޡڋk7³]P͊_ oda9FdBu*J6D 0(g@Wǃ\fYtL3jSn35p37B'Jx38H9z)u%rgv׹I=NyO[\چ{# -Ջ sIo |=u&mDDx6 89:2#i7DU[S~ut-Vr`5QHEl";BOp7'eK fnsZ6T ?w0 ҵd*a .6Zx{?σH((YDY +GGcNfNɤ 2VY_ir1=x=O)[٨JcS/'4 qy`ڨT1'?yO?ǟ~/;10(68 ckӔAijƎBB^%2$RLHi<'(l'p LN ִlupB 8jS6cD C> seK<:v^M o֮qV}Ld6]OAj;\ D^"S$ 8<,sSM:,y}t(SsKWJ iH E.N9K8^\}o{gwk Jvl牾~&;U?ɧ K&Z, v'i䇯7*uJMC )!  `):o3o)2 ٌN*RIRݥW_/~/]e3xU*("@pq2/0Bjd]f #ЕM.0LV`sj 9q},ׯ^ٜIr֑'r РbX~*if,=LM̠ΜA69|l0L_ݻ~mcƍ͝Wv-گM+=|8skd &f^;F42FmT7vdᶶ7v Z瓒 ) y3+MA"|"sn&pW3 1-:LN:. 5NAtdP9+yNuoRiTԐъǂ;N/F!>,KB rgO[ۖ'1?s[n;ݾͻ^N3TN X:e)c|kszguWJj_ʇuqvA3E\'fK7lLY7#PJ&¥᜗8qom]}{[~|n>}C_,/ڗG09V@%;yb!aDy4G7c,UDj ūK 2twR{pT1_n'm65[.NI)hie IjN3/+]+8~vCەw݇޹vJm^%G(v겇iČuW"zggLԈa(xcB#(Cd۪UR3hq Vj HC/:'[@&/@0qVZvX!6 q:b Ж2Z:[ohuA~YKX^+%G;:+Ww};ݫtޫ4LT!!T)e=Q+)eChwxr|r6k^RMß! gp#DX(zŋ x]G}#Zm?Q6{C'ٌ|d!T0A`øbtD$?I=xܺ}e <ГeoQ1l"LBG$xh(vNӍ[}߿}ZŐ1<ƙy͈x(ɠ)n"m.X#5GL mԀ[ֽ nQ0IsҤK_S1"ygE':K0}?7|zɨذ,N|VRSv%fr7n?xwk\vbɔ:TPTzKS#'ÑUhҰ۟J[2bF6fڌKF?U1S =K\ ;?jgf@c@38+ԣǡ-ga0!.Qz0pPp* 5n)=L<'" aҼyݻw^؆zQ@w:`րYZ>&#$$6#<UHmPBqg_3Z$/I,)LIeWy Zw 9iTh 1tΠj,&O>Ɛ5'ױ"I8Kd p%Aj -M6ң͎Ԟ,.sC8d89 w׌|{sI>CN4C5dy2L ^~<s @I,9nKHt^Ń7-PieV8 MW^IVh]Z>KԑFUM?WvG ͕T'W?>yzvVֱt䨅|ªaW;k99%gg'Y?"ϺiFU %)2SF k;*C&C+_ YG=$.lہ:n wzr4G@{@GJ81?:PzaK9Dvp[kf$|};9tPO2wrs{j)8ymE$Tjlu89CT98^G纯Իd)'SQYg!s/EsH O.C{(%f?M&[IG $'aƹ=zvsx¤vngVspz-_J>=}5A_@l9QFW~>'t|:Wmno|%\qF'zP~VX$G'Oώ:9ə( !2 GWX(qVw~vjGC qk,.>MۜP{?~C1WϠ%Cf4ҌF8ImIRFkyr{x9;a|eûMS{/v,bHȁwㄪ2s!ۮ3>9ցR-5Q=<5 rrO;/~代2֡d7ecfcKΒ_|FRwД{4TEbP$= 'Lkx߆%*I_㝜s(w_}o҃ty<~Aխ:'2p˗/iғ+T1 Խkw#%j#YH=9vJÝY p(U"j ΐ2Fz%S霺BIĻTF(R)8]3}QI8N۽.w5X\@ JTe. ^-ԱC1eB72$/Yu+/gFs7#t%p΂,[-_W*FNVra!crzQ8Sj 6ͰO@ +ol0|xx|u>"b [jh/8_vչ=[صDQV Ѡl>nvT 22- \xUNA(i5:X(gAN6BB|-=YPYk G&)h.1v!Dn {+B4SW9 6x0.i^\u@=68R=Ht Oh!] dR⟴JtDu؄ Y41].A*R&pwVM>zWX c@[QJtSko(2BG9$:C3 (9]3 A'TlݺE^5e; FG enTkz s69D|,sX,T29^L!m֪\DF>c-)>_K9-Wdsx ePҰuPiVjc*2B%C(թ҄%'$rOI'fҩoֳN!^ZnrsI׉V3f :spᵗgχ;󤘫+x#3YB!XQyKXY&iFfȂ\ ;ӗ!=ԉO HCNĨ! 6I鵙$7/;Y |̤ܨ< Z'ˏQF@jY'6T[OnCM}TQߐ b:`a`jDJd$#{wķlOUsFGXGe ԥ8v=Q Kan'E3F5;RScehKAZ:S`%4#OdjR!~Q驞6M+[r$ k5t P1˩zV-(qAd!}!Z'x1e*ϥRc XoK·@!l5׽E{a  ;m SEaez@;ֶXG3$aVDK1 {p1YN~P*FڥKW% ӊ0mNYz@I!&lR* `< ?zփ62)MxWo<oWR$t5,^(*Ep5r/ R"CJUW;q'ܲ6ՏD56M'ȵXSX Z;H@ERoyű 4) qZ76t s6O^WPD.0Ij֚֘`]FM|$&G>O"K$02xVR+z:4{SdƂ(GHSe+mWV\]FhY \8A!]WpFLɩ&i` (+\#gĄqF| !wĘAj kRð?yK$93~|F y!b{:L9Y'1Hm%,\y$Pm0'癦*T,+p6+@i bF!2ocwOlGTeP~GY8=,6-ڳ(U%tJ ;5bE(XNLezVڤd>0Tue>Ŭ 䪣C HPE!FG1<-&S3jS&ObɴF#G_WrV \ir$i;V<Z~!No}.$򸉺m@,c1oI}ʊSB\CVnF*QFfIg%[ ZN(f!Qk˲6M;MGPi0b#1J[ =Yꄑ}7Ԗ[>ѧc|JLE*`y"W})Or@|뚎3 0\wBI1ŎE1Bt_X 9%OhPW}W~DN\QU\ALt V:>9%ـbTY.>82@((K!{zz|6 dR@,oG3XQJud1i@(fΟ˥Vt2ʞ l=ܪ-O^l=CBV8jEj,z %ђkN2MuPZ4B9. r*oޡ;]L 00 -=SQ6;Am.hd^*gy>MQGOf9r h$(\tuy~q- +惂i𑑨3B@0\& r).T EWpdcCcuȇ /sY pWyvQ葎_Uni pQTޗA*P^[:zi [C m_|+ 2G7JIrBRHZg?!#q_}@d:/T~:T.7XN Mivt'Ԋk|υY p̣chv\>i"E+Vڠu\e{@SZi><EԿ>_ IyC'L bt2~;(c| :M~ J`k+x%5]7I忚A;̮ 5 fs;e,1ૂLRT hf&'dւѫ`m:[K5 2CB6U-MbRl2OJGt N#mf!Ax Cu J8!Vn o*ߒBYVg`iu :jb0P)+b+D];_x_">K^V'T)IYDw‘GVCz{Ydo|_0rc *D7t;c#I`#?=;H-1“Y}4`^?5 %\,'P(HC4ZmG6}#*t;wM}?wo@>}Bb_UӲ&q07 Ye^ ߒ2,ZIhI"ُ1$H,civ6*n{cGe)&`/"HO'ϩV^lS( +";DfGyOB0Zizfr\#)'LMެՇt*e4*>S4D {sogZ[xр;&GgxutgUI`? K#m:йIIhv΄IS 7]+FX7J3mnj!q!`2 ;'e"ݳ <;z:DORq„i8#J; 2SZƐ۴El.F?Tz7'eLC:zJF )h@u2 ܥ!X11d>VUK)~; yѾMRWIHJ|t/r|1(4Oe }mEkf+3C]rih2~zj4ѭN0$_hMg֙POVIGaw&g,B3iL!605|l#~]m}+O7%ThHсM> Jɇt\۾[Ӂ|(;* 5q %= nPiħ)$eΚb2f1+qtM U|LP` %3ߎ/ei@5r/0rLO3!l|?}B?L"$ci&dUu`\Šn 4$n#u+4E5, m#1Jl""N^\$$a)CH/&]=,L Dvmx%l \ｚP㧉(tQ)!n4=X |n!o;LDG U5w;( Q&ˤu;  !2Z5c\`|ug6h+ti@v~^ f'hLbE, RZ_T]d^v*廸^ԝkvsC[x&F~=xgs#Ͼwp#2r񟹗icQ%]80kp3uP˘7[EvvT>\WsDžtsH>~c=q%=*ҏ&EWF{))jyvTƐd!qi6w8Tm{ ͢)"_R.jm'\ceNьHetRJ"=D M-g2(?SsXV^nNnQSܩtm}7 t<\!tS܊Avj:k.s|Zm{acj 8"Ah֋$+#g~.flgTgӗǷ|tF!/ʋM*a (L>Ibg<[f=gQery RIZ5* q!I 'Uo|oV[2 L.7ƪ g.\Lgc?Dأ˝|RL*D>2k(h_(#cNFuCs1<߄˨.F¡QsMGh6M9?,Ux>2{/˩D[F< z L>A]v#!?JK'id0@30+@)' 2+'+գQ{f?KjnKldf[ろvaJ?xAh }A9onfQq`8,r:=8KH\{cۘ-@{ai# 9eW'ֽ`I̎?IA$Q4cL/$7 *-n"(Ddt <.3EawkfٛA?疾{%ЏTdV̒-"*-'9v`TYgm|!Ų얋Sg&-Vv Ru~6Ka?ϾJTvM\[SOLх4A9 2[QφDvْe0\#0U"}`r}7ݿ2sB';^N`^tr{~3:׬J?6҉&g)vd=&h"Vwjg[iaV&-N"حur+,2gEsq=Lo15HWǟ4V0/0t-y`>“LtiwQKD889T*,x ηTauCmW@Ϲ$+̎" ' j'TyH$^WP)ƹLqqaƃA"reacգ\SC cǽ-"O=JQ9zD*e, fKJ3`Kݓ]9|"38)}VHTsvXgxHO;.h70 /TWW4 [z͉ȶYi`+kҜ$攜3;,qQb^\hr>r&T͊KDz0 34e;ۦ ߊG3 &c8!RE>?f'Tհq#i0xĊ;"`_{=@$z2c:$3m}M 2R77Qa?R 5ŝّgT2[sL(y37o>PVIM?8NNC:8o8s=)&f3g)@857wAUևHtRWUyp) )1&5^;|qٮsK?a .W8~z|'4t}箏XWKeSdP/E|e)2P@1f篹4 xU4+hZMhŐ-aTdwJ>h W,BY?M)n=벱\4d)f+aYfs|WHM,xm8L5ﬣ71/lpqY4'㷲fިZYaݜeNy҈:^SiV,uROG8\J]Hfdd+n\$N"Y],,KWT߸/|.90Ni2z,`S=[+Ӵ-Nuij\<ohCrL ̍'TXϱ/k9M/ޝS l,=tAR8+Z,鋙|5O4-]&iHp 3 F_+ 8uF9z9PJ8Er;݁ٛـ3#)aҢeh !N`g'uV"=Y:7$'BG[h 2Q-*;Y_9k?$w .(C3mU)žѣr͈-.΀_HQ2q|NaQ]]FoI%s#Κ>#(gyi%Q΢Nۦ_ "X:8,B:koyFu&<}S1["4.lFClq,ֈ޲o7Mg^iO^d|?ʼnX9*Ewi/_wz/b!=2A{ےPKʪ QCAwzKldM_D#c,G ]|SiEEr! (bfj##Df+No5")\=,5|qaӼhJow,eY/"ڴ9"?K{u{QGڕZD;悺Dn:΋kTrS( F̌S$鏈9ݐqeU[:ٛKޒ}lb" 3kJ\ ;yoL~Eu,q}#[|>7Kθ\zt& nРMuo-#NZފҏ+<2S8b^ Go27&2bYMuaiQMY6~_$y׳^8j$J=0US>O;*f܈7D<}ų̀NiZU<ͿYTdHQJotUKOP2;y]]l=m.}a骅.:vOi/`#Xߑ &J (-0VʶuK>t([߮ORK}Z[ꠚHV4,nEWٓ5mwPSFw7$=xdn- uScM,ꭥؽO_\@禸MK'dfEmX1_Ko <(S¾_#­8!-P /sgܕ]p`XJ-N+wqov;)1[Ӝ3澴ȧ+z54i^s7t_*~nmr| QImd%]eYZ7_H3&NHO۞ 'cN!zFZqTCNړK^tJAo)_ֈ>g[͝t>~QQ  oJKԥYuRzͼYmcY.3ꪬ/[N=FXAqSq\x|/Wr[y -)駨gnjvKzߕz<#Z2 | >i]U[* |%]JR (wU36R*RW;`YIM Do>h>sYج\*7qF*-^~J6RCoroG\?ȧ( RzQ{es2 t|JxeFc rs$Z<_W\_EC2!X&Aine̊qq}MuW_+tlı9|:ο{pbxL1$ & >}d[xmP)+vBg}7xپpC5ℂ !ע5"?"|Fdc8v:x}FY7ljӺ9XW\HτV2YǖV"VD}nV&# SyeKW@! C gY[_9^"KX7ThhaS\}Wtll"N1,eml8 O8Ujt*6.[sHp7pXo^E1\2wuo&UϝcϹu^*zְlw{I֍U'Y0Ļb(Lxe^?ňm=?C2&ȶrq!{ D@߬X3B~b~2}sZSlYdn)=Kwdrp=xbITJkZruF<}9X0\+d)u}E#ow6#/X>|"QŪZW@o-RR۱̎d6,|Kz甆6 Aoa=?gǃ?+U^+iқ5#LUx-=FewQz˽"4zԄO5ygŠT^MzאH8G"b2k4Qo, /Qce/u/pu>ϣ@ H3)2ݟvw_Q؄tU >yKlCSEF{rzzu>gB߿&N%nÓXVjŻX`xx"z >kd5BV3ϒw#k?'/UxOoX+47ȑ}h|nJ,_sw' &nh`,}O.>Lo-3]]7ְ(sVv+q899ԁ|YgG?-z8 ,δ ~z2"8ykT7ζ63eZ!+q-YfR'wwP\@!=(wei 6Uni^qN]Ds7 IH[NtrEaMzK57Ӽ{abp>f%lsVKof\Ul&4%fuE.1axM7@OCpWN\,"%́bXN^ uᢺ{hXj8?̠KBvS*|}"O4( ĖRNY?'UZJ,TS^O|-Coӊrxә X` r=f]BDX"Y/4- U(?{s{ 8;0brLt;g{8?C ƶsoFc(\rE-(`LwѴ6LyY%[&\pb&7,xV#>*7\ǬhvfrRogAgI4/.`6`3J=rW6X{v=jfʸNkD+(uys$=G}գފo\K|wsIWB_;He5W>:rs+-;NoD]̳z`e`M61n ב'e ~7{d_эR(*RZ7rNF_k{=GzN)c{{[9)suvk'۪tl|O$8h qt[VGvt>>gԬ]%\rm{ՕXse6Us"p&q].N@:]>I֦}h<=z=*sӅXV9QJ*jGE:%“ 39v 8^'ac=IJ}m\uz^/g(󔈃s9sXD.{ɸ(8^s/KŒ23h(<=;z;;dZy{TJEbz8_'ݠVE F4YZq<'#/1htZIsr^\K U84U_1BoW+NVGYu)tq\\piol~ R~Wd:4y lK^T> k7Hi_KoVg ZOϗ)d2N 7@b?GId?gr_t"*mR%}g:._ƾ뭬f֒um.ÜŴRFt%2?X9E\7>9x2Um= :teP\A(Trogu {J(Orj򨚙޲wQ< ݇f\ Տo?տ|3G$hYRqD2h-13W{Z2jK$J Ggݩ;~IC+ҚU.>8 X7oouO?ꋧNWCgI+oϬxO..1?xLQΏ~3 .@>"y\V9a1't6 ُS2xD:F&:7,tAEzn3R!=Oei#9T֛js]nf_,!^,O{C[ݻnL;~ٗQ1f;>K{_h_vV\*>}y"s#\z J}+p: T}P}׶@PBQ|A+'VnA|.~?-^IxmH}&E&^vu' ;miV|pw>?>rt0w$d?~\T ژՅj4<凓&k4ʽ#THv}Cz7-ʂ/#)GpFWk߾dJfS,*iL?$I9_/{ 2WJe}<}9b9Q]g)&Qf;k#8ҰD\޹zbeӓܘ9bj>y:1f:t0:RO L6Q r?nK@wsյk<}+9NޢvOze*婦VҏV|uYmnoTKsaY`P)!p5*}՘i}۫=ؽ~}mVX0tr}n4)?4aY>GYf?i+j8%ۻ>>^<=XKaCՂ5G_8%yi <^rk/Dl^蜌MI >iqH a71ʦޭGwkI>ų'4Ĩ}SZ9Za8p6nn_yVu=Y͊<e>g“Xv_O*_zICe:Vj5r4E}RywmmVja֨A*-g[Beۛ!w5qu7wկ?|$1aoJ#7ꔃ% 4Mt7 !{N>xv}v.@moSk߽{Gd,<)ݵگ{޽;{kd0 hg gq~}R_퍫ol#Nd0zPTTn`x3H,pL6Yzk[I<_mPD͊yGme.䞑 =ڕk W<7}:%Y0cIG[7~umR"Ͻ5a|+"AfɄU8{\ím\Qn:B7sʰs]y,˕;@=:ύߛȗC07nz!4}kb0;so^NBq9֒J KGhn+Nn}t5t Hj4w_o*C`eⷤ%vĊRó!j2n1Cu>bbѿplTZ>h`{X!tI9-V!쳸psMotF76v+5'gI~rnr2J9ap ~|^ʻ+r3~\־>@EW.Q;)տqmG*uYbjU:j+HjaJ(WZQYTa#anD Kٟ+cu/eVүU_;s2] b%s8IQ|,krv~qkx]fڙOQv1) b]%yWY4@KZ(Z8_'Wݍkh>f{]W5ER{Gjun^;jkm^KZO/WOGCzwWVYJ(Sb3lՀ/ QjȔ2r12 =O_GٯY1o7߹:-A[(j?kf:WqVևɍFg,-[:n_ҰmLJ|$@@/?Wi25Ëe++(""!zYt<7vN^|^O3 C&#:i''oo~_|lB~ƅׯnN]tߊ~*%ïANd59f̝]0V k[i*yO=_B oךl`n}M)oc' U[M58^]$'}aItr4UEGʽ∍A fN0xO?ٿdrNM؄`vܛJ (nhO~w~w'`z?d0KܨSc #`/ (UpFY#cfexy^sUY1 ?]ʛWYwicz2/+tW/׽!+_LAzw]Iʵ8eÝhu@\NL ң1’G c&FY쓟}K^1 %NfRȳPioop p֤PKmAD"jaaLFѐr 4_>tKJq~B 1_DY-+n&77>sdA)L!`ܟФ5Hojb`T$jq@e}9)|pZ&:'R3X$R6 ZˆQ l;2/ &Is_KJ 5ԞxL/G혡~Z}tfć*zSl φ8։C?w#+˔bh~o-O2"_|AMR&|lmE=ƅrqPO YwJE^y鸕xU}+רn>z!A@וՆ`^l4a#Da<89 3{!E:2=yK)0 n[jjJW6*zZ%GY0Ty V yeVFvrG/&းY@ޞ Q?(ztǃ׃6RD6Gބh E;R}R>B@V%Zru{^׋.$C btI|C`( )sޤɺ'-EARQ.>G)aZ>FR8WNr#!8X4:`S *ݪ =?ADf>-֏z{'o6ߝ4^ w“IgP$rDIoǕ))*M*ivR/un"jpfgInOjs 뛧ِMI fk<}7Mk0]Zg{&A iFrnV'ANRL7""UsdmXj;LKX8P}}7/~j孵SlR& Mx-!&#\0TApJ"YJ=>;xD6R %B+6nl6ʕd4]/%*bOqRBw+6r+M N7M^3j3F<|1|aqJRk6hBRw5(Nf;;&DM:U%,nvgZ]ݾ~6yѧ3yߚH#w֏WϦI6ۼ/mr.*|&1Ok)Uo*RnϪ'ox7y]u hPpB> hJ_8 pbj ᕪ [?;gEwTIf7S];mjNVDmIJ?jO߭??A7`rN ur(ݥJ25cjBZ(C3AG[ƨL&Է1vˍ:awjyKTnȧf Mj;'!IWe;nFVհ9}qyXt%ʪMZLdI\iPÛɝtVBNA, d(4XюTte`RhQ椔?SN&jaTsqMhA&/tGFe7|wݺNbW6& )->\ƍJvw}s;vȑsXP_>(~y[ܪpgZ>W]~i0m57v}p懷ow}j%I\Nw3~VJ76 gGdVHs_|iN{o|RWo<v[N&UN', ;Vxzֽy˧ݓzP2V \+7?N=)gC\4?ye6J<MlMwv5n~z(L:4 X< fVse[I7>vvk퍍= JLᨒ+sػ+T[^wX!'RՖ;*6*vKy;W}a~D}I>b?YLT7·v}Oo47?~kt=d܍`^Kjݻ'|ܼq勧V6֖[|^cqFI >IZ6n[ME^迏dհ`/Tǻ~{wn4E,4V(vGD,O{7;ߢsWH u!WGğt[ImW?powwfRȱPJgroZSw>ƕ[Wx𛷔'^aUxp:nXɹ$on~G?J/?l|p۷Ysc\UA}pg%(3pn{k[w7{սjz}tMS>鞜''/_uO/Plw!7&ZvP|v⫳Ct/^=i@J\֡7 i,~/$uo襻VTog_ T2 k/Qb\ΗKѸv6lc@ǔ*F"BS}TaԸ 臊!^T1Nzrgu얮ZRe,jn'f\x37K{H*aI/_M :O{MybG"v(xB@~7QBn,ܵ dCFgbݺp@PE)B*O6l,ŋ‚`;WXf]҅R(n Qf0)  L eyGTkumniɅ2knb4iX/`)Ow@EHM~W_VT[42Zv%-'3==ˋՈdt0p1ÂApeakN/ 7k]V9[,erHL!9|N^@J۴B|aEA\A9JpqhK+N/=J,-lӂ| YFNLo (2T|<0; On߷ڱVZ>|OOO"+D<#hm|k$fK;LBF=iYsqh7/\ra)2]9vT5|lt&Ute#O}Ѿhm^[s9{:wblbV,VdV"D+qKCe@W éF?~xx )K - qRd99e5z;wɍc*E\b[|V000ϟ9Ni&S1'6&N2n;@ιeu:FSVOLL,..~"i!lPڝ\VL"Uv7-k W>JdDWm)R ,g( 2W;UbJU IJ]h82v_p4`jxvQ|w\[ dT Ry _6;EKlWX+X,Iv܄ 'OJ'"3+R,R`0쩪IG˚ˢ#׀/3 Bu,It.ks9\~o"D R᷁=QJfWn[IK5.,t"LɪEb D<~\t`zͬ+:ދԩ׮b((UiسG٫әZѭ{:{ >֡j+7Udw!n1&&E-'ըpcC@8ApXht&y\*`*.` ANIYU4({CBIކS쩚RT6xi;NR^q tOzv%Ϭ0hD \Fn4[FRtË[+P_*ύJ3oV]m!cA)g~%Ou0R>VMz'Z0V ,E722La5H: $ cbPkE9i*e Eb `"7ƌ6[ jBZd.@BiB"10ۚZ];Vx$e&\*WbU,O{@M0 ӜY% 8%@4e1iDׄG7lU>KFII gS@1$< DKa1=(xil# voGNI@/`GJ%nf@ʓ-Y *2f;ڋ-HR`^+7lba.h]cIIu3+')kb6z?RT: RG,#P9:KS?$m xDثZ?T{`W"%K[z,t~l=F#j=h֜,PprerYh5 d qDIԑ" K'WXi#5RZ݅$rD)VC(㦾*߃z ?ȞrY^Ο$ [}g._FmCom\eo=bzkÊhlX$q8kZV;G썝JU& ҋFt6- R<ջVEHjL9 `LcrA7|ZXV3U{~.讫ekr &UY$(?kUY, Cq)ͥM^#8@h%cTeҐ j1MX*&4{NfsJ@ qE<#heA ז;qiZgu@runiHB9P:0Z&qݨh'&DPH3[8*A\xӥ9ӄ} ;WU={1#NMeVm|2{,0PbPG_4&OaIe]2\2V5RykFT[7nė(LzO(YskW_[Ξݻ|ATa<03M ,\N Uҁl*>Q4|IIO"o;^SS4@.T+VWq6\.zreuD`?XSfEzstZ@Ŏ(h".IN+D8? 90d 3+9HE:-xN0"ej9/7It7ߦ3TUbsqeIYqikJ-]?Zg)wr?"o)\Su#<0LwDNGdExĝS[<#$z+%;]v l%NdӪĕw&jXix*yb`D s\XjEXz)kbЍ.g݇:PS+W"$.jI(_dFz}hUy&IFw. G49y-'!f3?ɓz2~)IF njN[ GՁ`um `Jpى&9W/=tw1ep[\lvÅDC+SZ4A6QːC䒆hT VH&񄷇,SzoYCG. |qAW }VԫU|@C*LX3 riW0k &ל> HeqT"iN& 0lp)K2Z*J\Zalr>1KgDaj4ô %(jҕց2i%E706rEmR#]u%`0(",lrBI{P¿ u[JT8JMUW[G1B7rE(Tm4V;?W*HYBYʸY~\Vꏩ911L2%zruAcw jpLBe&!C9<4)bt00qMKm\C < ʟѨ4 $;;ecc`d8&;@_."LKR3f$w\X$R0:`Pj҆BW O9 ۋX<jg=](cơ_^[¥08Qj8 #lM$ʅ%+p2-eE\J 5H^-0M~ aRQb>l, 3t: `,O K"瑷c["BsHSuV/*IP&R|>BdRfm5\`2(!N%ۯ3L(H C%F ד H&J!4-,4 4R 2 {ݲ@\JCvKgN z=dp3#zmjG^IdaNBi*LUx6M|U/^^9]Mls!.ݹu^>?<7Eh0Bڝ&d$OG#\0R Ni N6C+wݷ}}4fz'f½ S_( @G}p?q6B"d=$Xq5* Bi~<8mf3% +M *)PB_uBA ֩rC^:hWUn|`5%Y7/h(w&)a$|LKw;_|K-%Dzlm &A]Z{k_y / Y) pH#Qʏ,/gxޤ{džg… QE 4,5>ozg]wHKH3T\W zL XMW )~%+Y{{Mseai~G!L 2 +HG9&DY l$J)͔ R/EnB-!Pi#nׇtD!Rhu%Vgkz/|_~0&g<3+u58/./AYGs:E6vnCFzνx_kr2x’C'}Nexs:ft5[PipSٙ\P!dERK|B+a6[ֲdlj6\OG(:/g jZDU= L<~PNrI(P9fήIĬ S+S3e &4 }O𡄂p&<Z-#pl; ykAwQsԝ$'9X#T<e)09.Y:K$q^'ŵlxlvZP5|cTQ(!LZ8U܀ @o¸ſm$7u?e7(<őNH0U8, kiQe#q^SZM,\:s`*B !?40.'n \3̬򀜤ސ@*'"SfxQTGxn4צP36 Pf0PzgJ̕WzrlPXV "'klh!ѷ<*gi-nݽHO0e=IDATc MBp c]U'pS4O'W'dCªqF gulڝRsEg#o|byw&V,AcsU:i5tARz`&5'WstxavxᩐfW_HyjJ͈9Ŗ!$fӳ#acb.092_ F(npɥ𲘌V=5 3Qp.,z4F}.=G.rd\qaZ_|ޔux?z܄w''+^LP6{f?"b(2`Tx >_@[Uϱm y2GTTAhf>?st@ !5`**AU_B-] HwT o16e!Z-/U3lKȿFiƈ!Jc@tKEC 5 .p A{ )Fvl!c2Lp:wޟr!q-%lY<9-/%3brRcԢDe) *6UG}i;p.1JiwXVn IHDFPPj%So՚(bX!_pV,[sMlj0w/rZt "Is캗g=?>H!j1Ʉ  U#ԙ3fd[ԡf+-Ej4[sm}8[YYRվ`юi#II[V YSv5Bz*CC&$~e2IE6+[Ic2a[]ڊۗ\֦W1m3=A |*EuR{Mmٳ$3Mz](/Xk604ĩD@'yWh_"yv},$5UP-{ȲClU(9NYA{ Ѝ8L܋*֢io:\:;zW4"'X'pJdp'O`_177C^P<%F F1qy&i,\avҾ-;ȼ5-Wl,yEJLf14ˋT ERP-,642HhºO.s{zͮFI[ (wV,Qt o<~2坳&d}IB*i2&H<_\l/O_:ܟ:g]VNVzu ڕwOw,Y_XqJPn4,Ť%"@#SE(R%Ԝ3K +d%8 %a΋"lF$UGMP)a ndRABœgrmY'CADHeAS9_d=?OtԎjgm0"hāM7&XDρA-ND&4Ow;h*%cFc+Pc-mHO_ex,,RlKT B$NmAoPy= "6r3Zl|Ƕ+@ZDcWWS>HlqJa$ u!/ND$/d R苐PZdl*QEuA}rK6K YX>ǟZY'(Zg+ )`X`^Ep seuqf|d~iNbWsӛ퀕\jUhLB*Z#B\NN\$ISMJ&Q\6qV`?9KX7jnQpYIQDq1( bJ, r_pe yY拉x|%UXR[KC1$ң i!6!dsP,ΆWVi2Cu ^HDSCBahEP&H&}Tƥ ᣇi嘡5dUuB&Cg#KI^-CHʤ@jPxy)#TZrA'Ḥnm|cu q?<3*ۂ"{,v,?. kDXp7уz5ދGa$,YmlUMv8蕨2%qO0|K)UE!хZi&%\` b}*YW{tYZ!}O?yoԛmPH0ШqPo0 .mժwH mN`2ڠPM ܝOhDa1$.`SǾ. h"%ogX|0NUtqd骽F"V$ 6u4NcK1t OIDcV-z`@_F0Y,y$k- PhN!2W$"ĈgIѺ瑧 3#1=F6Qn K'Xӯh!{kTl ˽>PCmign\&FE˔SiQzG(v=*>2 QPyv*{%zb wuk; @~!ApTPCz3wchuP6e@>^; BΪy]Zm+\$]=Ds+B/\ ͵,\aKl;f/"PҰ,72N_ʘT)V|1@TSLҒB{[%/?bPQkD L]D@s؇ZPzm ,1sgfGd-3J0gC(y!U2o|SDTVtF&s[3N w]$CiEՔbg0[^qF^JRJ4$*y5iA6Ik9-dfɌh#{Uiiy+Z*[L0&P@b`S"j+?YuKJSSn3W>-"kU+1+L?IdI~/OO 4漰@~#?r0rKt`r+B NU[(\ӥF Y^__JyFC, _U-/3ug/y=T:.(W:rS.V&D Ԧ;o-^1-+'Ff&QZUwرG|𛐭v[0TJ DPﺴt-F2fr=Ro+.HvAIy\".% RZ c4J)#,z7MPWeI<Ҧ2";D8Q{eHXCe3qҤ-'ʹпBEPOӷbjT `,'`ڽ `P?x*MϏ 󊿤OQ0? g<7Xb91Z=Ux()9c"B;*(deR&%>Z_(f*s}=Mx\-Q;v>y+#s#IPdLPjUEK1,ֆ,c$@gAJo!uɂ?}m?{ܠW@(>I}־2U/ _g},soܤ/}TǦH'S_/}Jo~?BрY{TDd|UFrAom 2H'VP,ݢoJpŽ(֫-yAGẎ?h\+8!Frod K+BJ6A26fE_@Q| *9ފ zh6K!,ZU$z (M_W (ןWq"!"s8[NL SAͤ|WF?b吊`QƽATR[/ekTNoUy>6^"Q?SQ2Oz^j/6R췂i٩DĞ:)T6{;}Qս.N]p5i +v]ۮ䂩?4aۋ堛per<)λ 0PcUyHƟO*k[;sw}"H&5Ueȟ?ag쯻N*R/A>5]g$(uXO'l?J/I[} ORyO>s*WǠ__TB;!(+KO wJ[17;s4-lreʬ[I\X5(ԤmnQȌ{R[6ؾ-Y 6m'oPpkj66 u>dJm6*@4,yENҩV}i?j9+JHquR@Ee}olU|e&L*Eum IqdG )GIR&jE;m*ʩZ7[)f$ܻ.Y,MA^tu :sW(nz^@! ,MWKZzݢEOYPjfp;U~7\gօk T)Gٜ[lPY][0! o&#=p?y3cDw??>[,WWO٨0LKY>yKybb#F$Te:ǶY:%Y1?P1$P6`6p>LdW: Z^@-SQU52tB"VWyMBu0} 3_tQ-%nT!/tfgV( =ӮDy?m\_XrL薇>*1mMFX?Ue1;A_YV}"w^쐤t,VlL̰>"_R>?K-Zi`cDүԔӡZaj^?_ǠfbC} ô ek4 lP=8y׺t\:QPCmK1A+0qWBvW'^T"KvԺ!u`}7=?s[|V9:bC3y0mJ=kqY[̸^o,zIz쓮Ix%7ډ>@7RXI7ҏ|WbP%h7Z;M}*dzL_u큮_WFRJׯܴr_}*㩌y֯_YhMȐ_zKBBNMvDYipjpiQˬӋ`ɚnW]L v)N$#2YG|6)0=QC306LSV?we뢫. *dt;> O*O u_P}Xb)}ji}*;;l^z}Ke~Qn}>!Wl8GL wxS<8k2AVW+>[gpymoA26sq<:K>," .U̽KY?5 ¥W5%o>WEc'|]+nEJ ܽ">i+W&a0w݂)By$"ɘ/hnH`iIz d R-:/M$iA dq76;^M*]U%}F1ryy}k=y."yFoIgѕ@yI(upc]Sw- b:Xn@vݷ"z]T@4 GߜwM[o]O5<ˤoxSuэ:n|Kn麙a<ӇRგThs_:ST_nھ>?|_'u~38!1$@#F)c{ iSEB$!e0?^V?1stU>G=}yT>H;~Q?Հ\}, 8he!S%1'm&0:7#ɹhTzSφ#g9R}SmC=[~ KiLԇzL* ()ޓ>uB}2"B_}z+@*?Snw}}I n\ې<1y~!WϨ?WWj 䀨U#ӟZ_#2SZYG}~'V#̼dnܘ"jzн@ϋ>ofߵ.#\>;a 2i,(0F5PIeDTjn>l.z~53fwSwt}?I~\+st!wdϕ$W% }U 6w>_Pċ=tg35"l3tu$Gߟ'áfg.xyз]Ea`!UPLTNǥ21:߳ e]T]P~~{=ǿo>,G͢'YZn}w]ik>:V>yWR/ q6~?FyY\yOGVVw͓O0V?_KX}u_?y&鞎f .+?UH!"iHԌ+>M-2f?JTNZ}kl|=1>tOI&Equ񛨍i>?83ZyArSރUeuصXuOkZ[Wye7c<  ug>ǏOŔY`$yـ9="<>R?TJzERo{%.I7_l;!_@l]-;a?6GL.k>[z3uݎ~l썻~w]PgqUTfl}0dgLCLKGz݂]|Yf"68?u.z9<l }A5H~ׯ[PUIlsί$klސG_Ip݁zY%[Ko}Rtns=H(|/Iz}Jkn}N>7oBkO!Rgl0mheCqWyyk_h_wLRA^?#f_qKz@"@zJ66 ,O}'-f?ܶbmټ7fw]~W=!"]1V}?uoӷo̧c]wOUZڔJr էoH>'[,MRU.z<w-ǞwOZ'`=}JSB=+ 7z*q-};7뻴l>:CgZ|1uvm[$+2zWO"}U(gڟ>e|='SW֑TV^Fʭ%ϯͻY[ZٛUOzk+O+%UJG] %>Olmu/b(@Q@3`R?uyGg) Wk{A+XŴR_$CoX.5t-sg"w]Cdw?֛ZIUVdpH8]]VfU ;_{ثws$$Zl)a2GVGOYYB61՞NK*n7{O8T~]HFcgedozcuT8"LMG+?lB2Q2Ts7So^da~Q WY=w2K 1I\1)*(|}Ao꣝Pȕ}R.E*r_YǤG[l uwْ*5*{+$?_z\R/|gN 9 l/ R^Y) di L?\S:c}! rYx0ҡe8,`YWt= t8tyQHHas.y\P*B'\E{E`m6+=s A'u° MD+T &8 Ҭ(O$KC`3[r4@&ף߁47HCa&}"mM. pt2t!hOڄH0 %dpB$$,qtʖ>Irj${<4c-}0UH!a{~xdF|i"U[r?R_.nX\ gKYGZ{x.!+.KyFJP2v{orqqYZ3[u*ONDfb{ /McV!iE~SjSc59Rho0ehV˜i^v_Rn%_dsmV;یƜ%YmkIi\?W揲N"y-"E(ʗ ڵRtɸnϦS5X([ٔ&وaT-]’KSCffu䤿,eBc ӑbj>B?6JUE1#%ٷ #2‘5ӑYʊC3>.Slh6ƴ­U6\9yb٘,i8:38s`lAل `fK^?Q@I_aDZ]T^*BWkd9ؒ+hrSr[ˉ\:]DCJSy4{(j::8e z،t]bgj'lH99ZKH˜VLhq-[DB &G(mхќ&_ t/%{KeDtE.X? (͐Y(ۏ wJVY^]7w?\Vv*D&bY4r&;w8i//ה[tGɳgvuw3љ|6N]^n͊D-TY#JL<aªT`U,&y=hr(;ׄfE1,NlKFXqp"‘c(Gv#Dpg6:"hȓ?Of yL!E3fIjL xi_!2ji!-h8ql8liqZS'ښ[TRDzś7o75<>'KSL'Qq=E{`15b&ɜhQZc=18>Ziq{3[ZfC.]bjj c-lE<#ˠ7sΣj4fFc2ã#|p|Ǯn"F1IR(Nd!htypwiR3g2Vm #9>ehbŮ%tE+Qʹ%Q)ҟ>UKZ,%~%*NLvoZᛠ'ۉ-pN;[Zjjj\F6Ѳ ]ySt+KᥪCKo\{N=0ϟ;q!|T2גaչ r=;p|Wglr k v)W37\ymtzNřٺr%)ZQ okIy _uf߭C ZQ9[[^;m\<Щ6=>:ۃukDYp!=سtk+h*3 l5Zĉ(gJx߿ W,,/=`64ދHTNʚM֠b(' /f~sꃋ=3._to FX5ﮅz-GV҂JKEo?JsadN4}ftqyT>8#9bnb!gq D"q&Al# 7|ґkn#N,[BYSjUb4NcYJ?pr)6E]ǀ?ʾ1)ϼMEy1pdՎ62WI 2<>UCCv3#M'?niiÉB Qȍ1%kgի=7Y^CeY҇gN?U[wL[un9cH(^!F $V/~3 fw f*.$v#pVJ?u`D~L1o;Xc"AST&(d3ӄQ5{*GVө`$rZfVC)id%]*e˗guP҉"OvߢSfɉG'pm떪@5VX$|PLܾTWWاA4n#n\Cl*of/~_>oEB˳[2Y㙔Ikp:G1cwz+^ͭ/UUS˳7n8Oܵ+k{vrN]}un?KC{{ߞ=5֛Sho4ko!^OFCG[LRZ}1Z%iiP%KWL-k0fR)ÎZDv/}#xnP%V N| ibw/46舆ig=B"}#7{Giպ^+oϿ;.^8е}w_?l}Wۻ--/  _wcSO޵Ѯ-<Сϟ{Wvۻcޡ};SokG9;s^|^ϟ>RxlnG3BcI HK7𾮉wx}"s[B+}7弱6D4`&CV7FwL/,ί,pN7c|~|rfZb&(ᎩY/-G5s5x'o,^hVCkS3յ ;8x1o$sYj;6ޑ;Wn\hy<յe!PLbztjƭ3Ӊl:XUerx-MRnmDMN\yyna~z~Nհ}(CB(3J/.Vnꉕ{oώ ODRF{BtXac$1< ڊ`d|2I F{~!3k\j|yfh|o]Kl-XME𐠸6ZCsˋ˷ N 'JYWg3\ns=}D]U 7~FկZ<97995^iKRuuK+˫[qZkVăF]H sf~>o={syuByU}RyoTEPxذsK :ngt~w!?ċҟ,0)@ǡ<>>7/ZULjd kfCm[=.t39:-V]q# kWVVwq 4쓇d Ή;vv;'ϝuzhuo VqRdLF{>m-uz⇃wvun߻m7][YڱckQ9O}kl:[[I6ĝѦ&ێ-HBgn^ooo?}( bA^د߾w[ڱDil.3M5wĴdKk:lvD&7s2!P+넦r6Kb\⍫`CU>^  M GQ!Pm[bVF,sׯy{g]6[_Gk눮LOoa#V~;ٍ -1"\ܥM wImm*_M Xew͵-NMx⥶cG-͇">6Vkx<|h(W^Z0n4c#]_}_mZ~[h΍p6'իj+꧎<žk|n3:aAOVPi-W(Qwznܵ 3{)YUWBzo V0'[lچ8^}{?BptGk8ک gWwu{aeoh@joky;o?㗣6_++{c Cx#}ʹ+׮8SK3[:2߼kO_/*̅3nxzϭ![_[ώT+>:5~EZ,r¹]{ww5^dKk+I{c}&d{(pld1/Z2p,mEI2OKtέK%;m[;\voNέ`CZ:~5fBs\N߸x)ۻ^vqkS(~{DעP2qmil_{ Qwzsrt 3$q!ӷr/B3NٽȾ#8޴/~h"}~H"KKdrp'?sh/N> E"譾>r]m=p9M"SgNa3,̙s~[Cw Uv';*ckg-WďLjva06jN f[Z[]NɖAL% f*bh؝lRr[=3ӵqZ]B&+]ۧohֲO=aKO&S1WaK\K-H17~ut6M}K'KI! < 7/sa+m0v~wƇSuH}0~~`ÇF&mߟ+|x)>]$׵cVp. Y哗k۷tŴQOxin[a1602p47LW5ON]8g$h,cϾᙑP"vtj`1م~Vj޹ wfq̻=r'ز.XȄ,3[[jO0 <{ISASƛzgCC;W9MD>= }TOq~GqCնk1}X0$ |Zt-pή̒ckM-6{zicX]YZGVh'8832y|n=:Lcz㮨fsklinjilG|<`F:121^|}r՗^׾zFgR$t?[%sIȍNMT7}_W_ohEFDR 71|MG*vo3ްs¥i=sHL3_|~K鑣\}TWΚ܎| %#%Oxk&'\^^f9}rct-ί.,lP5kEݤ۽Mc+`ٳ333W^}{ 8#U.{[z4ݾ@`znÆڵ7􄖜^V:keնԷlk]# {kmڳK L 9Y]N. ӭQe7Z>w,#R!ة8{nUq5:̤8 vULi)"¹BG\ɭ"vC2cLv>13{)D*r#z/|9՚Z<α3N;\C{j?4]-2jJ"ܛ6˧o}SWΧ ԕ gBDK J幈L@B*ܶ}]-#c Q81j]5uUDrZHɫ۷wfe^|Og_{(XΏMM΄_Y:ȑ ~@ilv'Ios<1@"X3lF2M0[8 ΥX"^^ \QV;~m _|奧}&WGdžD ') X߇iGKuw^{mߎ3##Z&{lߑj];h5=2R(ѓPgډ-6?| z,d*Atj 4W.k1,-MͰ%Ad#GmNd[43!, $& lfbcbMEQ8"lӆĴ@#jۤeȬiƾz|}ی6ǣ`@'8-ZΗln>Ո{]=(d1sO<|rdDM/?ްkޙ$ x 0sC\y~xť%~f8==\jjkŅ#o(J-V+횝novբP-N;!7D(l{ k XPv BFK0t`xǓI2S) QD&Mh)eSqRZ6YN/~w7mg؄wϾ֯k.!L8fKtXw6TW7ĊمeI#]V\Lq ~}ɁaǍkD*ҒRy-WUt%Gx!p1AvD8ۦYJx$.w ̥20'XB;v7]hhԺwZkj(kAWpin̅ٙ-[Dr4, ?~.FqmIJs: u(*-b& Ɗ1eӜG0V9phᚔHZHbFLP Ʀ2[ qk.x(kk!H@6ʗ)-^_ @2RXLW:졵D>$JV&O[2s88s;62rO8qԩ$VkkZ[vYZ:`)*)*Ir b }W}mfJYB4 9l21x6\6͎O,Ƶ ĢY⸖̉/귾q;*_Hq ]m -zT*5pLٝD9pXZ[[o߾*jf iJ}m#z.ONiJj{pGb$kDlA0\NZDR!CTRd[ ^^:99JZnrr y&JzDfU}mK=e ff^If2n˩Sbv͉$/Y~c=wRaC78iͿk{Oջvɳ :$H CTHl+.>-FHAx'=l,T7 =kN %}- kd/;۩p\uZL;~X6bMpdbbh/n 2!xI;0PR*a>$jUk=hh租~ "!h PV\:G DNW D=UUԕ8Zu_lWէ9MBBfd9! |KӵD\&)A# OHC`/@Y؍@M|8LpwX@ Zٴ^+]gwuo25'rcqiޏ[oo//W/#4 E Feq\#BzO4ۅ[?a^)1ϯr @3v7~_=r|>/@O+`|/[pn8Mʔuѡa$0"Pۀ;9>\ukn77c-MKtܫqX86Q %Nl [2s" `s+ DK8*&NHzO=3Al.:6uXҽp]WIUL,OYf$@<-箷*dVuGi39t Zs]9lGE5@Sg1{B=zSj|S+ ۶lqhd sgs%^| e,px"6&BB1ln? Ͻǚ#p]Mm#Ҙ\ɂٺu/k]zQH5w_,M!;o!}~ =UNJq_MMݮm{ʓVY GJ@-K֍_qI4ݺݑ+'B.C|KO4!ֵӂ )lhn-[ $bLGq- ,˧Ϟ}/lݶ ,VN`ȃqPt"aT8 W5OYcЁ^/[CX0 =]o//W쟙Bhqm]_zʷ?{}o;&ϝ<{5D!G㍷~Etgv).fJP5 MLҡ?ILU.)7T8 KiYr@ˮ{[_7ʱAHoHR6Fo&ɵ]ݵt!wրqpU ?O= N z_@UnoG w!JZ= c21&94k_: ޞ;596V&RbqܙIk|u1dC -U6{i@ra*lŇN=|;w&ǜTgg'ڥNh)>8<l1,qrLi1sꪧ&&+`E|>2;; ZGQДJa=g*wqF)R8'Rj3M//<~1wy?xޝ{K@908sO?uy[|T|nzko#K1xlRnio\Y]ݺm+9?aXN:I /v\?ɪ}ngkp*49> wKSəŵɱŕEV{v09:=GCQ[l xz+//ݻaqLNOΌSS<}X{[{,_ZXKFoPrUQNNkqyy^lO>ej*rw|~ jmcOR12=syڰ«. r8%-mR&G p:w8=ve64 ̌Vv eݵԝ[$M{k{0ͫ7vlliՆVJ3swPO? Fb5`oy;FaxFOO2d>0@9ꈀ٫g{Ϝ$kȵ}==}#݇%2<8u)[ǃ <:5=Aa>T&c(zH0·:J=qo!]۶9 3QXZ U  2c>f72B<ؿo?3:RwzfNk_~G4YXX/%կ6S،/H%Ang.  &H!۵@),йnb#>{)șUP}Txt~KbdA+I`01_scN<$2^o)d$3{;w4Nhie~># .ǽ9(ͤ.:=ZZ0N}wkS/Ұ[MNO}lnCٰ0muo=tlѩAt}Oݾy{gWW b6,z}0۷*t=::GҸ}-[loliҁYWPP_.L`}٧0!8uF4UH$߽icʛҺ[jڒ{<-Z8}&o-FDX7AFmֆֺFI3A% ̿PQ[E%MM 8muFkڵ{N;x}{W'xn!*V0H將UPڊ ]?kWLpl(6s];: T|>ckg Vrm{wTð[;:%|[uSixjڃpaUmC1tSu}@zvL(.: C*#d2ETVaD`'B+)vUVp9um55G@V#?qq vՍ5RM`67v(hm#fD˒~زo"jmno2uȯ[ =(0I\N&Yo}9JSz t28tTS TdFL~H|a2B&s"NoyGL!|[h$*mxlWA[5q ~_u+3ftELFn*!e6~/o \8}՗BNj>n%ϾY|@@[\w&YO&!cQglɄƉWB<)4%uC:pax B L$^!% jqI&BAoT!Ӑ c%aJʐa.Vҏ$rX(pܰ҂^.pmuW'I`CVs,"WHW*t \M% EKAjа_U/AYdRc3ڼ ' W?‚.R }=[ibTQ lYON &&&͕ˤ8@[EMn&!* Yِ EF$1Y UV)@zV^oYtDD,^p@p"EA$| wW:S|zgbond-'VWpep5Xs01Z %g)p/=| ‚U4@%ʨx ˶#4%C,_ %Ҋ!e/&HX+"]i!wZj̭-2*6B(^ +tL9~'# ǤMT:m +WfgfƩ562k+ϽXATr<簅(\|p1 ܣGRJS$Cd R+$ehA!Hpy:a8>@"4͌ &biiJH,bgd4OMInY ^w|' ^"TC`lbPW D<gī"X{<[#⅌EWљth$ .#r#~hSB]tpbQƆw^p(앆T* %$NϱcraȧSn|/_b=noY3_*RBd.7e8o+cQ%bqz )){%Qp{"rUL\k# EC."+dCGeCD}aZ$5B]($%2œx2L.؝4a J誱jL,&yW8q$ Ө \^:~Na&B (LWbPlla+Qid,r{B >J AmQI`sA$QU;.ӈȪq ./Q<^\#f⨉jS%YH& Jȹ yYIO23~ ?wK6iA-#EfQwIWD R[%bC|684K&n͵l(lJ@|pe8yP",X]+u=?;jgs;[VqGΤ^&*}4N'=ǑEn\J[FG# ;*ɾ5rKPx@ $7f'摕bJD0,.OhuDIcS*$ʪUQga*KۤQ7"Y=hbHfa#KfA#myS& ǒLUU R0OLykh#o[0u;cq#¬9ڠ||VS(0e"DX2M̄S7rW䵺J.NbINLxnW9HO0֝h@m,l~\x啂-m*$ P'ck a Kʊɴ+z ĴY/{4CjK:wx=ZsBY3D.Q']rp1 NI2-R^&_LD؞l6J6.W>C&0utVsy߅5ěYz8P mMuQ!]-)Z( 1\ܜaR%9zWu4EVHU#$N,4DqrvTE  ʩStj?T _z6 %^9l",u0l!'P#06{)eNf2y+TEEIs74R!U,ydfSe#14b<H$JI&"EZH|q*N< (ZVBO&%жhVH HB!gӰ!ח sp֏ Szd`ݦBP$ IaU%*e҄Ų$3,z\CAy,81bYQԋX h>CƤ(tB$&9a=JIRy#J(^@7ؒDx<*!/P) áWt"aw9c`\YXS!%2|!l)"\AS|G>C鷨(4/MEc&-ÍvQSu3I pFg58+e_U5SJ'@YygFLl/1r`4R[*zKn/_z[w[֣ +2kBK|Vz2Y$ R>6,LK# Ix;(WNW@cg5G1K 򟼃7GϐD%2V9n\ܦH${A$c ,4"&' 1K) I\$00Zuؤ%Vc"(ik**(UCZ6?)~nMe`9%/? !i5UR_u $v!.ױD嬚vNX"8dLT>G)g!*Jng gg0FT1EZHPS&ng11 %4Tlb]GeBZ2dYh#.`9q^ Q2ƛ UkɜS%eMۄ^NP/8X, :4b0,g! o Bq8iiA %Y :tAOZ.6XSg#ӀI|fl!$nSMU(qo|eDgSC7TrQBՋIdp=GY"C4^Y b u_{.3ȣK8|Ně_stߓz>#Ri%p/u^Q0?Ș_ɕƕ^64g^:⇕ȋȑ#x߸[oDCЏ."@jNd‹2#pD Z)L.`'o{et/h"*lRQ6ihI|E1f1Ks FRVD9F^*2Qp$t:  -#re/Ӈ}PgC>#&bIϦ$cr(c+F[ Ÿ/Xn "EPo5EAb`[)gHLux28n}ԇAA #ͅlBusQ-V:[I$gU,aX2%~ȍ#h*V&{h!Vʸj!,rϤE-˔ҤIUJJ* jB|I/˸U@䙴#HE t&f(•0:¿UIT{ ]BF2I>@0t QԒ?!1r Q^>Q{CHB"[Af+gL<9YujlMF%ۇMPfa'"_?̬@ thPVE*)8m5d*!H{#No,Iz,TF# Z{ҕ*އWA$`@|^_*BUbߵ~?)-BCa$&IIa3+c#L5xHyS Xv;Fݓ"Nd [G5:C,$wV\%ܨLɯ$i^jD3h1 56A2L'&mH[ 7DO#|HxSE F骴*ZvNrftJ]! #&SM' DʸhK)9ev8diօJBEX2WeIDz"ڌFF"ƈHB?L#m#D9СuL8]jE%,bG[Iz[x+QT~yވ3!ص\Ci=dוQlFZ+B`^ *><483$m4Rԭ1X8DrQ݌!b:P5R aͦ‘%(2EkCBFtKl%yѸ/Jb(g1D#LX-тcvW6B*[If)vf/,AbHۻ'.vMhnaqLSsHL,t3.$AUpRZ1uSrMz䣉$1ꫲ;FW Dq!6<1IQvS`< rb )(LF0cpr͠R=Sbᑩኅ '?[HۃA]]dP_?96Y__K#ڐM\zP2wN]m[O<$\j`|iiRw~Spqj1Z}o3BM[ 4jV~'ylRE)VtH\ 2y@zqvap/iW%e&)RfzKp3n)U[ $nw\ ߯8-ʘ 'a+B!Wשt-xTTtZF銂*^k|%UN HM %7 C3$DG`Vf //)0$2hK7ҍ<(or*#$dÇ chj`viW#s*|%Qkia!4;"ls3JqJ05yMuhTbEwTo)ym޸J\fau &`ަE"ͲQ^ذI>#8}mKTNܳaHA<-*ᥚơ9j'u>sbNi.I挄>N %,=A`bH W&'\$rGH$SUu4!KC$ `eLb )#bf#퀍ixv|AӚAqLZ ywVVH tsSm-L]1F:  F=ڻAcddn/ $q}AL"nߠ&HX N#(J͊Ygʥ`UR$zEb" ЖK5ᔐpJ4R9R. B_Ű0 ZH`R.6D"8*(Ohm$fHyJ%K B%"$ )EFDh8{3S{wdc~#xFލ+O\<ևuvRMMN}qڸ@P #DNюSK +h#NG\%&4wʇ!BC@}O$_bKĕQat*[JF_zu׮CM4Z_bO].= ؉PLVg6ҒT-AV &[[|;BնH\n W2!'82L*m&L CD~㽷޺ïuKv?_ /-R_UItHo߸n ^X/~b`|c r,0ECV0M󧩷ʷ&_囻۽Cٹz^;F2Bʐ4χ uF`k6_f`=S(GϾ @S6S,rrkvE7vo/Mi_}kڽ}_޾)SOpA2uiilo޷~fRB!!9EvD) [}=7n߀K/|y[ghC4 vtuy><0x'f|ٺu[֘\s{KG0D8n4N'Fg>uY{F8vDǶ-؍g&OW5\UOBJBT )C^1(X J:MgQl rcY^X]^}OVZ*t!xǶawog[G`F\Iq5Fw.`.P-{CƦėIېKVV/~hdhd|t-]47D꽕,dC(Xm诫"SB+Uz#DhDGEi;4wOrV?eknb # LΦb#p>3 h++X[[؅qRIӗNCa7|<@}μ-$nuc |Նy782%(׼Aރmf{>s{}аbQ [u&\MvJ8%' ꦺgOnRGpB擈>&"wsCw=hN7M]X.NrSM"٫@^@->2^`�^bZs`X|j< @]s=]hgn ݺsAԋ7QhZ::0wA hECs3۶ "z+0M ޚZu8c]^/EYh]@1uRS;b˝w]>w/|=xlxd1ٷ ɥJ]X }kj8hrwNb{O_60>-'BĹ}ێ4qz쇗zoҩ2gT$Ƕg$X}U~AήÜ=w*DŽTllKng^ߗ1^{)3bfW;kúzœ$}sk׉+49zn nRܩӍu{wIS+|MÉ'M^Bvzz_)LSGN@M,V::r!#_ro]^:{gГS}Rhg@fZ6zƛCHJ\93+Z ltYR9Mg?AbJh_*Bh,F'֦'f'5In'oDXv73xřy3Ư?8u^x!ө\eRKO%3}v2'5Vߠ!tCA z[D_c;15INKGaH AMb+MDVwN"+M[;>p勣+$Zс]| H6qmtځxtlE> 3W/_w. _H6ƻoLMڻ~]7n\zgiEZL}cfVgyfv|سPܙ9}|NQ ^8sO['g)8O^:·Z!z̕KTb3ꝷBK`"?¢L+A^Iͬ׿ ׯxBK?7w憃 oxwpr vcN\8RF5Z|_%,[^H&Mϝyk6w:Pv ]-; [}il_K_<ч=tgneqSn\_ݽe_X kO=i74VW]/R:Wrte{.j{鬁U;9|k[+!yKL/\sϼ۶\u?ֶ]; ͍Dc{'j_E&go<,|?cV٥_-۷n5:o|p]Wwcw©[ 67ߖfߏ?ݾvmdˤZ@ u 52yM? C.ݲmg#o^3;m:Gx[{w E:ڶt~uRM7 Ŝ%`5vZ_0ԫiƋL`3nSG  Ÿbfi.^ =L{Ub[q #AwEI{\q<:8tiR&#ԳO>EقVگW_Y?.qu];w 00 )Bj悌HD|%>u Kq5]ckBCM; p6O4@xx4׾F'̹7n}m"' *=5S'$*B9(5㺠s#_zfvy\TpN_˞P<\07\PpϦF;3?[#790YReQ0m^z4G: $R~@JaXѮVװGB!19;Ô4l{[|W_LBA F8{Ux e^%8>( ە.50]L }\r' $⊵M-0}\2W! |X[7뫭zo]W|zF@{" ﻢ`Lai&Ώ<μ~17raKm"C| ^rO/pট e*0pBRneii Ml7)%qBǺ[_[{^yO?WyУf!Lq`{{;} 'hjtYX$p/GDXvU(Ew=[39(_ ٖO{Ijs&C8vh";S-n#Q\ckk@jBl Tn=wܫ/ڳ?m}` OG|H^fg*Ϝc|DcoRl!J#mȎ qt_7_}`qXVB 4FFFĦB<eڷ{O[cڒx̙l0eUXI~w~BV!drn)BdO_̌P ) b[A$t/t~?{VBPlhp0 uϹ^;O=I*To\eðvYa6fN/?Ojlr8<)0!Ԋ#)*!V2n> hd`NY\%}'*J;& jךǸ'Yu | 1uƩ<+3./AHqJxUCkZRXդzBLzUBWaclP<5}篪nֹ՜M>eFP_K/ Wkmol@W>VӮ&A${]f~ ZbsA5+6B)ֳm!3 b́]![__'ٜY< 2Nd V#]Ý4u24~,[>^rymFC^,6! 38mLs3|k;UgA_}Q<*)FVq???矣Z k -a\Y⚝E \Y]cWͅ7W󓳻j* 몒jb a#B:hTNku\hk  ۍC% d<-M-PswC3lĨ0aDm:s"O&p|g2ZE7åf_\<2A{7 Et…˗\OĹyN( .uQ8/r_n7c ~5INv5m1tڈ\z[Xyo ? ZeΙ92Itmzjb!aϾ u 嵖7Xb5ժb+ 0V_Rú|LUNubӖAeTa[dXf=s#/21vhw׍רk(-t [\ltjU"?Om[X}G2C>噚P<j)g7nCmTÚ!~ߩ3% {ioz\eu90avwa9#z ”.bl]Qo UWV=|0HГ=qj~`s-NMNQ[Um[*˝{2 ܳ.G:.7`x3?lJii1*ѱ[헱eÇWs'D8I Q(t^_P?2BR<6z{fsKEcV =kh NRϏã#"9uuKe6Vx6dCg' s"0?}jd3dGARg8uطԘrg5U?H|Z/79p}~prL["h/H<;bYdrEܜ UcSSE+բ|ٳg h,*KK4BRYVQspˢE]XRц LQIQywiuuѿ0.պA-j~A I\PYn,<6P}opMEW{oSˆ奥@~G?rVUDD-IѷHMLLF7gNML!ʶDvWዶ>Zy1Ks (zlhfpnշjwiP4P<NBLhrk LX2J#AgWbXF!-QD!-hbbGy#ahaZCG'A6LMB3#8fbyG)Vq4Md4./ec"I&r[h^ nbRU:F[T" N\'z.jrb(\H"d3pոδ1b wSPFr\.EGN (H5Xȫ <A41|u06@M]) XAW EDD$%@XY8M`Wr;7Q'#z/##o 8uGu ) KdD |,2LD5o_˿ǿ'[Z?qƮCIK +LFrEnd`B(EHNiI˜ZA`8ΛoGXc&"b2!ﲦtL]TL M B0 {*tʯEF ",F5sv$rIEs K1IM)x;,n1SSt_E]F BҐ@1)ykfQ 0!ː1@D"MqNHKn8$((E-[<3ϲ/_b#'?3[.e]@szIn]^w~Ҁol++(sJ))>Q%TyLyv^k-Q{ʎe՗j}מ=W۟؂GڨF#2ɒpzGMk┼O vťQEy暝s ^{rG;X  G[{④R,(>;>BcYYNq~yo_T$DhΙK^ǷfwFbpg K+_~}Os9~_9 Īn|k[یդ|Ar\/g~nTau"PZ3~i B.̛CCC͢|t»j[wߙa~lIؼ=G!o81VmACйFJhf(uӃ'ҴpmB͋ǥOCv(Ki2}?G">%hWux:ϭ;bZ_RQ6P:ZRmxDT;>W?I&(c)s/k]9;BgIENDB`DyK www.tig.org.zayK .http://www.tig.org.za/DyK yK http://www.tig.org.za/pdf-files/icc_serviceconfirmationletter.pdfDyK yK phttp://www.tig.org.za/pdf-files/icc_achmatcomplaint.pdfDyK yK fhttp://www.tig.org.za/pdf-files/openletter_gsk.pdfDyK yK .http://www.tig.org.za/DyK yK phttp://www.tig.org.za/pdf-files/tig_response_to_asa.pdfDyK yK phttp://www.tig.org.za/pdf-files/TIG_to_ASA_reminder.pdfDyK yK bhttp://www.tig.org.za/pdf-files/debating_azt.pdfMDyK yK http://www.tig.org.za/pdf-files/affidavit-aug06/BRINK AFFIDAVIT WITH ANNEXURES HYPERLINKED AND TYPO FIXES.pdfDyK yK http://www.tig.org.za/pdf-files/azt-mbeki_tshabalala-msimang.pdfDyK yK hhttp://www.tig.org.za/pdf-files/introducing_AZT.pdfDyK yK Phttp://www.tig.org.za/pdf-files/poc.pdfDyK yK |http://www.tig.org.za/pdf-files/azt-achmat_geffen_heywood.pdfDyK yK |http://www.stopsmilingonline.com/features_detail.html?id1=740DyK yK |http://www.stopsmilingonline.com/features_detail.html?id1=743eDdL  C A"`bšț?@K`Inț?@KPNG  IHDRw{MPsRGB pHYsj-IDATx^gW{-)!KR!XŐЊޛ&/(|#?T20Ou- , , |< ɏEEE_S`EEJtW-XXXA~u{Q`Q`EEJtW-K ^Y _D2tQybQȔ qjT𕨢J.{: #BeVjd-W_F.0/._՝ V¬BͿ7d m/FoUNT ӂԒ"_pt_8 =VW =?bXw1RNL 􀘟_#L%v3HoȘw$G6m-wIpV](UWo/G (5t+mp<5dZŽL;j)'Ѕ)IpsTUջ<=`}V*2ːGӞtVªJCGe.A.VQF/߽jo(t,ܯa_zZk7¬ 8^i˜ݰ4@ Bl|=*ڻ_!_WIK;կ~߰5y3pP`I Ž/8E|Sh[I-~^}Y!<KsZQ!#wND6%,b/Cd! x}Z0@ 2$pktfrD.cڠI(s+P9F%T{}^a[$)^3HX!.nIo$v hARNXMM}6RprOm2zȉ_XЄwcnP!6 T oŃŬ3!:%hssOuŶ. r K Xw%¯j8&N\q˟~>\ƒOj!=!DJ$&%+0׎7O;8_(V:b&kС;U@QCF8>Px^kd{ݦ@hmJV⑸\++A53 9e{F+hQTmn+b~L`43SxL] C]\ѡtd8 }X1"#!fs zĵV4{3ۥK{ԑ=qr͇.}vm+O7.ܻLNGTYNm %eۜʗ;g~4 }~# ;5,9\RKμa{S0-HnnYRC'jr\[噽7F#w7. DybꢩKI1{N;y}\ƷW[WI2X?hsӎ û.\lݜ} P`\Z6PW;.$V<*sNͤ1^#'bIPW>VI^>tٞN}2LOSIoHvW>ߝ\:ig%؂ M\?'!ڳ̈́ Y1$S?f 8 F|jY k.@Du}٫ `qiZ;e;b7 >A'L$Z}M_wl}Ӊo`agaj u>li(QɆ"wÙojI8"6+ם=vw1{9-М7O*92>bi͙Z"WH|DjLiVL2MvNƫَͷ;\qτr]Ǜ ^fG& q'PpttZ"{Xq/;x J ;)BJ)DapR ۼ2 b*Z2}QbmNHfsRoHc-ϋ7; 7Ș$́7׹lw[/66@RӢ=9#jQټΣb73}=$ I8XciXLL2+iL `Xhq;ߢk8Lbk[RZ1"2wƤL~ㆋ(Zsmv i%W1O+DX7qTK /5=Ӧ sna"З_pa&[|#:FpMV1m/sDktg|E89.x~GYuŸ7z=Y2zG!]&ts$5ª}З S8Օe0YER+CxbTi Dx4V8$4,Θ:<;!QHLCBFhB9b _#sU,= x6OM*s% uT|2/$e+7W9yNxz{k,Ƈ3mɴtaEqMg#M0iHv~QnQTiPC ( "ZlsRp0{侜NBP Ihr8γ;oFw)+ g2g, 1Ǹa2]*hB,V>(K0-'+ 5baI|o^Qo<7_n7.=T-t䳞Wk]jf`tD^hV5R@̦h^fbp1!ecϷ6K;-=_)-ktǤeX\E,6r2Gd7bFl}~lY׌^+kv3.y' x˝[bGy'YuQScj5t&&aep/]߅w;+NK~e`w'ib#W"^ضl^Treyf dzz_8)6sިQ [ p;,t-1^ܾ e`_C},3bl^\l.T[3{̇lOG:Fx(sl~#`&ŅVm ;WnjPp,>\xm6Uf0OjҸkNR*Q۽ \Q#ˋ._  i%]仰l5ǟ4UJإ_a" *$XFЋϘφ{Vpd7!N/Ʃ63U)쳤&Pا\ Ւ1o9$ԸBx- eĺvIn6P)P`IZqu_qw׬mh]P.Kݫ J!WeZ(J wNU"ڱK-!43d}Mb8f[AdmosF\=캟oO狥M4@COƻ9_"/.(P2 V\$8W1 13H,[uٶg{M 7 dac xS&i ?+e5pdyؗob9sPXb^xBTU LL<eaKav^&3)mEb'tp^~G%IVQߢxoi.+\=(tؑ^F=dk[O4S=l/p]C >2@It+a0r,9=V㘳ҍ]LNlNB1y v45l4N8FcA# $>BatM!uaYu K # \~QX;yȬCkpqf~MT=(߷ҭ!qv!n eMVȊ+&$2x+4u&`6f/ZWjO2<ԟ^eDN^)O7a.6q9z8;k+ sO?u =QlۥK+1HĬ9ܶS J(C@X6Yй<$e;7{|Fd˯E9Hĕ6L^9 ^2K@ֺ͋PKz*jv8)1p wm}/[REaO %]~,W@3bER?4]jBfIH4Nؼe{BIօzX5b&ٳы8XbC9aKݘpb.a6fnR'uPQD*0tA%̷LcfMHtJЛ6̲‰m^'fz.7.yki-O ]CկipG.X+Q})o$-gy$1zz`Ua}jn4?cS>98㢫B>EMZiXU#(.cK:r@VA14$;1olFs o\m!gƝdl8Jw}8s10зT`H{d>xzNRXv&x@- k~ױ;qUoE|=ZXlr8  $hk~VA̙VpѪG#0G.o&lpf#|iG+󊂉Ě!1E,#Spa|ݼb_m nhrk~uj__87bDFe:7F"".[A>K0xEP瑫s.@,y:nJ;Ʈu^xX?qn:e/rP˜c.?C>F YZRa7|WXNDČwmk;6_Ek4AbSAD_xm!y\DfBU/R W0΁ z. n>8s %5v/ Sr1+ťjo1 s| -q+⇃,FH<^sL:>K&Wf#_I0MucUٗAפ-NNDx.LW@QAؖ<¢mw&\5f MgEpw|Y/st?Q4r,#YOH9Nʶ us*fb-~Nٸ.7R69(pEF":U[`Tp*rN#ܠC(f֭ Kytꇃ?9B-e(V 'o# 9z$ψ$1q&mvBVwl;FWiuwtCF7+$ :HQA9oLth5jD!8p\+ݤbV?pʩץ'P+quK8Ѱ Tt2'Mlpyd~6Q݃z!#?utͱxev={Nhj#z G/G|u01ޤf =(!GmaKBp\ь*fikY#lC{ _A0Gz7:a)$Q(X?z*o7)]m,*0 &8*K8- V,k#Iѧ gg*Dk0C؃*1hn1*6c_QƾM8RI%^0%ķ}-2յ8>蜗QNh:SM8$5sZ>UR63<o7{,nF'Tn_٭#4ʾYN D }{aD层mŋLv S]-}}DZ᫝ӎ *B2hUt泿^#5RzǙnf 蘱~_ p(4} 8~F۶*nS{6k0d7KQ}j Њa6~uP0S~C:f~\:f5ۄ9Nw4ol*8sjV1|SX60o]sW;ˆ]_¾ֻYj[KLqCd1,TAW@\E `AXۄ:icKp'6wӔ& أ6ܤn R`cjη`{ڤ oLjcЌujO? TQ+^fZx+$hОuZ#d48+6c]97-XV\m)x8=֠6o-n,shMwAq=浌{-c@NCcjɿZl3|%@?KlZOԙf̈́#'1{X<&=yV\ClO8rY7ۘ`P|julG{fd žloLRE *bh78 W"ua7 7௶6 j mj%fqsQ⇌{i̘zrhA<jKhYnZVCĔx4! պ 17ya4Wg&>ф\ [l|At7|@Ykqm/mٝbק0oK㊝-"˜D{4QqADXOK и lCp Qj,/ffl>7oI|ŦdZ*B.n q2WE1͎WM']iX }z͟vFiԯљ$5xt{;>fN 4plU(5ƋL3ʻٖHn2E@}s>jɗ0zB鹎Y^Hol_R8-&Ds:Avn@+.G^g͕mֳQk#3볔m.kGA~ VqNӻ> Lh|E%t\ڑ")@?==+A@>9s; TZUD͝v4 .A^G hlݭe_dXsv6? ڐƁDAI Aʣon6p6~Y9 z& i13G62!8N>+i)@ʣ2NV :e>;q c~c>;F$&ش4y"ĞSWQ q;miIcZ#ʬCf&6ႨP.T,]{kFgYZ2M*L_1:;զт)6JN8 FT294/Zh5YߥrU%ٖ;(NHШYq]G 4'?IãKq,;1jL+t5^ҵֈJhM!` GyLcrF1GYEo`F򎳿n˺PBHLI-%] LI|6Wiqf:1nIQĦlUlڌش9'jx׬qb@i4Xkd+]D7}oZqs0J!K6Jtc-]DЙ|C =UJ;cfUtQ k%Њ+ff i9mI7A@]b{|;O*6ZeZX5@ݺC7N9yk6cƚ{վ b&CGTܰۆiq|YvǩK?|Si[j@Z6˙%7S]ߑ&COQsRvM,n*Sd-x\Z5U (n"uXMMX E2<Ƌ:Jv੿Zm).XKT<$CmӾHAöװ:(\z]|пAoa)wh6xDj͑ZXxutC6? ~ccV[͗i~'R ȰYj w0[.smL*մv/'BwL=W9gi}ͬtvh{jByb`oPRyBvHKv [;7m i4CRt+JksNʋ N[YƣYe_C[_ׄYQc\ӌ,s!و#L i0ҍtڙ3g+z󺱮#U17p x m&4ș@l1P:R]lKReGbo±égNunz41ƦY3yTo}aj0%dviζ;F4Fu0BUw[Hro|}MR47"2>gnh`*p9loQF&uAV β{Υ[HhёzͮЄ,uzQ]{/jw0ACѯ)=8~|[1 B-٨Q,[7uI4#igrMfv_%kԃ;?1b6p(ֺ5`GVqX;qʔ\A׍'A֘bű X3kzv(pM5f5h7m1?]@[A3@>~0ކS [PA&=tul޵~̭\zf~ 4F[nuU@G:V(7B/Z3[@nvD-WJ/l %? 4ӵFn2gXzaʙf߭6[adH?Xmp­@ۢLnFC<j@R̿q6-ecԤF*޵ 4[o8^<ٱ'NջfJ4rkL=凕h 4ʭ8V!ښFrP-}}Xg%,tom$j ^6>U-A"w5_W]J+΄~+tmgʽ/!mNKR{ԣQ*ETM d-xLd4kU a?yjٸ q&3s/"LCAatm]ԇn=!}8;쎨&6$ڌ8 &O p4qY֪؇6Xgs[M3eot[QX=`L 2O[ GWo‘tJɏXhQfee ق* J"?A$c;~kHssg0G$lC| FiBnó;{D~$FJ '|D"^Thw͚Gӯ3q0cny2֤[:"d8FA~v6Pz=b}G,Ϸ mX-@{r0m'a 0?ľ+H" Mbf]p&l;b#[L|׶{V!@76nTiQYU;5@֞x ^~D>lQ0Nag6% ฿#} s7r>bʙbz}V``.Lt@@wqzTPٛuN S;Kv02|1G* To`w *͘n=Ag_Mq]VQZn3m5eēpWh)^ikHׯ8é2ֈsiG/%``+kQ?F9L}ܱ1{JVͪ#gL6A0q+sDav ^mK۳\bғS`@GW8ls:QhĖo l:KԊl*ƮIT}Y2$,;Iqcq{O B&n>2:26OK3 ξ#v|ޮOEYn㺝PVd5T`M v&@g ^Pa%tL'k#g-g>x\#ogOӼymt _CfuЪ%-xuFx5i`7Kn2w-zz1rvfϞZU_pSaq7n>UԷ*pT.^ef! ͍Iy{Eͷ6CH5_\K&ʦix*6^81V9ݧEیW,c3k*(fŪΨWxUx=3g>fkV`9BUi)Y ˌ1w|ƕ$%jS rax+X nXb;`R#Sstԯ^ X n|/Hj7DHTi©@N-|*c08"^":A88WW)@Kx3e/l5| lǭ+_<' K0<'8gj̞h=.{̍fN詈ʹ<foxKyc)6f1McBJW"L!m 9/DᆦqL;&΋Vcj,;A샘]f眣u]Ow,./ÄX}GB ]ܶ4\qVAO&؍1G/ϼow||90H:ږ&"/ _'ȳž=EȘ-Cwh$2ZT%kF [kkU#r`TUrO`ǦQ"LBS;m׶#'! D~Ex8|gܣ2ٙmUpAp:ȧO@pSBo7u$W'tԪ QW'!; 44,njCqk7a#i>ns{gl''N5AJ͞ 4+l"ʑCc4^"\Ns~"=Ⴈ;fD ʫRCCz9GM']ЫMprT ilMqμ[¤dH8G NEWʙ߸:6T2f]Ra;ܱVc;"DTuՀnn jи.$KRNé0O>99P3xB=y?N;g/)9IMʱs{B-WTclke)Vc`scM[j^m#k̞RwJ.]-g1 qڶC=:4~!;|=0OH6oWbKQM'`Zw!sn [Ae 'r2Tґ`fdS{=PƦ={lmb/KI8O6zV)zkywtl ^` ]= J!Ũxɀf "}CQ: NEW1!9Yغ`Ks-gmF5kk~=3 8 26Fi#D̔f_MǮ[N1<+x#nnmbB4pZJ.i鹯4A$ۏQJFYʮ֖UWbD;iL4jŮ#rQu[Xv<ːnIoOߑ8x%v-=U]* 1)$<+#ڊJ~`[H=7e gW;67ጞ.&ŵ0"B=UY;Nm2Qm/Щ%]ȿB\3Bli3oe֪&1o_[֘cAO~%w&>6GƄt_ *bBalk}GScX8bfl}kP &\"׻2.A۸5Fw 3_<^ t0k+IΑA kbnL 4BVv"\]$^Qp㟑b(~yfx,p83Ɵ#ZEy7f4MCԩrsT<ĵ\DKTXIvnj)"dk |#e<|P>2(@i=;i>?w6E|+INxÜkAo- r+8D~;WMZX]!,α k4d8pϞM^H;BHۭuK]RXTu~w.g;\ID5"qy+ab <cިܔf]u/fA[ÑSPwdž6"W/B^d;Z / &k4̠ꠝUi7]30|-<n;vn}Q{QN+V: MeFOdؓ#l$Es/AxԪ#r.dx$ј7^MU~MH]i^!ꚱ!Lu1rw&ЧZT~Guq G]W&TeHTt2ܣ6S]TޝunƨѱX>gh!q.`c]{\3M.-xDsJȈe./` 5Bj2|;upJE^>OQH_42E&G7ьs%T ]^rх\ӣ: (_eXw91R;z[=RbfZ (:ݜ]5c&9Wo&|7VLΜeCggq1L;r8gV,3Wdp 0 p-WʔDs18(O#eVOKCA؉(?I h)lȻuNWc-? A1>-l;-]/Urñ障3?s wb \1cApo;QHqp{ ,IB a !adPZ[{dgJ?< JІ8#];1<♌'3^(Wjd)Fahݸaa!Д=/ƃ1Oif]L%n4|ưLrH$`w)SlEؐ^=!yq#z!F Vmƴ8&-5>E=:87Ԗ>?^Mm Bd{>E/OR־1 |PTƗ0mF햱6/ϯr+>bo7iɳM@n|^;@)0Wd [yj?̻fO{7=UM2R>ƾm9*S,$:B/|l5|f̄zhgU {+UlyQHԗ:]ttqr}DW[V }WY>`lFA #1ȉRb.LoEiO˹Ad04zzMjGBs# 0L%NܑF㛳՘;ɼ鷿mt= I5X F(p1KWܱ҄NFdF+ j;|H@8]HLlU)u}۾#u`Aܾ}]4sƻ8V2S~}YH}뇅&Vp֪۹]h,_ /nYZLl&Uk~L\kݿj5]ȺS }ʼPCz+\`JaH!uʐGU}M0'3i8U{M5&*)@UrBE,Wk1yݯ'|@rF%^pqz-*Y"Lu ([f^nkψ`YPO}v93Y8JK_0T8^ӈE GuӀ k0.kmP*B 9[d<r^T}67ʫٖＫ˔nncY}PsAb؆0@%,V5w>"osCݱٕ%E{\/ֳr-;Kec4fvH]K1nzYJ)rh"WVHOZ%䪋n/'RwƊ* K^w!~\T[h&Xck3^ i '2oEf:s^Q=:#BG".^ئ 1\EՈ.vdaSCC:U otYΚQUz6gaik@=ɡĹ .:.7ʿgD70vę7fl(e Ia$&vƙR4Jti`<K /?rԠQmq,nAg28vDЊRLAUِG ջB d:Xԅ2- ]c.Sj2 Vl&ۛ7"՘(ÃY:8YmCUvVv7Bߖub D>3q6ҟ@Le)KT5 8C-xo!Vv3-rxo 3 UZ/y衤>U<5K`q3M5!83;F+S*T e,V U4fOȞnc\}95 A {~X?X&Lc(s[,UT/&脺5M"LT8UBmȶ2ι# RF#}7w߅(5< E>i|.9*r[N|c ]ٲQ#y^֝p񗮲AzWٷ[\Q!qe8rl֒]kv $$,tEK'Itm.B {`g0zّ*0TXO19 f[ >1t1d1u)0s.{ _C4H>d4Av,QW#uP`){ѾG[+`x5NsxL?$}MHc<5BIc>hBj:g3 0Q{:tl*v< ^z~Z*=  hw *5@K+Ucq$\"﬇Ifk7/7Бg 8fiӕ>2 싂nHag(iKzi=DvQrN%"~VukWgȳW- e*gzѝ UT} |*  Yc`+pSt@*gzwЕ U{xcߨBn03N>oTG|Dw~@ @ȫvʥtx]NB3@p+Q2`Qw_jq.n;GZ1PJ߸>kg% 6O^l ۷PO)@sH% !1(hby[{DbTu,W}sl=@]ĖWm+_ߑo4-E \Qa7(dy鿶jQ ٬B}-,OvJ\2,а=3-Sr?Ӫ&<<^䅲J?zf7#Ւ| 1V{-u:i#4@%   =Vu)mB=B[vpM4/ycIA=8X0 S໺lBg' l *z4.Y`z8C*{hۉs*jC߈7;R?%GUN)$3 ῝]S"* /D#מmt (RB7rTX‹SF} V(tq4WB("T􋁉iP8ɏ5(D8L@\ge '@|FFPG^%sFO\b 2F䒭9T5? r+ӯcv lw8Q`{ja˸+s0kw;RK|^Ijˏ&-G`[pw@;9466]n0U.rf+F␘xw.ȗr ȄWvt",yoxxsܞ`G|h,tKiKʹMG< ;52넍Fs+P%?P#=ƺe6mzcFۭigruqWٴ<$f½u51}CRL 1x q&J"Ypm齿azJp86xWmrso9-;MN;)GaAjg=D?h6#bbB:mTmڴE)Lr;L$=c|(ZG5s+PrGGWO |] yckFkl3Tzt[ Viwǻ-x·tt77V?gXaO5nѷrDLfvf 6`/Nդ>XXUGӐl%b6)9p&lBI*J}y3Kգr{ll?C+t N)vWx W,3đL;$Sm76;aءzy >mSy*Ӳ|~P3diKzZPiC팕Wp9Fai?RKs+2biˉC[{ӎgn90q:Z?Dqs^C9q[Hi0ux]&CVqVup[nP0qo#{"9P+:Qߛ q4D7\Sm&lu.;F|إg%q{[GlwdE῱ã~γٻ >XmؚA'ϳ3a4q"Y(_cٹ#W?s}xŠn(tkD!}`:Ք_bɟM[D>{lNi" ڨ" ]ƞ=bܓ e״MLلJ2ʯm[O6nt3sHL/\^BvuV5B(YԻgG80ˮec6(˫?U*pc}[NXf {ܘ@=6f ~-#Ӝ&7)oʄ}6{[m ylK+(H=UQ cIqHmY!ÎRlp9fI^*Ƕ[EN?#8,]`dT8_J ha_efsi]>q3|&& '21èyf.c?qmbGG:h4Nt>1?HpݏXf2sUt438X :i173`;0:.: m!㫹:; Ku&X&zk+STgK٧"DxV|.X3JF*sI b夒45‹i\2I0' +E5U )%\VN|^LFz]|_`7Xo/oiUEN `',qo}噍C$QѹlO) # c#zVlX3E YiXY=[̫kMh`Mm2_}U6($Z߭7hڷ߷p Hԝ(fl-gʱ;~U J`q,*\lc~c7icvR(e(i4pNC&17%eު[ N0tW *m$8Ll(/|0KK=kŖu4$κ=FÓK0Y#LEv*wa-OEXկ2Z-쪂jv $,KC=1H7/?#͢jZvPrrJt[N̪>Ue59  Xyp߷KXN5A8 0'7i`up?u01WAZۊ^94ǘbGoCp~'뫵_+_Y)Qm06ǩK>ÑQQ/a1o(_*bJGF`.A@U5\:14TMI,CV9/ %4G`2x&δѰo&Z1~7R>-غރO O7!C|]F=h̭QGl ؽZs;+uNu9,+|++^+PZBXgD,'źpPE {)79頤՛n]Q.JFA<~Y*'쳝#p܋~icѤ.|<5a_Mqޕ!{BMmI)B;;'Y cˈ}zq/ |SdHCg{>Hng&ZmZ~Smfu ҈6|>6{xVt"A<$lN3f~z%{AASO:`CG;yYX|dۢƚ81mS/>Ms\ŘJIYtfvuROֆX:K ?U;o|t -a\F௑c:BMPBC1OyOǔ ︵>=/Q CZN%h5Y,Nv}P"VpaƐhv)Qp>%ɑWeO?q8huUn핃O{ A/7LX^HnmVzd3S?a$jn9>'@:ˀ7-+XwzsCdF>&# $GO eim&ta89'^;#m[.z#n2 $[#86N aͅ%E|:^!M2Ol,Ot~g=b{ +;"ŻsC_q;\G|.~ q`hpg"vzyğ\_> kDsLhփN¸Vtq9ZL!VNXo#x \ 7guG7Hckd1^%lY6WWm=@CFpggxoP@- IP͕i$Ayg> CXLgb44#=v QH%f{?9X:/ ɩ`sgFvT0<+A>B_vc53Ksp?,\Iu"&a;X+B'MY1g Ѕ{hI̵M8֞?UT(>5DL,@T>HGAv7 d'F؋8=b /:ξEg ю EdU.z :딟vQO#%,_ܮ1h$å9g'.mAy7H{{b'53is$Bєb\\=(\-3X 4ʇYHʹ%W~w\}C5|!AÐg.g*!{|DoGxS/]Gc>&B<=A|h@ݓTmo0FM;@+4'g dW`miG a-$[#gcF5h#UWH]_(5m\SHtUc+']FX-\ګ\tc|W7e[m@KCaFK:@a֡MK~9^zC@qGz 7*/m7{f/+੃fk)8Y#xP^ѿ?-b⢃ _ž0"ijt@lBG#ʌG=wKҟOUY/I IKnTr# @TfXZD&%+HU&߱XȨ`s\o(}t #fKqeueE1kagte}l@<}Y%9k0G4k]5YG-I# 噓rGM6,!b|]{(ҹ찖âs x-ez4^8m A";. :BekRCj<-UZ%vjDXtv46A]{đu;yGtuT=TH<0s;^sx6=hPV0c$n%1S霋( `ʘ`/$yJ6n4fyJd |Q<϶JM/# GVQ va)SEmcN&ͦYQAo$6t8:qQzZBpRNq|Ĉ1ǸnNY-N!pÅ8zZ~_&̂*}еg&Pߋia_ptTpu5J 75ID}/lVJ ɝu^Dar O{d=b':wx{(1<%MI0CnX׍d9oķ$fF 59KzHg'o}\N~Ö]|J+GԤ~&WKS厇ԩNm`nL^b}UBRD}/8USoKdoFDwAy :ܜ򻟬d6r@@LiݡIe'ƢiVKb;I&j`ew,W[72s Y oB [{`O|T3&ݜRoX[Hdh }Q KO7IH {mi_hѤ.V,{XQ}K~F$QN8'amqۺY6%?Z*|º!}(&k¯xAyN\iI+z ֒^˗bWzM6b(jj.R,?b,&,2}T|C-{[sm7-T )0N "l5 L#shsԏ^)>'ը8/"tsgW_Ɩ!'Wcl=qI?pfw"$ҜYgF5'PA4NlBG4ifY": M"{DٔutChM~I-Mq.S8Ye9H([|`\h]rZ~#<(j,{h&?ի] Bć'g:`-*]"wD;A^&x5]"<(/6zp4]/g<§I7TϦPCO("'2n`czB] ߲4Du7c$]'noOϛ fdac\i75p Dqh`)c%wz0#qRrIׇZ'sh4Ύ &n07>m>v§ 8e):ѫ-y4SP{tbsdcYsb'kW) ӒS/|}[ {>!޷zâ"$6i`\Lv׈-tg '4YM钰/13QHmM\W'J#[zi Ϥ|+ۅ.;w33J'8gay#gqn~?6kxQ(t>m7M[Ɲ‡E/0~HtS kn:Px*2[NXR1S\V8{ͩY;o8xwvh nߗY\{L ^H bFKgYkit/mOG#YۼRA+qNހ@o|xWfҧ #84m jā l96q&ly; M(YXV<mXBRl!ұH#L8*`n\+k:srƖhf/GiŁG,7gI(Қ &% Z!Xv&Jck:=t:m몍 sqqi|1G(c֜K >v،s \X׾ Z3O7dE*X )dBUsp :=Z{kI-Y<LJRvk8U{1JޚzdjcdIj69aYOsӏEG)y`Z-o-/h--h]Sh+bi78LDa+՘"E/k`<0/]8uBOesZ2n? x^0G(ͰȘ&mGfĢ=zV7Mmj)Y ;)LΕ'kΒ ">5ᇏZoMsX@abB!%9Gq(AڡOYV?_ߡNҕfv.<6@7n;q'zEӚO +گzHK2ݱo`>6S޽;ERQk$l᥿GrZgE`|}; +> ݐ2K,gs{@i[K`HkЬz)0 \zcx.;}b>QBʰx#<Q+}aΡe ms }Bs 8Ηߘ3Y+Ʋ?Eg!!Ӎ{:{+Y7lMA[@G@+t9DVX#+f>%Xwcb#-[$O?t#~rp"sJxG R!5<1<Fr+ g[\8&%}]G=_ӂxkl)}-3L/+h~ߜ&Բ,Q Α]}0 l*we8eW{*[߉>^Ub׷::&[]pM"6wh #$:9qOVqJB液CHl/cֶ[\'q,"*F .A+"{:O ]7u3-i_(nuzPC`13F|K#0|jfk |6Cș:124H uقWI(8"Ө9[w=6Mͅy/yuSimme&uӣ8ҧpS42X,b50O^yz^hVX;3}ky~/7d=_\pmSdi΋d'źB27;VDFNjb=tk$gN .ΉrvP~qd !ZIJ\ (\h٢׍2$17;PcxhJoB|Q.uk/EC/}#D5sibQƻNɿP7V5C[ :W:VNY9n KXY:@v g]"+5$\'[Kjv63M~X.B b86dqw3o{nnkwcйBx?؂鈠$K ZzI|t]s99/kGNV't+! ٮa'#=D&k }RKMYTte)LYc%:vd쳉خ!ֳ rb'~4ِJ{ݹd#wIj?_W1;`8--tL~D~[CTc_ VߍՂkPOk"RZ8=KX|3DKnt2le&p1;)owάGp)/Km^o%]yH,@^!~l]Ba_wuqWƪJ|c,Jlv,fu@#)0cbb愅dbȌ'_W똆l}fbKŖ'njN_8(إݹX `goR}~3 ω %L̷> -Y qAJf kn` ;6AZ,LrK-X-2$ c سǣD(I$aXܟUe)}{ /j}̍{deݵnC`zVmIbq+| z#F\׫XWItsxE͍H1 <*77h,`h@]~l+D] uCٲ|uz@0}>KeGaS%kQ~l|oFV^7)Iw^U_k%s'٧sL#J8" 08^lZe('|,{? /Z` j8 JlwsHL;7ap'\g? >s16 AkX+_nz$o]Q`)jo9#HsyiA%l RH"*:9Ф,;T,` =̜PۊZa3e X;t6t\sū {(A؃9l扯2{:/] !3ӓ u3gVLyݰL vZF1"yOIhYNOvVMrGb! 4mlhUNUف[˭#u%Bٹ/_QɢlPzdnѮeqzK+Siկ&<8>췋/`a6G[>8Qi%-Z<|s2zv2c/m]0u%+ V80.;USHyT'=q|f8[iyr+c=:OUD7* zlr6FWX \an4:IS|0ef07 M[<\xb;WH{)hbmdȳw ͼqIj)j} 3?9v@UVHՕf*f" ALtsޕs;DsE:Ev'VZH/}%]gQ8vZYT8IҦӦ:U4Z"@zրD}%Nvk_^f6jo7hw3,OA!ฏXDWB:ԔKHAӰO|AWZf}mvtڥ'|Sgk%}>tԩfIdF(cwĨbXH}ފԄ&B) stTJ(֔@q6Ժ-L{y3K஽t:O$ yKW ELS>q/;/ҟP`߃0kv78ַik1]Bȋ麍<# "$6GO/c L^$ m=j-;^g=ߋAOEբB:orwDhb+gK |ΐ sдXBw p߻t`ݬ%&}M- *z2'%xk-8-iF^;"I REl#9&e8Nui:0$e/{2~S7;1}`Q'hM;WO8xxsn رN$DPm.\_)hTG&#*Em'-ݙ z-ڮwze;Tvڦ=0ةȋN!fc5"t+:74uXIu] .FTD A+@fBҚBNJ?抔&H TUSj,0DBtRw˥Ȥ-~f]2;va3 8J6 rln=<74;in29I^΂y,m6 ?`C KN:Z}߆V$5R-d׀DN8ҋ<#;`AM hݽ8ЦrxTw8g<(f4n`Z#XI|\L! HOU(mt\a . 0ȓҴ8I_w-k@̂ ˧ V~Sa=N{OZvݚjRc@)һnnLw߇1S_׾F­IUl]#fޔR=Uł YJATQ_Mat#l:llOw=NRl(-,1Bdg''яo}[2YcS3)z ՝(Veͱس#;|v ,{;23]~giw_w~wj/%ou^-pzwoswzЖ&¦bGsEl|AM< B7 Kg٪QQ-P6  ކyWToBhs e$#.Ws%$D\y?Q@)]%dVVݴ "l7 g7ЋQ]<Ԍz8F:X $2Ww`.ToTN/=@SYjٹQk׻,BUtBG#GL;c)k&0ƙf<"ʜA]JvAi V@(EV$;L`VB; ,OПުq=xg:hOjS'c5)ݯTD^MG_ wmL0HH ݮ FN"Tb", -/X϶ԧqsjiH0/?P(\ ~4$2$n/Ѐ&ɌƆG|t*6Ŗ>!@'u',+ޞb5}<ΐ @66D,^,ƓP`I'!c@,leS F6ΓtesTZ(,h~M(~ҜTP7'ƞ~m8SQPuU >4'4a+|O~:Ja l ]&xeLf|3*Xt'X/up~'rWH7!D̩uƁkԻ.@[#&tLatG8Ox XƝZ+d&r?ۺqNBvdv8\q|+pZ" HM9Da!W:l)"f wé؇'[DSi~-jz}cuB{ /mnh ۯFU0 4\&:yz2+G +>.S^ .KmNnDLU>NrxɆ~0vAjȀo*qeZ6]{Z=g`fOEDg P3qsH^ zXi~5:,/P'z0h̻jG>h|a C&/4tTl> ^wԿ^]8=D^'/v߇ւ ,ѷ" ?Vgo nvha|| @0ٰ[HwӷЇw.7")/4{!`_1SߢUâ[)\o~g_ا ڈY{CH[h?iOJYWsK}FWxBtTkqչ(<8]]ݑna%a7 .rOJ%0瞎o@/0 R/#s8Fu-  G]2_.'ktZLec\Ŕ(O4h`JgR~LZ|6@!%C Ц~gcV|'$U7vbBlcO IR`)g%-< 50@-r=.ï~+%N~\q"=_E+ sn;q0v "3r=]s/$c7k/pD¾9%LNt Bd8@|Ai ~LXw1R2j-0AHD?J[r& Yע(L]F11fSJWUKA^6Èr@.ָ z̑ a=0H1 7Ո;;j~D/B\4D8Tfu- K}'맡@ƾT<7q$H5pAu- K{ֻ'8>Nv~?Q NF]В>L5-4a3#毆%wxNK%#wCdi\xX=<wy@HAa~ }IB\~@SQr((pgX j(T\, , ـ. ,  NEU΢Q`ߝ j(T\, , fR6IENDB`!@@@ ,NormalCJ_HaJmH sH tH V@"V , Heading 2dd@&[$\$5CJ$\aJ$mH sH V@V , Heading 3$<@&5CJOJQJ\^JaJDA@D Default Paragraph FontRi@R  Table Normal4 l4a (k@(No ListHQ@H , Body Text 3$a$CJaJmH sH 4U@4 , Hyperlink >*phJ^@J , Normal (Web)dd[$\$mH sH .O!. , mw-headline.O1. , editsectionFV@AF ,FollowedHyperlink >*B* phRR@RR ,Body Text Indent 2dx^4 @b4 ,Footer  !.)@q. , Page NumberVOV },Default 7$8$H$!B*CJ_HaJmH phsH tH &O& X'Iti2CJaJ:O: Dfeatured_linkouts&O& DlinkbardOd D affiliation2xd x^xB*CJaJmH phsH LOL % Body Text++2x1$7$8$H$mH sH >O> %quick1dd[$\$mH sH <P@< % Body Text 2 dx4@4 Header !   @0 @0+56]yz{|}~$7TvCjmx*+@ g o %r/1%>!#"$ 's'(()*x+ ,-&/003677S9j;=>??@A_BCDGHIsJ K]LMMLNNLQQRTUdWX]YZ[Q\^ ``-cdehl nnop}qrtvwyzz{R|}~Nǂ̓ Uxyz;ȍ8 ӑ5ze,ęڜ ϭгR3hɺܺʼkNn:VDC /uw v2+~\8mPTOH6I}!#X%') +I+u,v,,1*2+2-2;2f2222223#3g3v33354644444444444444444444444444444555555555 5 5 5 5 5555555555555555555 5!5"5#5$5%5&5(5E5j556666X77;9N;K=@K@}AXCDzE5HJPL|MNPRiSTUVXXzYrZZj[\^_cvddceBfimnpqtuvvix{{#|n|`}}~TI˃΅F*ey̔zÕM]<͞ s 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000@0I00@0I00@0I00@0I00@01@0@0@0@0@0I0016]yz{+@g o %>!#"$ 's'(()*x+ ,-&/037S9??@A_BCDGHIsJ K]LMLNNLQQRTdWX]YZQ\^ ``-cdh nnoptvw{R|Nǂ̓ Ux;ȍ8 5zڜ ϭгRhʼkNC u v+~8mTOH +I+u,v,(5E5j567;9N;K=@zE5HJPL|MNPRiSTUVj[\_dceBfimnuvvixI˃΅F*̔zÕM @0@0@0@0@0@0@0@0@0@0@0K00%@0@0@0@0@0@0@0@0@ 0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0K00K00K00K00@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0K00@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0K00P@0@0@0@0@0@0@0@0@0@0@0@0@0K0,12K00K0.12@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0K0g1K00@0@0K00K00;K00%K00%@0K004?K003K00K0$0K00*K00)K00/K00*K00*K00(K0 0*K00&K00#K0 0"K0 0!K0 0!K00&@0K00$K00PK00%K00$K00"K00!K00!K00!?K00 K00@03@0K0 0!TK0 0K0 0K00K00K00 K00K00K00K00K00K0+0 K00K00K00K0(0K0$0%K00K0%0  @00%K00,F0 00$ $$$' f  F '05NC EtFIPdY\c_/hPmopubw z{~gL‰cϔmR8672Z9vOqkZ(("D  &Dn "#&6(^)s*+n,X-.w0[1!2Y3[455z6a7188T99:;;<5=?Tksrw{ï      !"#$%&()*+,-./013456789:;<=>?@ABCDEGHIJKLMNOPQRSTUVWXY[\_acdeghjlm  % 4_J`Qdkv}&:<=E=RqF  '2FZ]^`bfikn 3$434N6s667L8S8W888]]^ccdhhh iSi\isjjjvlmmXooppKpprrs`ss?t"ouwħ˧ XXXXXXXXXXXXXXXX  '!!8@0(  B S  ? OLE_LINK5 OLE_LINK6 OLE_LINK3 OLE_LINK4 OLE_LINK1 OLE_LINK2 OLE_LINK7 OLE_LINK8 _Hlt159477438 _Hlt159477355 _Hlt158167442 _Hlt158167787CCAANNhYijtp @ @ @ @``4444hYijtp E$wrE uEuuE uETuuE uEluE luEmuE DmuE muEcuE4duEtduEduE duE`uE`uEauETauEauE |\uE\uE \uE<]uE |]uETuE DTuETuE TuEUuE JuEKuE \KuE KuEKuE ?uE4@uE t@uE @uE@uE TEr?E 4r@ErAE\rBE rCEܩrDE rEE rFErGE,rHE lrIErJE|rKE rLErMEN>\>\>??CDDFIIaYaY \ \Q\Q\C`C`/a/abb^dddjkkknoooooppprwww*w2w"%>>~~mm tx["&& (111 2Y2Y2+3+3333{5{55577889+999B.E.EGIJJLcScSTkUX`ThmmmgqxJy{{{}?LL˜˜       !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIMJKLNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxzy{|}~44 " 4 N N & ss00llllJ,J,0<J>X>i>i>??CDDFIImYmY\\]\]\I`I`5a5abbadeejkkknoooop ppprw)w1w8w8w%($DDoo ((w{^"&& (1222e2e2034333355557788"98999B:E:EGIJJLgSgSTnUX`WhzmmjqxMy{{{}GQQלל    !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIKLMJNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxzy{|}~ _*urn:schemas-microsoft-com:office:smarttagscountry-regionhttp://www.5iantlavalamp.com/h*urn:schemas-microsoft-com:office:smarttagsCity0http://www.5iamas-microsoft-com:office:smarttagsV*urn:schemas-microsoft-com:office:smarttagsplacehttp://www.5iantlavalamp.com/k*urn:schemas-microsoft-com:office:smarttagsaddress0http://www.5iamas-microsoft-com:office:smarttagsV*urn:schemas-microsoft-com:office:smarttags PersonNamehttp://www.microsoft.comZ*urn:schemas-microsoft-com:office:smarttags PlaceTypehttp://www.5iantlavalamp.com/Z*urn:schemas-microsoft-com:office:smarttags PlaceNamehttp://www.5iantlavalamp.com/i*urn:schemas-microsoft-com:office:smarttagsStreet/http://www.5iantlavalampft-com:office:smarttagsi*urn:schemas-microsoft-com:office:smarttagsState0http://www.5iamas-microsoft-com:office:smarttags Z  {''@)D)\*d*f*t*[,i,r,},,,,,,,--..........,/1/G4W45!56788::I@O@GGzIIMMdOoOPQQQTT7YC>DDILNL|MMSSrZuZmn@tAtv vixxx5y6yynzz#|,|~~TYIR˃΃΅х!']a͞Ԟ  333333333333333333333333333333333333333333333333333333333333@Bgitw5"5  t:|Snb 0; 6 db2% ipPUlZHh$^`6CJOJQJ^JaJo(hH.h eke^e`ko(hH()h L^`LhH.h   ^ `hH.h   ^ `hH.h xLx^x`LhH.h HH^H`hH.h ^`hH.h L^`LhH.^`6OJPJQJ^Jo( ^`OJQJ^Jo(hHoSS^S`OJQJo(hH# # ^# `OJQJo(hH  ^ `OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hHcc^c`OJQJ^Jo(hHo33^3`OJQJo(hH^`OJPJQJ^Jo( ^`OJQJ^Jo(hHopp^p`OJQJo(hH@ @ ^@ `OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHoPP^P`OJQJo(hH^`CJOJQJo(^`CJOJQJo(opp^p`CJOJQJo(@ @ ^@ `CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(PP^P`CJOJQJo(^`o(. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.^`OJPJQJ^Jo( ^`OJQJ^Jo(hHopp^p`OJQJo(hH@ @ ^@ `OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHoPP^P`OJQJo(hH 0; t2% iPUl dS{B[       >t        x                 xo\[        Z5AO AO23A AOg C/Sg1 `3A AOG=3A /S%3A e3A L3A A3A H3A 3A F3A b3A d3A &OnTK/S%13A =3A HAOg 3A I 3A %3A \/(Lu)3A )p%.) -3A p%.@qJ/3A D/3A l-"13A $1p%.9R53A 963A I[)73A `7p%. <3A J=3A &a6>Lfl>3A .m>OnT4@AO A3A xC3A s^E3A |@H3A ~aH3A i&HAO!J/Sf[uL3A uL3A h_TMp%.AO% R3A OnT <U3A }E>V3A Y3A C6Z3A ekqZ3A g[d[3A \3A OL_3A ;_3A `Ifbp%.!Xd3A 6\f3A gg3A no3A yoltFo3A q3A ltg1 b8t3A {4v3A v3A 'v%SOx3A &}x3A x3A 1%zAO9`|3A P O /#HAZWa5i lpzSC,9k?L@tGTWJ[lAm*o*p%f'k< A-HS%l,D$46 W^mrZvq >#V79,=~RWcq0s* .5%7FHnI%Tbz}> 9! * ,D'lB E&(/SJ`r}.2M QWXoq u M   ( . : ZA [ Mf o  9 /    - o4 B9 H {Z o D   ' 7 ^ J_ c gh k  b R ' 6 &C T WZ _` f * 4 _ a "r ~ ',-12:4kCPY_dd2/i098E?I\W[]+^o}$63C8UEE^e)ltmnn~o<PKEOalms4g2;M?lE0PTUZ_ms_6M;=q{A#<E?BZ)_cm ( 6BGN0^jz8 nJ"]LRj k>lq$rt@'*}019<<{@LkMg:nszk#Y7c899DJPUXt5z 4x87I'A'UH'J'M'P'\'^''w'&~',(((u0(t(uu(v(z()d ) )O&)I))}-)gP))Y)@)*0****w***F*O*AQ*fa*a*/g**I +{+$+'+S+L+),n ,9,e,,s ,+,9,O,S,_,u,2--d----\-7.tD.M.T.].l.z.F~./g/ /&//&/(/:/>/A/IO/tV/1]M1HX1d1v12W'2H0232F2Z2a2"d2se2|22O3-3.3936C3d3Ln3z{3X,4/04T4bY4[4k4l4o4t4|4T%5/5dF57R5d^5m5 66[ 6 6%6'96S6>*>^.>=>YX>)s>_t>~>?? ??y&?(?1?e3?>???E?AI?I?^?c?z?]}?~??o@D@%@J3@09@D@o_@i@{@ AAAdAA.A2A?:A-SA~]AM{AyBB+B4BXBFC CCC'#C*Cu-CjCkC2tC~CD DD)Db1DV2DIDOODWD ]D`DdkDvD EEEEIEZElEpE'F:F>FIvFGGGiG`:Gy:G;RG6oGpG2vGHHj HuHHP)H+Hq;H?HOHMWHmHuHfIMIX'IT6I|?IXI]I^IcI9hIrI}I|~IJTJ?Jk J-J0JTVvT'|T~TUr U UU,U3;UTEUzUV%Vu,V_0V'KVWVaV@gV#rVsVqwVn}VoV/ WW'W(WAW[W3wWmXXX&X(XBX-YX eXgXiXiX~X YYYY`+YTGYLYVYkY.zYQZZ'ZCZEZXZ; [~[![#[-[0[2[4[;[?[vU[rn[mp[\\\ \\B\u!\Z/\#0\L\iO\V\Y\6[\ ]\^\_\w\-~\]^]% ]J$]*]]5]9]>]Z]Yr]=z][|] ^^^j'^w:^_B^D^!E^J^O^ U^r^0__w __<_O?_J_JL_U_Zg_v_x_`q`1`@`@`S`U```q`Y`aaza{"a)a2a]4a9a=La@MaMaYaS\akgayaab bH.bjSb_b_bzbcc c ccc*c.3cEcOcD^cYdcic^mcYncddd3d:Md OdzdVe*e,epAeWHe>[eDleqeye|efff4fADfOfDcffftfg!gp&gW(gp,gUgwghhhhhX9h=hThPWhbhlhnh#phb{hii9imBiVei}ijjjj!'jf:j!Jj\jdjdj&kjyjck$kE)kE-k/k'9kVk]kFikxmksk< ll!l)l2liBluFlHlfgl-jl mFmJm&m'3m9mppp6p`9pTpsp>vp&|pqqqH3q mqrqvq8rUrYrersr{vrsv)s Xs[s_sWesos t#tt^)t42t=9tHtWt`Xtat uBu.uuuuuu!uv+u9u=uNVu ju>quXqu2!v;3vEvTv[vavevrv5wv\yv}v w" w$w[7w9w:w?=we>wBwSKwKwmWw_wfw swxxXxc9xPxXxy#y=y>y7Gyfyxy'{yz/z<2z|?zvVz5Yz;jzXjz?{{{&{7{7{L{S{||'|10|0|"<|D|$J|P|-}} } },:}J]}d}d}9r}Zy}|}~.~W7~^8~K~O~Z~fd~p~j0@\w~)!TY* $@29u:[\cqg QUYn<}5,/@4# b!BUD.GoPsT8V-_jf}7@z2C7rFRUyYjmu) ?#$8JgQVX[\df&p)t0u )X*}5<=^?\*wxz 9>@BVKGWXz'MIU_azvv'x#~637lGdmA{\o'59uE?``nou$&/19:OOQ/Tfpr|D Qah x/2-9KT`C{F&!HXGa5g{:~ #68JN[^*bg$K2v6:.\nwa e&'0_;AO4Uaaj v_)6^9AGLX[;am{] 26;NXZfA~A"X)`6JA`~2 %18N "+NRZ^e}fk#s5vt2g3t:Z=EF JJ \ *3q>?MQg~nwq!A*255;]xWB;GB|*0e66:GO?UUJXdv}'  5<[Z'^hnoN5;>S eXs)"0SZlou+#OAQSZo| Z)1s29> A(DU\x_fs>#(^, 07eGwLjc?i/y\mLkV[z1> ''LOTWii{ <lCo}s $:'CXIffpw&(.79ALo^VpBTV-[iqx{<b ?LVZgui~~%x FGK^lP}6&>ELT Xak@\(9UFaHH7VXZ a3r}#%+ 9:w@ EOhjz FbGHRB[]qeeqsvv}~3E(KKat"8CJhR`|j~ |$|'x*12U^chvwJ1=-NUX_v78TZ)]vg{P8>)I NQY`Lwxzz/@6;?PPRE_0kolR - .R..66AJlnRwX Z 5JGNBocouf"$3:DEY__lt '1)1.45EzGLwLcQSQfx ,-HQcfitXh",$,;(ShW[bkq| 7!;<^'u+vy|| u !'+38h9@l{ "9GW_d ehgu *4&A&/3?3AMjnxy~7P7G9FX[aa -,6~9mX[$1A$VV&aotr0v|}[35]B|[[ikH%*4LVolp(#,?EKNsz #"l.<KTAgci3<")<E2P|QSfiqkwv.!VMK[fbsy }&:^b_aXd!_+t-7MWWdVfi#s}~D#C:VRrt %V,aK_ab} $iFPVi|2.w:;<acivKw,1D*kp9x4|X~\"3QW(Zcil0vc~ G:JhT:y5 R$d%57z9P?Yqw+{| .  ]!o3]9;<?JLK`"xeB*A"BNnTVbl u +2Lvx~5;;BBrC cGxf69?}y /%>=%5&5;9K=PTBf A?@P @UnknownAnthony Brink Anthony Brink Anthony Brink 20050911T11288735Z Anthony BrinkGz Times New Roman5Symbol3& z ArialK@Palatino LinotypeI& ??Arial Unicode MS?5 z Courier New;Wingdings"1h,f2Æ3^?l?l!SS4d  2qHX?,20IN THE INTERNATIONAL CRIMINAL COURT AT THE HAGUEAnthony Brink Anthony Brink $      Oh+'0  $0 P \ ht|4IN THE INTERNATIONAL CRIMINAL COURT AT THE HAGUEAnthony Brink NormalAnthony Brink 51Microsoft Office Word@! @t~@J9p?l՜.+,D՜.+,` hp  Dr Rath  1IN THE INTERNATIONAL CRIMINAL COURT AT THE HAGUE TitleH  8@ _PID_HLINKSA `8->http://www.stopsmilingonline.com/features_detail.html?id1=743 8*>http://www.stopsmilingonline.com/features_detail.html?id1=740 `.'>http://www.tig.org.za/pdf-files/azt-achmat_geffen_heywood.pdf &*$(http://www.tig.org.za/pdf-files/poc.pdf )!4http://www.tig.org.za/pdf-files/introducing_AZT.pdf XiAhttp://www.tig.org.za/pdf-files/azt-mbeki_tshabalala-msimang.pdf Hnhttp://www.tig.org.za/pdf-files/affidavit-aug06/BRINK AFFIDAVIT WITH ANNEXURES HYPERLINKED AND TYPO FIXES.pdf 61http://www.tig.org.za/pdf-files/debating_azt.pdf ;8http://www.tig.org.za/pdf-files/TIG_to_ASA_reminder.pdf  58http://www.tig.org.za/pdf-files/tig_response_to_asa.pdf *ehttp://www.tig.org.za/ Th 3http://www.tig.org.za/pdf-files/openletter_gsk.pdf ( 8http://www.tig.org.za/pdf-files/icc_achmatcomplaint.pdf LfBhttp://www.tig.org.za/pdf-files/icc_serviceconfirmationletter.pdf *ehttp://www.tig.org.za/ *ehttp://www.tig.org.za/   !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnoqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]_`abcdeghijklmvRoot Entry F#wpxData p1TableWordDocument>SummaryInformation(^DocumentSummaryInformation8fCompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89q